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Summary 
Mycoplasma pneumoniae has a cytoskeleton-like structure. Based on genetic evidence, it 
was proposed that the 1818 amino acids long protein HMW2 plays a central role in both 
formation of the cytoskeleton-like structure and adherence to its host cell (cytadherence). 
As gene products of the hmw2 gene (MPN310), two proteins were identified, the full-
length protein HMW2 with a molar mass of 216 kDa and a smaller one (HMW2-s) with 
only 25 kDa. HMW2-s was considered to be the processing product of HMW2, but it could 
be shown by determining the N-terminus of HMW2-s and by expression studies with an 
artifical hmw2-s gene in M. pneumoniae that HMW2-s was synthesized by a new internal 
start within the hmw2 gene but in the same raster as HMW2. This internal expression unit 
also ensures the transcription of the two genes, MPN311 and MPN312, located  
immediately downstream. 
To characterize HMW2, it was expressed in Escherichia coli under various condition and 
with alternative E. coli strains, but, it was poorly expressed and degraded rapidly 
independent of the applied conditions. Therefore, it was impossible to isolate enough 
soluble full-length protein to do biochemical and structural analyses. 
The proposed function of HMW2 requires its interaction with other proteins of 
M. pneumoniae. Pilot experiments with the two-hybrid system suggested several 
candidates. By applying the “pairwise tests”, an internal fragment of HMW2 was found to 
interact with the C-terminal fragment of HMW1 (MPN447)  and with the MPN297 
encoded 17-kDa protein. The latter one has not yet been implicated in cytoskeleton 
formation. In addition, the interaction between the main adhesin P1 with HMW1 and the 
gene product of MPN297 was established linking indirectly HMW2 to the P1 adhesion 
complex consisting of at least three proteins: P1, P40 and P90. 
Further evidence for the interaction between HMW2 and the P1 adhesin (complex) derived 
from comparative protein analyses of M. pneumoniae WT and the mutant M. pneumoniae 
A3 (hmw2?). Western blot analyses showed that in M. pneumoniae A3 the turnover rate of 
the proteins of the P1 complex was significantly higher. This was interpreted as a 
consequence of the missing binding partner, because without HMW2, the P1 complex can 
not be formed and inserted properly in the membrane, making those proteins useless for 
the bacterium. 
First attempts to isolate protein complexes containing HMW2, to which a TAP tag was 
fused, were succesful. Twelve genes/ proteins were identified from the purified complexes: 
MPN015, MPN140 (ORF4 gene product), MPN141 (P1), MPN142 (P90), MPN160, 
MPN297, MPN392 (PdhB), MPN426 (P115), MPN430 (GAPDH), MPN447 (HMW1), 
MPN573 (GroEL), MPN665 (EF-Tu). These results confirm the two-hybrid analyses of 
proteins interacting with HMW2. Eight of them (P1, P90, PdhB, GAPDH, HMW1, GroEL, 
EF-tu and the gene product of MPN297) were also found in the Triton X-100 insoluble 
fraction, which contains almost all of the known cytoskeletal proteins including HMW2. 
Furthermore, the interaction of HMW2 with EF-Tu (elongation factor Tu) and PdhB 
(pyruvate dehydrogenase E1-beta subunit), of which a subfraction was reported to be 
surface exposed, provide evidence, that HMW2 might also have an important function in 
organizing other proteins than cytoskeletal proteins. 
Finally, a new antiserum against the N-terminal part of HMW2 was generated, which 
improved the immunocytochemistry and allowed to co-localize HMW2 with the rod 
structure (co-operation with Dr. Hegermann), which is one  of  the  predominant  structures 
seen in thin sections of M. pneumoniae.
Zusammenfassung 
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Zusammenfassung 
Mycoplasma pneumoniae besitzt eine Cytoskelett-ähnliche Struktur. Auf der Grundlage 
der Ergebnisse genetischer Experimente wurde vorgeschlagen, daß das 1818 Aminosäuren 
große Protein HMW2 eine zentrale Rolle bei der Organisation Cytoskelett-ähnlicher 
Strukturen und bei der Anheftung an die Wirtszelle (Cytadhärenz) spielen würde. Als 
Genprodukte des Gens hmw2 (MPN310) wurden zwei Proteine identifiziert, das 
vollständige HMW2 Protein mit einer molaren Masse von 216 kDa und ein kleineres 
Protein mit einer molaren Masse von nur 25 kDa (HMW2-s). Letzteres wurde bisher als 
Prozessierungsprodukt von HMW2 angesehen, aber in der vorliegende Arbeit konnte 
durch Bestimmung des N-terminus von HMW2-s und Expressionsstudien mit einem 
künstlichen Gen hmw2-s gezeigt werden, daß HMW2-s von einem  internen Start-Codon 
von hmw2 neu synthetisiert wird. Zum Zweck der weiteren Charakterizierung wurde 
HMW2 in Escherichia coli unter verschiedene Bedingungen und mit alternativen Stämmen 
exprimiert. Es war aber nicht möglich, ausreichend lösliches, vollständiges HMW2 zu 
synthetisieren, um biochemische und strukturelle Analysen durchzuführen, da HMW2 in 
E. coli nur schwach exprimiert und zudem schnell abgebaut worden ist. Die 
vorgeschlagene Funktion von HMW2 erfordert dessen Wechselwirkung mit anderen 
Proteinen von M. pneumoniae. In Pilotexperimenten mit dem “Two-hybrid system” 
wurden mehrere Kandidaten gefunden. Durch Anwendung des “Pairwise tests” konnte 
gezeigt werden, daß ein internes Proteinfragment von HMW2 sowohl mit dem C-
terminalen Proteinfragment von HMW1 (MPN447) als auch einem Protein von 17 kDa, 
dem Genprodukt von MPN297, in Wechselwirkung steht. Letzteres war bisher noch nicht 
mit der Ausbildung des Cytoskeletts in Verbindung gebracht worden. Außerdem wurde die 
Wechselwirkung zwischen dem P1 Adhäsionskomplex, bestehend aus den Proteinen P1, 
P40 und P90, und HMW1 und dem Genprodukt von MPN297 nachgewiesen und damit 
indirekt eine Wechselbeziehung zwischen HMW2 und P1 hergestellt.  
Zusätzliche Hinweise auf eine Wechselwirkung von HMW2 und dem P1 Komplex kamen 
von vergleichenden Proteomanalysen zwischen M. pneumoniae WT und der hmw2? 
Mutante M. pneumoniae A3, die zeigten, daß die Abbaurate der Proteine des P1 
Komplexes in der Mutante deutlich höher waren. Das wurde damit erklärt, daß in 
Abwesenheit des Bindungspartners HMW2 der P1 Komplex nicht gebildet und daher auch 
nicht in die Membran integriert werden kann und dessen Komponenten aus diesem Grund, 
als nutzlos angesehen, schneller abgebaut werden. Erste Versuche, Proteinkomplexe zu 
isolieren, die HMW2 enthielten, welches durch ein Peptid (TAP-tag) modifiziert waren, 
verliefen erfolgreich. In angereicherten Komplexen konnten zwölf verschiedenen Proteine 
identifiziert werden: MPN015, MPN140 (ORF4 gene product), MPN141 (P1), MPN142 
(P90), MPN160, MPN297, MPN392 (PdhB), MPN426 (P115), MPN430 (GAPDH), 
MPN447 (HMW1), MPN573 (GroEL), MPN665 (EF-Tu). Damit wurden die Ergebnisse 
der „Two-hybrid“ Analyse bestätigt. Acht der zwölf Proteinen (P1, P90, PdhB, GAPDH, 
HMW1, GroEL, EF-Tu und das Genprodukt von MPN297) wurden außerdem in der Triton 
X-100 unlöslichen Fraction von M. pneumoniae gefunden. In dieser Fraktion sind alle 
bisher bekannten Cytoskelett-Proteine, einschließlich HMW2, angereichert.  
Die Wechselwirkung zwischen HMW2 und EF-Tu (Elongationsfaktor Tu) und PdhB (E1-
beta Untereinheit der Pyruvatdehydrogenase), die nach Berichten teilweise Oberflächen-
exponiert sind, zeigt, daß HMW2 auch bei der Organization solcher Proteine eine Rolle 
spielen könnte, die nicht an der Bildung des Cytoskeletts beteiligt sind. Schließlich wurde 
noch ein Antiserum gegen die N-terminale Region von HMW2 synthetisiert. Damit konnte 
eine verbesserte Immunogold-Elektronenmikroskopie durchgeführt werden, welche es 
erlaubte, HMW2 mit der „rod“ Struktur, einer besonders markanten, in Ultradünnschnitten 
sichtbaren Struktur, zu co-lokalisieren (Zusammenarbeit mit Dr. Hegermann). 
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Abbreviations 
 
1-D   one dimensional 
2-D   two dimensional 
aa   amino acid(s) 
A, Ade   adenine 
AP   alkaline phosphatase 
approx.  approximately 
APS   ammonium persulfate 
ATP   adenosin triphosphate 
?   anti (for antiserum) 
BCIP   5-brom-4-chlor-3-indolylphosphate 
bp   base pair 
BSA   bovine serum albumin 
°C   degree Celsius 
C   cytosine 
Ci   Curie 
cpm   counts per minute 
DIG   digoxigenin-11-dUTP 
Da   Dalton 
DNA   deoxyribonucleic acid 
DNA-AD  DNA-activation domain 
DNA-BD  DNA-binding domain 
dNTP   deoxyribonucleic triphosphate 
EDTA   ethylendiamintetra acedic acid 
e.g.   for instance (exempli gratia) 
et al.   and others 
EtOH   ethanol 
FCS   fetal calf serum 
Fig.   figure 
FHS   fetal horse serum 
g   gravitational constant 
G   guanosine 
h, hr   hour(s) 
HEPES  N-2-hydroxyethylpiperazin-N ethane sulfonic acid 
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HPLC   high performance liquid chromatography 
i.e.   that is (id est) 
IPG   immobilized pH gradient 
IPTG   isopropyl-beta-D-thiogalactopyranoside 
k   kilo 
kbp   kilo base pair 
kDa   kilo Dalton 
L   liter(s) 
LiAc   lithium acetate 
LiCl   lithium chloride 
?   micro 
m   milli 
M   molar 
mA   milliampere 
MALDI-TOF   matrix-assisted laser desorption ionization–time-of-flight 
MCS   multiple cloning site 
MgSO4   sodium sulfate 
min   minute(s) 
ml   milliliter(s) 
MPN   prefix for ORF numbering used by Dandekar et al., 2000 
mr   Molar mass 
mRNA   messenger RNA 
MS   mass spectrometry 
MW   molecular weight 
m/z   mass-to-charge ratio 
n   nano (10-9) 
nm   nanometer 
NaCl   sodium chloride 
NaOH   sodium hydroxide 
NaSO4   sodium sulfate 
NBT   nitro-blue tetrazolium chloride 
NH4Ac  ammonium acetate 
NP-40   nonidet-P40 
nr   number 
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OD   optical density 
ORF   open reading frame 
p...   plasmid 
p.A.   per analysis 
PAA   polyacrylamide 
PAGE   polyacrylamide gel electrophoresis 
PCR   polymerase chain reaction 
PEG   polyethylene glycol 
pI   isoelectric point 
PPLO   pleuopneumoniae-like organism 
PVDF   polyvinylidene fluoride 
ref   "literature" reference 
RNA   ribonucleic acid 
mRNA   messenger RNA 
rpm   rounds per minute 
RT   room temperature 
sec   second 
SolA / B / C  solution A / B / C 
SDS   sodium dodecyl sulfate 
TEMED  N,N,N',N'-tetramethylethylenediamide 
tRNA   transfer RNA 
U   unit of enzyme activity 
UV   ultraviolet 
V   volt(s) 
vol   volume(s) 
v/v   volume/ volume  
vs.   versus 
W   Watt(s) 
WT   wild type 
w/v   weight/volume 
YT   yeast-trypton medium 
?   Ohm
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1 Introduction 
1.1 Mycoplasma pneumoniae : general information  
The first Mycoplasma to be isolated in culture was the bovine pleuropneumonia agent now 
known as Mycoplasma mycoides, which was described initially by Nocard and Roux in 1896 
[Nocard and Roux, 1990]. 
The organism now known as Mycoplasma pneumoniae was first isolated in 1944 by Eaton and 
coworkers from the tissue culture of the sputum of a patient with primary atypical 
pneumonia. Thereafter it became known as the Eaton agent [Eaton et.al, 1944], later as PPLO 
(pleuropneumonia like organisms). Chanock and coworkers succeeded in culturing the Eaton 
agent in a cell-free medium [Chanock et al., 1962] and proposed the taxonomic designation 
Mycoplasma pneumoniae in 1963 [Chanock et al., 1962]. 
The species M. pneumoniae belongs to the genus Mycoplasma. Together with the eight 
following genera: Ureaplasma, Entomoplasma, Mesoplasma, Phytoplasma, Spiroplasma, 
Acholeplasma, Asteroplasma and Anaeroplasma, Mycoplasma belongs to the bacterial class 
named Mollicutes [Tully et.al, 1993]. About 200 known species have been detected in 
humans, vertebrate animals, arthropods, and plants. Several important differences between the 
Mollicutes and other eubacteria are summerized in Table 1.1. 
 
Table 1.1: Molecular properties distinguishing mollicutes from eubacteria (E. coli) 
Property Mollicutes Eubacteria 
Cell size 0,3 – 0,8 ?m > 1 ?m 
Cell wall absent present 
Requirement of cholesterol 
in the plasma membrane 
most species no 
Genome size 580 – 2220 kbp E. coli: 4639 kbp 
G/C content of the DNA 
(mol%) 
23 – 40 
M. pneumoniae: 40  
25 – 75  
Number of rRNA Operons 1 - 2 1 - 11 
Length of the 5S rRNA  104 - 113 nucleotides 114 nucleotides 
Number of genes for tRNA  
25 – 35 
M. pneumoniae: 35 
84 (B. subtilis), 86 (E. coli) 
Number of proteins 460 - 1500 E. coli: 4288 
UGA codon usage  
tryptophan encoded by 
Mycoplasma,Ureaplasma, 
Spiroplasma, Mesoplasma  
stop codon 
RNA-polymerase rifampicin resistent rifampicin sensitiv 
cilia and flagella absent present 
Introduction 
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Members of the class Mollicutes are characterized by their small genomes consisting of a single 
circular chromosome, the complete lack of a cell wall or cell-wall precursors and their 
commensal or parasitic life style [Razin et al., 1998]. 
Among the mycoplasmas, M. genitalium is so far the smallest and simplest self-replicating 
organisms with a minimal genome of only 580 kbp[Razin et al., 1998]. The drastic reduction 
of their genomes has significant consequences. The mollicutes lack many synthetic and 
metabolic pathways (with some exceptions in the genus Acholeplasma) such as the enzymes 
of the tricarboxylic acid (TCA) cycle, most enzyms for synthesis of fatty acids- and amino 
acid, etc. Therefore, many essential molecules have to be imported from the environment of 
the bacteria. As a consequence,  mollicutes appear in nature only as parasites of 
humans,mammals, reptiles, fish, arthropods, and plants [Razin, 1992]. Furthermore, some 
species are pathogenic to their host cells. They infect particularly animal and human 
respiratory- and urogenital tracts, others damage useful plants. 
Among the mollicutes, Mycoplasma pneumoniae is the only pathogen that fulfills Koch’s 
postulates. Although never found freely living, it can be grown in the laboratory without host 
cells in a rich medium containing 5-20% serum. M. pneumoniae is a prominent pathogen of 
humans and perhaps the most throughly characterized of the mollicutes [Tylor-Robinson, 
1996]. It is the leading cause of an atypical pneumonia in older children and young adults. 
Symptoms are flu-like but characteristically chronic in onset and recovery. Infection can be 
treated with antibiotics like erythromycin and tetracyclin. No immunity remains after infection 
for unknown reasons [Jacobs, 1991; Taylor-Robinson, 1996]. Also important is the 
observation that, after successful therapy, part of the bacteria still survive in the host, probably 
by invasion of the host cells. M. pneumoniae moves by gliding on surfaces [Bredt et al., 1979]. 
The damage of tissues of lung epithelial cells begins after colonization of M. pneumoniae 
[Razin and Jacobs, 1992]. It has been proposed that the intimate contact of the wallless 
mycoplasmas with the host cell membrane may result in local, perhaps transient fusion of the 
two membranes or exchange of membrane components and hence in direct “injection” of the 
mycoplasma cytoplasmic content, including hydrolytic enzymes, into the cytoplasm of the 
host cell. Thus, the potent nucleases of mollicutes combined with superoxide radicals may be 
responsible for clastogenic effects [Almagor et al., 1983; Razin et al., 1998]. So far, bacterial 
toxins have not been found to be a cause of M. pneumoniae pathogenicity. 
M. pneumoniae has a pleiomorphic shape with sometimes long filamentous extensions 
[Krause, 1996]. Electron micrographs of infected bronchial epithelia reveal that the 
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mycoplasmas firmly attach to the host cells (= cytadherence), often, although not exclusively, 
by a differentiated terminal structure (attachtment organelle) which was called a “tip” [Krause, 
1996]. The correct assembly of this organelle is a prerequisite for binding of M. pneumoniae 
to specificc receptors of the host cell [Krause, 1996; Razin and Jacobs, 1992]. 
This attachment organelle is a membrane-bound extention of the mycoplasma cell and is 
characterized by an electron-dense core orientated laterally within the tip [Boatman, 1979]. 
M. pneumoniae attaches to receptors common to a wide variety of cell types [Razin, 1985]. Two 
types of receptor moieties have been identified for M. pneumoniae binding: glycoprotein having 
sialic acid linked to the terminal galactose [Baseman et al., 1987; Roberts et al., 1989], and the 
galactose moiety of sulphatide glycolipides [Krivan et al., 1989].Therefore, M. pneumoniae is 
able to bind to erythrocytes. The molecular basis of the host-pathogen interaction is one of the 
most interesting scientific questions concerning infection by M. pneumoniae. 
Among the proteins known to be present in an intact attachment organelle are the proposed 
adhesin proteins P1 [Hu et al., 1977; Inamine et al., 1988; Krause, 1996; Su et al.,1987] and 
P30 [Dallo et al., 1990; Romero-Arroyo et al.,1999], and a number of other proteins including 
P40 and P90, cleavage products derived from the ORF6 gene (MPN142) of the P1 operon 
[Inamine et al., 1988; Layh-Schmitt and Harkenthal, 1999; Sperker et al., 1991], and HMW3 
[Ogle et al., 1991; Stevens and Krause, 1992]. The P1 protein was identified as the main 
adhesin. It mediates the binding of the bacteria to the host cell [Feldner et at.,1982; Hu et 
al.,1982]. It is densely clustered at the tip organelle but also appears to be scattered elswhere 
along the mycoplasma surface [Baseman et al., 1982]. P30, P40 and P90 are responsible for 
the the correct localization of the adhesin protein P1 in the terminal organelle. By cross-
linking experiment, these four proteins were linked to each other in the intact bacterial 
membrane, indicating that these proteins are located at a maximal distance of 12 Å in the tip 
structure of M. pneumoniae [Layh-Schmitt and Herrmann, 1994] (Fig. 1.3). 
The complete genome of M. pneumoniae was sequenced and annotated [Himmelreich et 
al.,1996]. It has 816,394 bp and contains 688 open reading frames, according to the latest re-
annotation [Dandekar et al., 2000]. About 65% of these hypothetical proteins are assigned to 
function based on significant similarities to functionally defined proteins from other organisms 
and therefor their functional features could be predicted and catagorized. 
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1.2 Cytoskeleton-like structures in prokaryotes and cytoskeletal elements in 
M. pneumoniae 
The cytoskeleton plays a crucial role in the organization of eukaryotic cells from yeast to 
human. The main components of the cytoskeleton are actin filaments, microtubules (MTs, 
polymers of tubulin) and intermediate filaments. In eukaryotes, microtubules are involved in 
various transport processes and in forming the mitotic spindle during chromosome 
segregation, actin forms a dynamic cytoskeleton involved in cell-shape regulation and 
mobility as well as the cytokinetic ring during cell division, and intermediate filaments 
provide mechanical support to the cell and nucleus. [Lewis, 2004] 
In contrast to the situation in eukaryotic cells, the occurrence of a well defined complex 
cytoskeleton or cytoskeletal elements in prokaryotes remained unknown for decades even after 
introduction of the electron microscopy [Mayer, 2003; Nanninga, 2001]. A first hint for the 
existence of a kind of true bacterial cytoskeleton was obtained in the early 1990s, when the 
FtsZ system and its functional role was discovered and further investigated [Lutkenhaus, 
1990]. The current knowledge of the bacterial cytoskeleton are summerized in this chapter. 
 
Cytoskeleton in prokaryotes 
Tubulin-like filaments: FtsZ 
FtsZ is the key player in bacterial cell division and forms a filamentous ring around midcell 
that constricts during division [Lutkenhaus, 1990]. In vitro experiments demonstrated the 
ability to polymerize in a GTP-dependent manner (like tubulin), into straight filaments, flat 
sheets or tiny rings [Lu et al. 2000; Lutkenhaus and Addinall, 1997]. Later, the structure of 
FtsZ and tubulin proved to be very similar [Lowe and Amos, 1998; Nogales et al., 1998]. 
 
Actin-like filaments: MreB, Mbl and ParB 
MreB has been known for a long time to affect cell shape [Wachi et.al, 1987]. Its known 
relationship to actin [Bork et.al, 1992] inspired an immunofluorescence study of MreB and 
Mbl (MreB-like) in Bacillus  subtilis showing that these proteins form dynamic, helical 
filaments on the inside of the cytosolic membrane [Jones et.al, 2001; van den Ent et al., 2001]. 
The MreB homologue in Escherichia coli (Mbl and ParB) was also found to assemble on the 
cytoplasmic face of the innered membrane [Carballido-Lopez and Errington, 2003]. Mutations 
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in these proteins cause bacteria to grow as abnormal spheroids or misshaped rods, indicating 
these proteins regulate cell shape [Abhayawardhane and Stewart, 1995; Jones et al., 2001]. 
Mbl is responsible for guiding the machinery for cylindrical growth, and Mbl filaments have 
been shown to be dynamic with no apparent polarity and with a half-life of 8 min [Carballido-
Lopez and Errington, 2003].  
The protein ParM forms highly dynamic actin-like filaments in the bacterium E. coli and uses 
a self-assembly mechanism for force production and transport [Mollor-Jensen et al., 2002]. 
The crystal structure of the ParM monomer has a clear homology to those of actin and MreB 
[van den Ent et al., 2002]. 
 
Other filament systems: EF-Tu,  fibril protein and cytoskeletal elements 
It has been speculated that the bacterial elongation factor (EF)-Tu has a dual role, acting as a 
“cytoskeletal web” as well as aiding in translation [Mayer and Gottschalk, 2003]. This is mostly 
based on the the fact that overexpression of EF-Tu mutants induces E. coli to lose shape and lyse 
[Mayer, 2003], its high intracellular concentration of up to 5–10% of the total fraction of soluble 
proteins, and its apparent association with the membrane [Lowe et al., 2004]. Many years ago 
this protein has been shown to be able to form filaments and bundles thereof in vitro under 
certain favorable conditions [Beck, 1979; Cremers et.al, 1981; Helms and Jameson, 1995]. 
Williamson [Williamson, 1974] reported the isolation of  cytoskeleton-like structure in 
Spiroplasma by cell lysis and detergent extraction. In Spiroplasma citri, the subunit of the 
cytoskeletal fibrils is 515 amino acids long (molecular weight of 59,000), as deduced by 
sequencing the cell’s fib gene [Williamson et.al., 1991]. 
It is interesting that the pathogenic bacterium M. pneumoniae, although plylogenetically 
closely related to B. subtilis does not encode an mreB or related gene [Jones et al., 2001], 
exhibit a very differentiated cytoskeleton that, according to electron microscopic observations, 
might funtion in shape preservation [Hegermann et al., 2002]. Most of the proteins forming 
this cytoskeleton-like structures are not defined. A selection of the most important currently 
known cytoskeletal proteins in prokaryotes are shown in Fig. 1.1. 
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Fig. 1.1: Currently known cytoskeletal proteins in prokaryotes: FtsZ [Lu et al., 2000]; MreB [van den Ent 
et al., 2001]; Mbl [Jones et al., 2001]; ParM [van den Ent et al., 2002]; EF-Tu [Mayer and Gottschalk, 
2003]; fibril protein [Tractenberg and Gilad, 2001] and cytoskeletal elements [Hegermann et al., 2002]. 
 
Cytoskeletal elements in Mycoplasma pneumoniae 
Over the past 20 years, evidence has accumulated that M. pneumoniae possesses a 
cytoskeleton-like structure, probably as a substitute for the missing cell wall [Biberfeld and 
Biberfeld, 1970; Gobel et al., 1981; Krause,1996; Meng and Pfister, 1980; Wilson and Collier, 
1976] . By analogy with eukaryotic cells, such a cytoskeleton could provide the necessary 
framework for maintaining and stabilizing the shape of M. pneumoniae, for motility [Radestock 
and Bredt, 1977] and for the formation of an asymmetric cell. Furthermore, a cytoskeleton 
might be involved in cell division, chromosome separation and cytadherence [Krause, 1996]. 
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The first experimental indication for a cytoskeleton-like structure in M. pneumoniae was 
provided in 1980 by Meng and Pfister, who detected by electron microscopy rod-like 
condensed structures localized in the attachment organelle and thin fibrous structures extending 
into the cell body. These observations were confirmed by other researchers [Gobel et al., 1981]. 
In these experiments, M. pneumoniae cells grown on cover slips were treated with 1%Triton X-
100, a non-ionic detergent which removes membranes and cytoplasm. The remaining proteins 
were stained with uranyl acetate for electron microscopy. In most pictures, a rod-like 
condensation, with a terminal button and a basal node was visible [Gobel et al., 1981; Meng 
and Pfister, 1980]. This structure is sometimes still surrounded by membrane fragments with 
some filamentous extensions attached [Gobel et al., 1981; Meng and Pfister, 1980]. These 
experiments and studies on the architecture and composition of eukaryotic cytoskeletons from 
many different cells [Herrmann and Wiche, 1983; Starger and Goldman, 1977; Steinert et al., 
1978] that have been treated with the detergent Triton X-100, suggested that a cytoskeleton-like 
structure could also be concentrated in a Triton X-100 insoluble fraction of M. pneumoniae. A 
typical Triton X-100 insoluble structure of M. pneumoniae is shown in Fig. 1.2. 
 
 
 
Fig. 1.2: Negatively stained sample of Triton X-100 resistant structure of M. pneumoniae. Repeating 
feature are indicated by arrows. Bar, 100 nm. [Regula et al., 2001]. 
 
Some proteins of the Triton X-100 insoluble fraction of M. pneumoniae were already 
identified: HMW1 (high molecular weight), HMW2, HMW3, P65 [Proft and Herrmann, 1994; 
Proft et al., 1995] and P200 [Proft and Herrmann, 1994; Proft et al., 1996]. These proteins 
were candidates for structural proteins based upon their predicted features. But none of these 
proteins, or any other of the predicted 688 ORFs [Dandekar et al., 2000], has a significant 
sequence similarity to a known cytoskeleton protein from other organisms except FtsZ. This is 
not surprising, as structural components may not be conserved at the sequence level even 
though the proteins have similar structural features. 
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Based on the complete sequence of the genome of M. pneumoniae [Himmelreich et al., 1996], 
the protein composition of the Triton X-100 insoluble fraction of M. pneumoniae was 
determined using two-dimensional (2-D) gel electrophoresis combined with mass 
spectrometry (MS) to characterize this fraction and to identify new candidates for structural 
components of the cytoskeleton-like structure [Regula et al., 2001]. 41 Proteins were 
identified as components of the Triton-X100 insoluble fraction. Most of the proteins known to 
be involved in cytadherence (HMW1, HMW2, HMW3, P65, P40, P90, P1, P200) were shown 
to be components of the Triton X-100 insoluble fraction. In addition, several other proteins 
were identified, which might be candidates based on their predicted structural features. 
The correlation between the correct organization of the attachment organelle and cytadherence 
was shown in several studies [Krause et al., 1997; Romero-Arroyo et al., 1999] by isolating 
spontaneous mutants with a cytadherence-negative phenotype that possessed the adhesins P1 
and P30 but had lost the high-molecular mass proteins HMW1, HMW2 and HMW3 [Krause et 
al., 1982; Layh-Schmitt et al., 1995]. Cytadherence positive revertants had regained the HMW 
proteins [Krause et al., 1997], reinforcing their correlation with cytadherence. This raised the 
hypothesis that in adherence-negative strains, the putative cytoskeleton-like structure is 
lacking, malfunctioning or absent [Krause, 1996]. 
 
The high molecular weight protein: HMW1, HMW2, HMW3 and structural related proteins 
The HMW proteins are elements of a cytoskeleton-like network in M. pneumoniae. Their 
functions are consistent with a possible scaffolding role [Krause, 1996]. 
HMW1 [Dirksen et al., 1996] and HMW3 [Ogle et al.,1991] are structurally similar,  with an 
internal domain that is dominated by repeating patterns rich in proline and acidic amino acids 
[Dirksen et al., 1996; Ogle et al., 1992]. They are members of a family of mycoplasma 
proteins that include P65 and P200, which also have such internal proline-rich motifs. HMW3, 
which is thought to play a critical role in stabilizing the attachment organelle [Willby and 
Krause, 2002], is found exclusively at the terminal structure of the attachment organelle 
[Stevens and Krause 1992]. HMW1 is found on the mycoplasma surface at the attachment 
organelle [Seto et al.,2001], as well as the trailing filament at the opposite pole [Stevens and 
Krause, 1991], and is essential for normal cell morphology [Hahn et al., 1998]. 
HMW2 is a large phosphoprotein (1818 residues, 216 kDa). Its structure is predicted to take 
the form of periodically broken coiled coils, and its presence is required for proper assembly 
of a functional attachment organelle [Dirksen et al., 1994; Krause et al., 1997; Fisseha et al., 
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1999]. Comparison with protein databases revealed 18–25% identities over much of the length 
of HMW2 with proteins characterized by their potential to form coiled-coil structures, 
including the tail region of myosin II heavy chain [Krause et al., 1997], suggesting that 
HMW2 is capable of forming higher order structures. 
HMW2 is required for cytadherence and stability of HMW1, HMW3 and P65. In mutants 
lacking HMW2, these proteins were synthesized at normal levels, but accelerated turnover 
results in reduced steady-state levels [Jordan et al, 2001; Popham et al., 1997], suggesting that 
HMW2 is required early in the process of attachment organelle assembly [Jordan et al., 2001; 
Krause and Balish, 2001; Popham et al., 1997]. 
The large number of proteins present at reduced levels in hmw2 mutants therefor suggests a 
key role for HMW2 in promoting the stabilization of those proteins, indicating an important 
role for HMW2 in promoting protein-protein interactions. 
Fluorescence microscopy showed that HMW2 is present at the attachment organelle [Balish et 
al., 2003]. However, a defined correlation between the structures identified in the attachment 
organelle and HMW2 has not been established by immunoelectron microscopy. 
 
 
 
Fig. 1.3: Diagrammatic view of a longitudinal section through a cell of M. pneumoniae. In the 
elongated part of the cell (“tip”), a flat blade (“rod”) is shown. It is indicated that this blade can be 
twisted or bent. The edges of the blade are connected to the cell periphery by “spokes”. The proximal 
end of the blade is in contact with a wheel-like complex that is connected to the cell periphery by 
fibrils. The distal end of the blade is attached to an undefined mass. Fibrils crossing the cytoplasm are 
also drown. Subcellular localization of adhesion complex (P1, P30, P40 and P90), HMW1 and HMW3 
are indicated [modified from Hegermann et al., 2002]. 
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1.3 Methods for detection and analysis of protein-protein interactions 
It is evident that protein-protein interactions are much more widespread than once suspected. 
Many fundamental cellular processes involve interactions among proteins and other 
biomolecules. To properly understand their significance in the cell, one needs to identify the 
different interactions, understand the extent to which they take place in the cell, and to 
determine the consequences of the interaction [Phizicky and Fields 1995]. 
Comprehensively identifying these interactions is an important step toward systematically 
defining protein functions [Eisenberg et al., 2000; Lan et al., 2003]. Function of an unknown 
protein can therefor be inferred from the identification of annotated interaction partners 
[Drewes and Bouwmeester, 2003]. A number of physical, biochemical, molecular biological 
and genetic approaches have been used to detect protein-protein interactions. An overview of 
such methods is presented in the following chapter. 
 
Physical/ chemical methods to select and detect proteins that bind another protein 
Protein Affinity Chromatography 
A protein can be covalently coupled to a matrix such as Sepharose under controlled conditions 
and used to select ligand proteins that bind and are retained from an extract of soluble protein 
[Cuatrecasas and Wilchek, 1968]. 
 
Affinity Blotting 
In a procedure analogous to the use of affinity columns, proteins can be fractionated by PAGE 
transferred to a nitrocellulose membrane, and identified by their ability to bind a protein, 
peptide, or other ligand. This method is similar to immunoblotting (Western blotting), which 
uses an antibody as the probe. Complex mixtures of proteins, such as total-cell lysates, can be 
analyzed without any purification [Schaltmann and Pongs, 1980]. 
 
Immunoprecipitation 
Coimmunoprecipitation is a classical method of detecting protein-protein interactions and has 
been used in literally thousands of experiments [Phizicky and Fields, 1995]. The basic 
experiment is simple. Cell lysates are generated, antibody is added, the antigen/ antibody 
complex precipitates and coprecipitated proteins are eluted and analyzed. 
 
Cross-Linking 
In cross-linking experiments, chemical cross-linkers are used to covalently link proteins which 
are in close association, e.g. enzyme complexes, ribosomes, etc [Phizicky and Fields, 1995]. 
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Typical chemical cross-linker reagents are N-hydroxysuccinimide (NHS) esters, imido esters, 
carbodiimides, maleimides, thiol-disulfide exchange reagents and aryl azides. A most 
usefulness feature of this method is that some of the covalent bounds are reversible. The 
stabilized protein complexes can be isolated and their subsunit compositions determined by 
several methods, mainly by mass spectrometry. 
 
Library-based methods  
Protein Probing 
A labeled protein can be used as a probe to screen an expression library to identify genes 
encoding proteins that interact with this probe [Phizicky and Fields, 1995]. Interactions occur 
on nitrocellulose filters between an immobilized protein (generally expressed in E. coli from a 
genomic DNA/cDNA library) and the labeled protein probe. The method is very general and 
therefor widely applicable. Proteins as diverse as transcription factors and growth factor 
receptors have been used succesfully as probes. 
 
Phage display 
It was first demonstrated in 1985 by Smith [Smith, 1985] that an E. coli filamentous phage can 
express a fusion protein bearing a foreign peptide on its surface. These foreign peptides were 
accessible to antibodies, such that the ‘fusion phage’ could be enriched over unmodified 
phages by immunoaffinity purification. In the past few years, there have been numerous 
developments in this technology to make it applicable to a variety of protein-protein 
interactions [Gupta et al., 2003]. 
 
Two-Hybrid System 
The two-hybrid system [Chien et al., 1991; Fields and Song, 1989; Fields and Sternglanz, 
1994] is a genetic method that uses transcriptional activation as a measure of protein-protein 
interaction. This method was chosen for studying protein-protein interactions in 
M. pneumoniae and will be described in more detail in the next chapter. 
 
Genetic methods 
Extragenic Suppressors 
Suppressor mutations are mutations that partially or fully revert the phenotype caused by an 
original mutation [Hartman, 1973]. A mutation of protein Y to Y* compensates for the defect 
X* to restore activity to the XY dimer. 
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Synthetic Lethal Effects 
Mutations in two genes can cause death (or another observable defect) while mutation in either 
one does not. This phenomenon is called a synthetic effect and can be caused by the physical 
interactions between two proteins required for the same essential function. For instance, the 
formation of the dimer XY is required for function and loss of this function results in a 
detectable phenotype [Dobzhansky, 1946]. 
 
Overproduction Phenotypes 
The overproduction of a wild type protein (X) can suppress phenotypes caused by mutations in 
genes encoding another protein (Y) [Rine, 1991]. In other cases, overproduction of a protein 
(X) can cause a phenotype that is altered by overproduction of an interacting protein (Y) 
[Meeks-Wagner and Hartwell, 1996]. The overproduction of the mutant protein is rather used 
to investigate interacting domains/ subunits within proteins which are functional as dimers or 
multimers. Overproduction of a nonfuntional version of a subunit [Herskowitz, 1987] can 
result in a mutant phenotype due to disruption of the activity of the wild type protein by 
competitive binding to wild type subunit to form an inactive dimer/multimer of the protein. An 
analysis of the sites of mutations is a standard methods to define the domains involved in the 
organization and function of a protein. 
 
Unlinked Noncomplementation 
Individuals, heterozygous for two different recessive mutations, sometimes display a mutant 
phenotype. This unlinked noncomplementation is often interpreted as being due to mutation in 
two genes that encode interacting products. 
 
Others experimental techniques 
Fluorescence resonance energy transfer (FRET) 
One of the few techniques that are capable of detecting molecular interactions with subcellular 
resolution relies on fluorescence resonance energy transfer (FRET) from one fluorophore (the 
donor) to another fluorophore or non-fluorescent dye (the acceptor) [Phizicky et al., 2003]. 
Energy is transferred through the resonant coupling of the dipole moments of donor and 
acceptor. The Observation of a significant transfer efficiency between donor and acceptor 
strongly suggests actual physical interaction [Zal and Gascoigne, 2004]. 
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Protein microrarrays (Protein Chips) 
Protein chips allow the detection of different kinds of binary interactions in vitro, such as 
protein-protein, protein-lipid or antibody-antigen interactions. Proteins are covalently attached 
to a solid support and screened with fluorescently labelled probes (e.g. proteins or lipids). 
 
Mass spectrometry analysis of purified protein complexes 
General approaches for protein-complex purification use targeted proteins fused to a standard 
affinity tag as bait or entry point, which are in turn captured by antibodies or affinity resins. 
The tandem affinity purification (TAP) procedure developed by Seraphin and colleagues 
[Rigaut et al., 1999; Puig et al., 2001] has been used to purify protein complexes under native 
conditions. This method was also chosen for studying protein-protein interactions in 
M. pneumoniae and will be described in more details in the next chapter. 
 
Databases for Biomolecular Interactions 
Many databases have been created to store the tremendous amount of data required for and 
contained in these networks; some of which are summarized in Table 1.2. Some databases are 
more comprehensive than others; for instance, MIPS contains not only protein-protein physical 
interaction data but also information on genetic interaction as well [Mewes et al., 2002]. 
 
Table 1.2: Summary of the databases for biomolecular interactions 
Name URL Type of networks Reference 
Database of Interacting Proteins 
(DIP) 
http://dip.doe-mbi.ucla.edu/ Physical Xenarios et 
al., 2002 
Biomolecular Interaction 
Network Database (BIND) 
http://www.bind.ca/ Physical Bader et al., 
2003 
Human Protein Reference 
Database (HPRD) 
http://www.hprd.org/ Physical Peri et al., 
2003 
Munich Information Center for 
Protein Sequences (MIPS) 
http://mips.gsf.de/ Physical & genetic Mewes et al., 
2002 
The Yeast Proteome Database 
(YPD) 
http://www.incyte.com/sequence/pr
oteome/index.shtml 
Physical, genetic & 
regulatory 
Csank et al., 
2002 
The Transcription Factor 
Database (TRANSFAC) 
http://transfac.gbf.de/TRANSFAC/ Regulatory Wingender  
et al., 2001 
Regulon Data Base 
(RegulonDB) 
http://www.cifn.unam.mx/Computa
tional_Genomics/regulondb/ 
Regulatory Salgado  
et al., 2001 
Kyoto Encyclopedia of Genes 
and Genomes (KEGG) 
http://www.kegg.com/ Metabolic Kanehisa and 
Goto, 2000 
Encyclopedia of Metabolic 
Pathways (MetaCyc) 
http://metacyc.org Metabolic Karp et al., 
2002 
Alliance for Cellular Signaling 
(AfCS) 
http://www.cellularsignaling.org/ Signaling Gilman 
et al., 2002 
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1.4 “The Yeast Two Hybrid System” 
In the few years since its introduction [Fields and Song, 1989; Chien et al., 1991], the two-
hybrid system has been widely used for identifying physically interacting proteins. 
The conceptual basis for the two-hybrid system was established in studies on the regulation of 
eukaryotic transcriptional factors [Allen et al., 1995]. Certain transcriptional factors, such as 
the yeast GAL4 proteins [Chien et al., 1991; Harper et al., 1993], were shown to consist of two 
distinct and separable domains: a site-specific DNA-binding domain (DNA-BD), and an acidic 
region that is required for transcriptional activation (activation domains; DNA-AD) [Hope and 
Struhl, 1986; Keegan et al., 1986] (Fig. 1.4). 
 
 
 
Fig. 1.4: Shematic illustration of the yeast Gal4 protein. The given number referred to corresponding 
amino acids. The protein contains 881 amino acids. The DNA-binding domain is 147 amino acids long 
and the DNA-activaing domain is 114 amino acids long. 
 
 
A GAL4-DNA-binding domain binds to a specific upstream-activator sequence (UAS) [UAS; 
Heslot and Gaillardin, 1992] of the DNA [Keegan et al., 1986]. A DNA- activation domain 
binds to a DNA-binding domain, thereby takes a contact with the transcriptional apparatus and 
activates the transcription of the gene downstream of the UAS [Hope and Struhl, 1986; 
Keegan et al., 1986; Ma and Ptaschne, 1987]. Both domains are necessary for the gene 
activation. In case of the native yeast GAL4 protein, both domains are part of the same 
protein. When they are physically separated by moleculargenetic technique and expressed 
together again in the same cell, they could not interact directly with each other and therefor 
could not activate transcription of a specific gene [Ma and Ptashne, 1988; Brent and Ptaschne, 
1985]. However, when both domains are physically brought together near a promotor region, 
where the DNA-binding domain can bind to a DNA-binding sequence, then transcription will 
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be activated. Based on the described features of the two domains, the two-hybrid technique 
was developed to provide a method for identifying proteins that physically interact in vivo 
(normally in yeast cells) [Frederickson, 1998].  
Typically, the two-hybrid system utilizes two plasmid-borne gene fusions that are co-
transformed into a host yeast strain containing inducible reporter genes. The protein of interest 
(X), or ‘bait’, is encoded as a gene fusion with a DNA binding domain (BD) of a well-
characterized transcription factor (e.g. GAL4). A second protein (Y) is encoded as a gene 
fusion with a transcription activation domain (AD). Interaction between the two proteins in the 
nucleus of a yeast host strain results in the binding of the transcription activation domain to the 
DNA of the host strain, activating transcription of the adjacent reporter genes and generating a 
phenotypic signal, such as the expression of nutritional markers (e.g. HIS3, ADE2), which 
provides a scorable phenotype. 
An important useful application of the two-hybrid system was extended to the isolation of 
unknown interacting partners of protein of interest from a genomic DNA gene bank. This has 
typically been done by screening a protein of interest against cells expressing a random 
plasmid library of genomic DNA and applying a genetic selection for monitoring interaction. 
Plasmid DNA is recovered from cells expressing interacting proteins and their identities are 
determined by DNA sequencing. This application makes the two-hybrid system to be the most 
widely used genetic assay to detect protein-protein interactions [Guo et al., 2004; Mendelsohn 
and Brent, 1994]. Fig. 1.5 illustrates the principle of the two-hybrid system. 
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Fig. 1.5: Schematic illustration of the two-hybrid-based protein-protein interactions in the yeast nucleus 
(strain PJ49-4; James et.al, 1996). Informations of the reporter genes are described on the next page. 
 
The two-hybrid host strain used in this work is PJ69-4A/?, constructed by James and 
coworkers  [James et.al., 1996]. The terms A and ? correspond the two different mating types 
of the haploid yeast cell. Yeast strains previously used in two-hybrid system employ only a 
single promoter (gal1 UAS or lexA operator) for all their reporter genes. The yeast strain 
PJ69-4A/? contains three different reporter genes, which utilize different inducible promoters: 
The GALI?, GAL2, and GAL7 promoter (Fig. 1.6). This was thought to eliminate many false 
positives and allow an extremely efficient two-hybrid selections. 
The first reporter gene is the gene HIS3*, which is essentiel for the biosynthesis of the amino 
acid histidine. This reporter gene allows only yeast cells carrying interacting proteins to grow on 
selective media lacking histidine. This reporter gene is under control of the GAL1 promotor. A 
                                                
? these nomenclatures are corresponding to the article James et al., 1996, by which the yeast strain PJ69-4 was 
described 
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GALl-HIS3 region was introduced downstream of the LYS2 gene. This construct exhibits more 
stringent regulation than other GALldriven HIS3 alleles, reducing or eliminating the need for the 
drug 3-aminotriazole [James et al., 1996], a competitive inhibitor of the HIS3 gene product 
which helps to reduce the activity of the HIS3 gene and eliminate weak positive signals. 
The ade2-101 allele of the yeast strain was replaced by a wild-type ADE2 gene under the 
control of the GAL2 promoter. ADE2 was chosen as a reporter because ade2 mutants form red 
colonies, while wild-type cells form white colonies. Intermediate expression of ADE2 results 
in colonies in various shades of pink; thus, the colony color can be used as an first indication 
of the strength of an interaction or of a hint for loss of the plasmids [James et al., 1996]. The 
GAL2-ADE2 reporter is especially useful, because it is very sensitive to weak interactions and 
eliminates nearly all false positives in the selection 
The third reporter gene is the lacZ gene, which encodes the enzyme beta-galactosidase. This 
enzyme initiates the conversion of the colorless indicator X-gal (5-bromo-4-chloro-3-indolyl-
beta-D-galactopyranosid) to a blue product. Yeast cells with an activated lacZ reporter gene 
can be easily identified in a medium containg X-gal by their color. A lacZ gene under the 
control of the GAL7 promoter was inserted into the coding region of the MET2 gene to provide 
a quantitative measure of interaction strength [James et al., 1996]. 
 
A. 
 
 
   LYS2         Gal1p HIS3 
B. 
 
 
       Gal2p  ADE2 
C. 
 
 
         met2  Gal7p   lacZ       met2 
 
Fig. 1.6: Genomic structure at the reporter gene loci in PJ69-4A/?. Gal4-induced promoters are 
indicated by     ; reporter genes by    ; and adjacent coding regions by    
(A) Structure of the LYSZ::GALI-HIS3 reporter locus.  
(B) Structure of the GAL2-ADE2 reporter locus. 
(C) Structure of the met2::GAL7-lacZ reporter locus. 
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1.5 “The Tandem Affinity Purification (TAP) Method”: A general 
procedure of protein complex purification 
The TAP method was developed by Séraphin’s group at the European Molecular Biology 
Laboratory (EMBL, Heidelberg) [Puig et.al, 2001]. They descirbed the fusion of the TAP 
(Tandem Affinity Purification) tag to the target protein and the introduction of the construct 
into the host cell or organism. The fusion protein as well as associated partners are recovered 
from total protein cell extracts by two specific affinity purification/elution steps. The material 
recovered will be analyzed in several ways. For protein complex characterization, proteins are 
concentrated, fractionated on a denaturing gel by SDS-PAGE, and the individual proteins were 
identified by mass spectrometry (Alternatively, Edman degradtion or Western blot may be 
used.) Because the various TAP purification steps are done in a gentle native manner, purified 
complexes may also be tested for their biological activities or used for structural analysis 
[Gavin et al., 2002]. 
The TAP tag consists of two IgG binding domains of Staphylococcus aureus protein A 
(ProtA) and a calmodulin binding peptide (CBP) separated by a TEV protease cleavage site. 
Originally, a C-terminal TAP tag was described, but an N-terminal TAP tag was also 
generated (Fig. 1.7), by which the relative order of the modules of the TAP tag are inversed in 
the two tags because the ProtA module needs to be located at the extreme N or C terminus of 
the fusion protein. 
 
 
 
Fig. 1.7: Structure of the TAP tag. The various domains constituting the TAP-tag are indicated. 
 A = the N-terminal construct, B = the C-terminal construct. 
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Both affinity tags have been selected for highly efficient recoveries of proteins present at low 
concentration. ProtA binds tightly on an IgG matrix, requiring the cleavage by the TEV 
protease to elute material under native conditions (Fig.1.8). The eluate of this first affinity 
purification step is then incubated with calmodulin-coated beads in the presence of calcium. 
After a washing step, which removes contaminants and the TEV protease remaining after the 
first affinity selection, the bound material is released under mild conditions with EGTA. 
Optimized conditions have been developed for the general use of the TAP strategy. 
 
 
Fig. 1.8: Flow chart of the TAP tag purification. 
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1.6 The outline for the experimental approach 
The aim of my thesis was to contribute to the understanding of the formation of cytoskeleton-
like structures in Mycoplasma  pneumoniae. In particular, the following experimental 
approaches were taken. 
 
1) Re-analyses of the gene products of the hmw2 gene (MPN310) with emphasis on a second 
small protein which is believed to be the processing product of the full-lemgth HMW2 protein. 
 
2) Expression of the HMW2 protein in Escherichia coli or in other hosts, to isolate sufficient 
material for doing structural and biochemical studies. 
 
3) Identification of direct or indirect binding partners of HMW2 applying the “two-hybrid” 
analysis and supportive methods. 
 
4) Localization of the HMW2 protein within M. pneumoniae by cytochemistry (in cooperation 
with Dr. Hegermann). Improving the hitherto unsuccessful attempts by generating a new HMW2 
specific antiserum and adding “new” structural features to HMW2 with a high binding specificity. 
 
.
Materials 
 
 26
2 Materials 
2.1 Bacteria strains  
Escherichia coli 
TOP10   (Invitrogen). Genotype: F– mcrA ?(mrr-hsdRMS-mcrBC) ?80lacZ?M15 
?lacX74 recA1 ara?139 ? (ara-leu)7697 galU galK rpsL (StrR) endA1 nupG 
 
TOP10F’ (Invitrogen). Genotype: F’{lacIq, Tn10(TetR)} mcrA (mrr-hsdRMS-mcrBC) 
80lacZM15 lacX74 recA1 araD139 (ara-leu)7697 galU galK rpsL (StrR) 
endA1 nupG 
 
XL1-Blue  (Stratagene). Genotype: recA1, endA1, gyrA96, thi-1, hsdR17, supE44,  
relA1, lac [F’, proAB, lacIq, DM15 Tn10 (Tetr)]; [Bullock et al., 1987] 
 
M15 [pRep4] (Qiagen). It is derived from E. coli K12 and habouring pREP4 plasmid 
carrying lacI gene encoding for lac-repressor. Phenotype NaIS, StrS, RifS, 
Thi–, Lac–, Ara+, Gal+, Mtl–, F–, RecA+, Uvr+, Lon+. 
 
TG1 (Maxim Biotech) Genotype: F’ traD36  lacIq ?(lacZ) M15 proA+B+ /supE 
?(hsdM-mcrB)5 (rk - mk - McrB-) thi ?(lac-proAB) 
 
JM109 (NEB) Genotype: F’ traD36 proA+B+ lacIq ?(lacZ)M15/ ?(lac-proAB) 
glnV44e14- gyrA96 recA1 relA1 endA1 thi hsdR17 
 
Mycoplasma pneumoniae 
M129-B18 (ATCC 29342) is considered as the wild type strain of Mycoplasma 
pneumoniae throughout this work. The genome of this strain was completely sequenced 
[Himmelreich et al., 1996]. All experiments, unless described differently, were done done 
with this strain of the 30th passage. M. pneumoniae M129 represents subtype I. 
 
M129 mutant A3  was a kind donation of D. Krause, University of Georgia, Goergia/USA. 
It was generated by transposon mutagenesis [Krause et al., 1997]. It is cytadherence-
negative and lacks HMW2. 
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2.2 Yeast strains 
Saccharomyces cerevisiae PJ69-4  was a kind donation of Dr. M. Kögl, RZPD, 
Heidelberg. Mating typA and ?, genotype: Trp1-901 
leu2-3,112 ura3-52 his3-200 gal4? gal80? 
LYS2::GAL1-HIS3GAL2-ADE2 met2::GAL7-lacZ;. 
[James et al.,1996]. 
 
2.3 Culture media 
2.3.1 Supplementary ingredients and culture media 
Bacto Agar, Difco Laboratories, Augsburg 
Bacto Peptone, Bio101 Inc., USA 
Complete Supplement Mixture minus variable aminoacids (CSM), Bio101 Inc., USA 
DifcoTM PPLO Broth (Beckton, Dickinson and Company; MD, USA) 
Drop Out Base for Synthetic Defrod (DOB), Bio101 Inc., USA 
Yeast extract, Difco Laboratories, Augsburg 
 
2.3.2 Antibiotics 
Ampicillin  (Serva; Heidelberg, Germany) 
Carbenicillin  (Sigma-Aldrich; Freiburg, Germany) 
Chloramphenicol (Serva; Heidelberg, Germany) 
Gentamicin  (Serva; Heidelberg, Germany) 
Kanamycin  (Serva; Heidelberg, Germany) 
Penicillin  (Serva; Heidelberg, Germany) 
Streptomycin (Serva; Heidelberg, Germany)  
Tetracyclin (Serva; Heidelberg, Germany) 
 
2.3.3 Culture medium for Escherichia coli 
• LB medium (Luria broth) 
   1 % (w/v) tryptone 
0.5 % (w/v) yeast extract 
   1 % (w/v) NaCl 
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• Standard I medium 
2.5 % (w/v) Standard I Medium 
 
• YT medium 
  0.8 % (w/v) tryptone 
  0.5 % (w/v) yeast extract 
0.25 % (w/v) NaCl 
adjust to pH 7.0, add 40 % sterile glucose to a final concentration of 1 % 
 
2.3.4 Agar plates for E. coli 
400 ml Standard I broth  (25 g/ L ) were supplemented with 6 g Bacto Agar. The 
suspension was autoclaved. 
Agar plates contained antibiotics at the following concentrations 
Antibiotic  concentration  stock solution 
Ampicillin  100 µg/ ml  100 mg/ ml in H2O 
Carbenicillin  100 µg/ ml    50 mg/ ml in H2O in 70 % ethanol  
Chloramphenicol   25 µg/ ml    25 mg/ ml in 70 % ethanol  
Kanamycin    25 µg/ ml    25 mg/ ml in H2O 
Streptomycin    10 µg/ ml   10 mg/ ml in H2O 
Tetracyclin    10 µg/ ml   10 mg/ ml in 70% ethanol 
 
2.3.5 Culture medium for M. pneumoniae 
M. pneumoniae M129 was grown at 37°C in cell culture flasks (500 cm2) containing 100 
ml of modified Hayflick medium [Hayflick, 1965] supplemented with 20% horse serum. 
The full medium is composed of two components: component A and component B. 
 
Component A 
       7,3 g    PPLO  broth w/o CV 
          2 ml  phenol red (5 g/ L) 
                 11,9 g    HEPES  
set pH with 10 M   NaOH ( ~ 2,5 ml) to pH 7.6  
            ad. 400 ml  ddH2O 
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Component B 
100 ml  fetal horse serum (inactivated) 
  10 ml  glucose (500 g/ L), autoclaved 
    5 ml  penicillin G (100.000 U / ml), steril filtered 
Component A was autoclaved and stored at room temperature.  Component B was stored at 
-20°C.  The full medium can be stored at 4°C 
 
Phenol red solution 
One gramme phenol red was crushed in a mortar while 30 ml 0.1 M NaOH is slowly 
added.  The solution was then filled up to 200 ml with H2O and stored over night at 4°C. 
The next day, the solution was filtered, the pH is adjusted to pH 7.5 and autoclaved. The 
solution could be stored for several months at 4 °C. 
 
2.3.6 Agar plates for M. pneumoniae 
400 ml component A were supplemented with 5 g Agar Bacteriological.  The suspension 
was autoclaved.  After cooling to 56 °C, 115 ml component B was added.  Ten to twelve 
milliliters agar were plated in Ø 9 cm Petri dishes.  Gentamicin agar plates contained 80 
?g/ ml gentamicin. 
 
2.3.7 Culture medium and agar plates for Saccharomyces cerevisiae  
Saccharomyces cerevisiae is normally grown in YPDA-Medium. 
 
• YPDA (Yeast-Peptone-Dextose-Adenin) 
   21 g           Bacto Peptone 
10.5 g           yeast extract 
     2% (w/v) Glucose 
     2 ml         adenine (10 mg/ml) 
 
• SD –LU (Synthetic Defined Dropout Medium, leucine-uracil free) 
    13.5 g   DOB 
    0.37 g   CSM-Leu,-Ura 
         2 ml adenine (10 mg/ml) 
ad 500 ml deionized H2O  
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• SD –LUH (Synthetic Defined Dropout Medium, leucine-uracil-histidine free) 
    13.5 g   DOB 
    0.33 g   CSM-Leu,-Ura,-His 
         2 ml adenine (10 mg/ml) 
ad 500 ml deionized H2O 
 
• SD –LUHA (Synthetic Defined Dropout Medium, leucine-uracil-histidine-adenine free) 
    13.5 g   DOB 
  0.285 g   CSM-Leu,-Ura, -His,-Ade 
ad 500 ml deionized H2O 
 
Solutions could be stored for several months at 4 °C after autoclave. 
For agar plates, 400 ml Medium was supplemented with 8 g Bacto Agar and autoclaved. 
 
2.4 Nucleic acids 
2.4.1 Cosmids 
All Cosmids used for the polymerase chain reaction were from the the cosmid bank of the 
genome of Mycoplasma pneumoniae [Wenzel and Herrmann, 1989; Himmelreich et al., 
1996]. 
 
2.4.2 Plasmids 
• pBC sk+: for blue/white screening, Stratagene, Heidelberg 
• pBS1761: TAP tagged containing plasmid [Puig et al., 1998], Dr. Jansen, ZMBH, Heidelberg  
• pCT461: cloning vector for gene expression in M. pneumoniae [Pirkl et al., unpublished]. 
• pGAD424: for expression of GAL4-AD fusion proteins, Dr. Koegl, RZPD, Heidelberg. 
• pGBDU-C3: for expression of GAL4-BD fusion proteins [James et al., 1996], Dr. 
Jansen, ZMBH, Heidelberg. 
• pKV74, pKV104: for gene expression in M. pneumoniae [Hahn et al., 1996, 1999], 
Prof. Krause, University of Goergia, USA  
• pMT-Red: cloning vector for gene expression in M. pneumoniae [Zimmermann, 2005]. 
• pQE9, pQE60 for expression of His-tagged proteins in E. coli (Qiagen, Hilden) 
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2.4.3 Oligonucleotides 
Primers used for cloning were synthesized by metabion (http://www.metabion.com); they 
were HPLC purified. Primers used for sequencing were synthesized either by 
Thermohybaid (http://www.interactiva.de) or by the lab of Dr. Frank in the ZMBH; 
Thermohybaid oligonucleotiedes were HPLC purified. 
 
Oligonucleotides for sequencing:  
 
Nr. Name Sequence 
7135 5’ A2 AAC GCG TTT GGA ATC ACT ACA GGG ATG TTT 
7136 3’ A2 TGC ACA GTT GAA GTG AAC TTG CGG GGT TTT 
7171 5’ U GTG CGA CAT CAT CAT CGG AAG AGA G 
7172 3’ U CGC CCG GAA TTA GCT TGG CTG CAG G 
7221 9050 GAT AAA GTC CGT ATA AT 
7297 pQE60_vor_Ecoforw CAT AAA AAA TTT ATT TGC 
 oPQE60/forw/Eco GAA ATC ATA AAA AAT TTA TTT GC 
8008 pQE60_rev CTA GCT TGG ATT CTC ACC 
7403 hmw2_Forw2  GCA GCT CAA CGA ACA G 
7404 hmw2_Forw3 GGA AAA AGA ACG TTT G 
7405 hmw2_Forw4 GCC GCG AAT TGG AGA AG 
7406 hmw2_Forw5 GAA AAG CAA AAG GAA ATG 
7407 hmw2_Forw6 GCA GAG CTA GAT AAG 
7408 hmw2_Forw7 GAA TTG AGG CAA AAT G 
7409 hmw2_Forw8 GTT GCA ACG CGA AGC 
7410 hmw2_Forw9 GAA ACC AAA AAG AAA C 
7411 hmw2_Forw10 GCA ATC TAT CAT TTC 
7412 hmw2_Forw11 GAA TTA ACT GAG TTG C 
8050 S.aureaus Tn4001 
Transposase 
GAT AAA GTC CGT ATA ATT GTG T 
 
Standard sequencing primers T3 and T7 were provided from the firm GATC (Konstanz) 
for sequencing inserts in the vector pBC sk+. 
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Oligonucleotides for cloning:  
 
Nr. Name Sequence (bold = restriction site) 
5137 HMW2_Start ATG AAT GAT ACT GAC AAG AAG 
5143 HMW2_Start_2AS AAT GAT ACT GAC AAG AAG TTC 
6504 HMW2/BamHI_3’ CGG GAT CCT TTA GCT GCT TTT TGG GCA ATT AG 
7174 HMH2_BamHI_start CGG GAT CCA TGA ATG ATA CTG ACA AGA AG 
7175 ClpB_BamHI_forw CGG GAT CCC GGA AAT TAT GCC TCA AAC A 
7176 ClpB_BamHI_forw_neu GCG CGG ATC CGC GAA ATT ATG CCT CAA ACA C 
7291 hmw2_start_ATG ATG AAT GAT ACT GAC AAG AAG TTC CCC TTG 
7292 HMW2_Start_ATG_24nt ATG AAT GAT ACT GAC AAG AAG TTC 
7293 6 ? his_BamHI_3 CGG GAT CCG TGA TGG TGA TGG TGA TG 
7294 clpB_EcoRI_Forw GGA ATT CCG AAA TTA TGC CTC AAA CAC AGC 
7491 hmw2_FW_25kDa TTA TTT CCA CCG TTA TTT AAA ATT AAC 
7492 hmw2_FW_25kDa+32AS GCG GTA GAA CAG CAA TAC CAA G 
7493 hmw2_FW_25kDa-10AS CCT TAC CCA TAT CCT TGA TTT TAT C 
7519 hmw2_CTerm_2.AS_FW AAC TAT CCT TAC CCA TAT CCT TGA TTT TAT CC 
7520 hmw2_RV_9His_stop CTA GTG GTG GTG GTG ATG GTG ATG GTG ATG AGA TCT TTT AG 
7541 1his_stop_Bam_RV CGC GGA TCC GCG CTA GTG G 
7567 hmw2C_300FW_Bam CGC GGA TCC AAC AAA CAA CGC GAA GAG 
7568 hmw2_ohne_TAA_RV TTT AGC TGC TTT TTG GGC AAT 
 o9his_hmw2/5’ ATG CAC CAC CAC CAT CAT CAT CAC CAC CAC AAT GAT 
ACT GAC AAG AAG TTC 
 ohmw2/rev/3?his_573AS TGG TGA TGA TCC TCT GCA ATC TTT TGT G 
 ohmw2/rev/ganz_9his_Bam GCG GGA TCC TTA GTG GTG GTG GTG ATG GTG ATG 
GTG ATG TTT AGC TGC TTT TTG 
 ohmw2/rev/ganz_Bgl_ 
9his_Bam 
GCG CGG ATC CGC GCT AGT GGT GGT GGT GAT GGT 
GAT GGT GAT GAG ATC TTT TAG C 
 ProtA_5’ ATG GCA GGC CTT GCG CAA C 
 CBP_EK_3’ CTT ATC GTC ATC ATC AAG TGC CCC G 
 ohmw2/stop/Bam3’ CGC GGA TCC GCG TTA TTT AGC TGC TTT TTG GG 
 ohmw2/Cterm/2.AS AAC TAT CCT TAC CCA TAT C 
 ohmw2/for/Bam_2ndAA GCG CGG ATC CAA TGA TAC TGA CAA GAA G 
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Oligonucleotides for cloning in the Two-hybrid system:  
 
Nr. Name Sequence (bold = restriction site) 
7578 H10_orf119/FW/Eco/ATG CCG GAA TTC ATG ATT CTA GGC ATA GGG 
7579 H10_orf119/RV/TAA/Bam CGC GGA TCC TTA ATT TTT TCA TGG TGT TTG 
7580 H10_orf149FW/Eco/ATG CCG GAA TTC ATG GAT AAC GAT AAA AAG 
7581 H10_orf149/RV/TAA/Bam CGC GGA TCC TTA AAA GAA ATC ATC ATC 
7582 P115/FW/Eco/ATG CCG GAA TTC ATG GTT TTT CTC AAA CGG 
7583 P115/RV/TAA/Bam CGC GGA TCC TTA GTT CTG CTT ATC TTT AC 
 ohmw2-4a/Eco/1414 CCG GAA TTC AAT GAA GCT ACG GCA CAC 
 ohmw2-4b/Bam CGC GGA TCC TTA TTT AGC TGC TTT TTG G 
 OP1/3’Bam/2HS CGC GGA TCC GCG TTA CGG CAA CAC GTA ATC AGG 
CCA CTG GTT AAA CGG ACT AAA CAA GGT TTG GGG 
 
Oligonucleotides for mutagenesis:  
 
Nr. Name Sequence (bold = point mutation) 
7539 hmw2-CTerm_mutATG_RV GGG TAA GGA TAG TTA ATA TCA TTA CC 
7540 hmw2-CTerm_mutATG_FW GGT AAT GAT ATT AAC TAT CCT TAC CC 
 
Oligonucleotides for other approaches:  
 
Nr. Name Sequence  
7330 CAT/for/412 GCT TTT TCT CTT TCT ATT ATT C 
7331 CAT/rev/203 GTC GCT ATT GTA ACC AGT TC 
7343 CAT/stop/3’ TTA TAA AAG CCA GTC ATT AG 
 
2.4.4 DNA Ladders and markers for DNA gel electrophoresis 
• GeneRuler™ DNA Ladder Mix, MBI Fermentas 
• GeneRuler™ 100bp DNA Ladder, MBI Fermentas 
• M. pneumoniae cosmids, digested with EcoRI [Wenzel et al., 1992; Pirkl and 
Herrmann, unpublished ]. 
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2.5 Proteins 
2.5.1 Restriction endonucleases 
Enzyme Manufacturer U/ ml 
BamHI New England Biolabs 2,000 
BclI New England Biolabs 15,000 
BglII New England Biolabs 10,000 
EcoRI New England Biolabs 12,000 
HindIII New England Biolabs 20,000 
NdeI New England Biolabs 20,000 
PstI  New England Biolabs 20,000 
SmaI New England Biolabs 20,000 
XhoI MBI fermentas 10,000 
 
2.5.2 Polymerases 
Enzyme Manufacturer U/ ml 
AccuPrimeTM Pfx DNA Polymerase Invitrogen 2,500 
Platinum® Pfx DNA Polymerase  Invitrogen 2,500 
DeepVent® DNA Polymerase New England Biolabs 2,000 
Phusion TM DNA Polymerase Finnzymes 2,000 
Taq DNA Polymerase Promega 5,000 
 
2.5.3 DNA modifying enzymes and other enzymes  
Enzyme Manufacturer U/ ml  
Desoxyribonuklease (DNaseI) Roche, Mannheim 10,000 
Lysozyme from chicken egg white Sigma 57,500/ mg 
Proteinase K Fluka 290 
T4-Polynukleotidkinase New England Biolabs 10,000 
T4-DNA Ligase New England Biolabs 400,000 
TEV protease Invitrogen 100,000 
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2.5.4 Antibodies 
primary antibodies: 
A collection of approximately 50 monospecific antibodies against fusionproteins and 
synthetic peptides were supplied by the lab. 
 
Name of antiserum Antiserum number dilution 
anti-EF-G 66708 1:3000 
anti-EF-Tu AIR8 1:5000 
anti-H10_orf 149  MX-95 1:5000 
anti-HMW2_N573aa MX-94 1:5000 
anti-HMW2-Cterm 88256 1:1000 
anti-HMW2-Nterm  28050 1:2000 
anti-HMW1 84267 1:5000 
anti-HMW3 65376 1:5000 
anti-P1 45790 1:1000 
anti-P24 85952 1:250 
anti-P40 42326 1:1000 
anti-P41 86630 1:500 
anti-P65  66578 1:3000 
anti-P90 43558 1:1000 
anti-P115 35 1:1000 
anti-His tag Sigma,  Prod. No. H1029 1:3000 
anti-Triton X-100 insoluble 
Fraction 
60631 1:5000 
 
secondary antibodies: 
• Alkaline phosphatase (AP) conjugated goat-anti-rabbit antibody IgG (H&L) (Dianova 
GmbH, Hamburg; Code No.111-055-144) 
• Alkaline phosphatase (AP) conjugated goat-anti-mouse antibody IgG (Fc? fragment 
specific) (Dianova GmbH, Hamburg; Code No.115-055-071) 
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2.5.5 Protein ladders and markers for SDS-PAGE 
• PageRuler™ Protein Ladder (MBI Fermentas, #SM0661), a mixture of 14 
recombinant, purified, unstained proteins with melecular weight from 10 to 200 kDa 
• PageRuler™ Prestained Protein Ladder (MBI Fermentas, # SM0671), a mixture of 10 
recombinant, purified colored proteins with the apparent molecular weights from 10 to 170 kDa. 
• Precision Plus Protein unstained standards (BioRad Laboratories, catalog #161-0363), 
a mixture of 10 recombinant, purified unstained proteins with the apparent molecular 
weights from 10 to 250 kDa. 
 
2.5.6 Other standard protein 
• Albumin Standard (BSA) 2 mg/ ml in ampoules (Pierce, Rockford, USA). 
 
2.5.7 Peptides 
Peptide from P115 protein for immunization of rabbit was made by Peptide Specialty 
Laboratories GmbH, Heidelberg. 
amino acid sequence: CGGKAEQYISKDKQN   (bold = amino acid of P115) 
amino acid position: 971-982 (the last 12 amino acid at the C-terminus of P115) 
 
2.6 Buffers and solutions 
2.6.1 Reaction solutions for enzymes 
For all enzyme reactions, delivered buffers from the manufacturers were used.   
 
2.6.2 Solutions for plasmid isolation 
SolA    SolB   SolC 
50 mM glucose  0.2 N NaOH  3 M sodium acetate 
25 mM Tris-HCl pH 8.0    1 % SDS   2 M acetic acid 
10 mM EDTA 
 
2.6.3 Solutions for Colony transfer 
           Solution A                               Solution B  Solution C 
       10% SDS (w/v)                       500 mM NaOH  500 mM Tris pH8 
                                            1.5    M NaOH   1.5    M NaCl 
Materials 
 
 37
2.6.4 Solution for Southern blot transfer 
Denaturation solution    Neutralizing solution 
0.5 M  NaOH       1    M  NH4Ac 
1.5 M  NaCl     20 mM  NaOH  
 
2.6.5 Buffers for hybridization 
• Buffer for hybridization of Colony blots with  radioactive labeled oligonucleotides 
 
Prehybridizing and hybridizing buffers 
5 ? SSC 
1 % SDS (w/v) 
 Wash buffer 
      5 ? SSC 
0.05 % SDS (w/v) 
 
• Buffer for hybridization of Colony blots or Southern blots with  DIG- labeled probes 
 
Prehybridizing and hybridizing buffers (50 ml) 
     5 ?  SSC  
     3 % milk powder 
  0.1 % N-lauryl sarcosine (w/v) 
0.02 % SDS (w/v) 
Wash buffer 1 
   2 ?  SSC 
0.1 % SDS (w/v) 
 
Wash buffer 2 
0.5 ?  SSC 
0.1 % SDS (w/v) 
 
2.6.6 Buffers for DIG-detection 
DIG 1        
   0.1 M  Maleic acid      
 0.15 M  NaCl      
 pH  7.5 (the pH was adjusted by addition of  NaOH pellets to the 10 ? solution) 
 
DIG 2    DIG 3 
DIG 1    0.1 M Tris /HCl pH 9.5 
3 % milk powder  0.1 M NaCl 
 
DIG-wash buffer 
 DIG 1 + 0.3 % Tween 20 
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2.6.7 Buffer for DNA gel electrophoresis 
E-buffer for DNA agarose gels  
  2 mM EDTA 
20 mM sodium acetate 
40 mM Tris-HCl 
adjust to pH 8.3 with acetic acid 
 
sample dye 
  50 mM      EDTA 
    1 mg/ml  Bromphenol blue 
    2 mg/ml  Orange G 
    2 mg/ml  Xylenxyanol 
500 mg/ml  Sucrose 
    2 %          SDS 
 
2.6.8 Buffers for protein gel electrophoresis 
Protein extraction buffer 
  10 mM Tris/ HCl, pH 7.5 
150 mM NaCl 
complete-proteinase inhibitor (1 tablet / 50 ml) 
 
Protein Sample buffer (2x) 
125 mM Tris/ HCl pH 6.8 
    4    % SDS  
  10    % beta-Mercaptoethanol 
  10    % glycerol  
  0.02 % bromophenol blue 
  
Protein running buffer 
Concentration and weight for 1 L 10 ? buffer 
Glycine 192 mM 144 g 
Tris  25 mM 30.28 g 
SDS  1%   10 g 
pH should be 8.8.  Do not add acid or base to 
adjust the pH. 
Stacking gel buffer 
0.5 M Tris/ HCl, pH 6.8   
0.4 % SDS (w/v)   
 
Resolving gel buffer 
1.5 M Tris/ HCl, pH 8.8   
0.4 % SDS (w/v) 
 
2.6.9 Buffers for 2-D gel electrophoresis 
All chemicals with p.A. quality should be used only. 
 
Lysis buffer 
 Concentration For 50 ml solution 
Urea   7   M      21 g 
thiourea   2   M    7.16 g 
CHAPS   4   %         2 g 
Tris 40 mM 0.242 g 
DTT   1   %     0.5 g 
complete protease inhibitor         1 tablet 
Pharmalyte, pH 3-10 0.5  %   0.25 ml 
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Rehydration buffer 
 Concentration For 50 ml solution 
Urea    6 M    18 g 
thiourea    2 M  7.16 g 
CHAPS    2 %       1 g 
DTT 0.3 % 0.15 g 
Pharmalyte, pH 3-10 0.5  % 0.25 ml 
bromophenol blue  traces 
 
Equilibration buffer 
 Concentration For 100 ml solution 
Tris/ HCl, pH 6.8 50 mM 10 ml 0.5 M Tris/ HCl pH 
6.8 
Urea   6    M 36   g 
glycerol  30    % 30   g 
SDS   2    % 20 ml 10 % SDS 
 
2.6.10 Western blot transfer buffer 
Schafer-Nielson buffer 
      
48 mM Tris / HCl 
     39 mM glycine 
     20    % methanol (v/v) 
0.037    % SDS (w/v) 
pH should be 9.2.  Do not add acid or 
base to adjust the pH. 
CAPS buffer for electrotransfer of proteins 
onto PVDF for N-terminal sequencing  
 
10mM CAPS  (3-[cyclohexylamino]-1- 
            propanesulfonic acid), pH 11.0  
10   %  methanol 
 
 
2.6.11 Buffers and solutions for Immunoblot analysis 
Incubation buffer (TBST) 
   10 mM Tris/ HCl, pH 8 
 150 mM NaCl 
0.05    % Tween 20 
Incubation buffer (TBSTT) for ECF Western blot 
   10 mM Tris/ HCl, pH 8 
 150 mM NaCl 
  0.1    % Tween 20 
 
Materials 
 
 40
PBS buffer for anti-His tag antiserum 
140 mM NaCl 
    8 mM Na2HPO4 ? 2 H2O 
    2 mM NaH2PO4 ? H2O 
TBS buffer for ECF substrate 
   10 mM Tris/ HCl, pH 8 
 150 mM NaCl 
 
  
Alkaline phosphatase (AP) buffer 
100 mM Tris/ HCl, pH 9.5 
100 mM NaCl  
    5 mM MgCl2 
 
Alkaline phosphatase (AP)-stop solution 
20 mM EDTA 
 
 
Substrate solutions for the alkaline phosphatase 
NBT 50?g/ml in 70 % dimethylformamide 
BCIP 50?g/ml in 100 % dimethylformamide 
 
2.6.12 Staining solution for polyacrylamide protein gels and protein blots 
Coomassie Blue stain solution   Coomassie Blue destain solution 
   50 % methanol (v/v)   5 % methanol (v/v) 
   10 % acetic acid (v/v)    7.5 % acetic acid (v/v) 
0.06 % Coomassie Brilliant Blue G-250 (w/v)  
 
Colloidal Coomassie stain solution 
Component A : Coomassie Brilliant Blue       
                          stock (CBB) 
5 % Coomassie Brilliant Blue G-250 (w/v)  
Component B : Colloidal Coomassie dye 
stock 
 
           50   g ammonium sulfate 
             6 ml 85 % phosphate acid  
ad to 490 ml with H2O 
        + 10 ml component A (CBB) 
Colloidal Coomassie stain solution: 
200 ml of component B  
  50 ml methanol 
 
Ponceau-stain solution    Amido Black solution 
   5 % acetic acid (v/v)     45 % methanol (v/v) 
0.1 % Ponceau S (w/v)     10 % acecid acid (v/v) 
       0.1 % Amido Black (w/v) 
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2.6.13 Buffers for His-tagged protein purification 
By ÄKTAexplorer™ 10 
All buffer and solutions are filtered through a 0.2 µm filter. 
 
 Buffer A Buffer B Buffer C Buffer D 
Guanidium hydrochloride     6    M    ?    ?    ? 
Urea    ?     8    M     8    M     8    M 
Tris   10 mM   10 mM   10 mM   10 mM 
Na3PO4 100 mM 100 mM 100 mM 100 mM 
Imidazol    ?    ?    ?     1    M 
pH (with HCl)  8.0  8.0  6.3  6.3 
 
By gravity-flow chromatography using sepharose column  
 
 Buffer A Buffer B Buffer C Buffer D Buffer E Buffer F 
Guanidium hydrochloride     6    M    ?    ?    ?    ?   ? 
Urea    ?     8    M     8    M     8    M     8    M   ? 
Tris    ?   10 mM   10 mM   10 mM   10 mM   ? 
Na3PO4 100 mM 100 mM 100 mM 100 mM 100 mM   ? 
Acetic acid    ?    ?    ?    ?    ? 0.2 M 
pH (with HCl)  8.0  8.0  6.3  5.9  4.0 2.7 
 
By paramagnetic precharged nickel particles 
For all purification steps, delivered buffers from the manufacturers were used, with 
addition of guanidium hydrochloride to a final concentration of 6 M by purification under 
denaturing condition. 
 
2.6.14 Buffers for TAP-tagged protein purification 
IPP150 
  10 mM Tris/ HCl, pH 8.0 
150 mM NaCl  
(NaCl can be varied from 150 – 300 mM) 
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IPP150 was used as basic buffer for further purification steps. By adding  chemicals and 
detergents to following final concentrations, individual buffers for each step could be 
prepared.  
 
 IgG binding 
buffer 
TEV cleavage 
buffer 
Calmodulin 
binding buffer 
Calmodulin 
elution buffer 
NP-40 <    1 %   ? 0.1   %   0.1  % 
SDS < 0.1 %   ?  ?   ? 
EDTA      ? 0.5 mM  ?   ? 
DTT      ?    1 mM  ?   ? 
2-mercapthoethanol      ?   ? 10 mM 10 mM 
Magnesium acetate      ?   ?   1 mM   1 mM 
Imidazol      ?   ?   1 mM   1 mM 
CaCl2      ?   ?   2 mM  ? 
EGTA      ?   ?  ?   2 mM 
 
2.6.15 Buffer for M. pneumoniae transformation 
Hepes / D(+) Saccharose buffer 
272 mM  D(+) saccharose 
    8 mM  HEPES 
 
2.6.16 Solutions for S. cerevisiae transformation 
Lithium acetate (LiAc) solution 
    1    M Lithium acetate 
100 mM Tris/ HCl, pH 7.8 
  10 mM EDTA 
For 100 mM LiAc solution, dilute 1:100 with distilled H2O 
 
SS-DNA solution  
distilled H2O (1 ml) was added to 2 mg Deoxyribonucleic acid, Herring Sperma (ICN, 
cat.#152274) and stirred overnight at 4°C in a beaker. 
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2.6.17 Other buffers and solutions 
TE (Tris-EDTA) 
 10 mM  Tris/ HCl pH 8.0 
0,1 mM  EDTA 
 
Enzyme-stop solution 
  25 mM  Tris/ HCl, pH 8.0 
  25 mM  EDTA 
300 mM  NaCl 
1/10 vol  Phenol 
in TE-buffer 
 
15 ? SSC 
150 mM NaCl 
  15 mM Sodium citrate 
 
 
2.7 Chemical compounds  
Standard chemicals in p.A. grade were used. All special chemicals and items which were 
not nearly described were provided from following companies: 
• Amersham Biosciences, Freiburg 
• Biomol GmbH, Hamburg 
• Biozym, Hess. Oldendorf 
• Carl Roth GmbH and Co., Darmstadt 
• Roche, Mannheim 
• Merck KGaA, Darmstadt 
• Qbiogene, Heidelberg 
• Serva Feinbiochemika GmbH, Heidelberg 
• Sigma Aldrich Chemikalien GmbH, Deisenhofen 
 
2.7.1 Special chemical compounds  
• Acetic acid 100% (Merck, Darmstadt) 
• Aceton (Merck, Darmstadt) 
• Acetonitrile, HPLC grade (Merck, Darmstadt) 
• Agar Bacteriological (Oxoid) 
• Agarose, Gel Electrophoresis Grade (Biozym, Hess. Oldendorf) 
• Amido Black 10 B extra (Serva, Heidelberg) 
• Amonium acetate (AppleChem; Darmstadt) 
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• APS (Ammonium peroxodisulfate) (Carl-Roth GmbH and Co., Karlsruhe) 
• ?-Mercaptoethanol (Roth, Darmstadt) 
• Bacto TM Agar (BD, LePont de Claix; France) 
• BCIP (5-Bromo-4-chloro-3-indolyl-phosphate) (Roth, Darmstadt) 
• Boric acid (Mallincrodt Baker B.V.; Deventer, Holland) 
• Bovine Serum Albumin FractionV (Biomol, Hamburg) 
• Bromophenol Blue (Serva, Heidelberg) 
• Calcium chloride 2-hydrate (J.T.Baker, Deventer, Holland) 
• Calmodulin Affinity Resin (Stratagene, La Jolla, CA, USA) 
• CHAPS (3-[(3-Cholamidopropyl)dimethylammonio]-1-propanesulfonate Hydrate)  
  (Sigma, Deisenhofen) 
• Citric acid monohydrate (Sigma, Deisenhofen) 
• Complete EDTA-free (Roche, Mannheim) 
• Coomassie Brilliant Blue G250 pure  (Serva, Heidelberg) 
• D-Glucose-Monohydrate (Merck, Darmstadt) 
• Deoxynucleotide triphosphate  (Peqlab, Erlangen) 
• Digoxigenin-11-dUTP (Roche, Mannheim) 
• DTT (Dithiotreitol) (Sigma, Deisenhofen) 
• EDTA (Ethylenediaminetetraacetic acid), disodium salt dihydrate (Carl-Roth, Karlsruhe) 
• Ethidium bromide (10 mg/ml) (Carl-Roth GmbH and Co., Karlsruhe) 
• Formaldehyde (37%) (Merck, Darmstadt) 
• Formamide (Merck, Darmstadt) 
• Freund’s adjuvant (complete and incomplete) (Sigma, Deisenhofen) 
• Gel 30 Acrylamide (Carl-Roth GmbH and Co., Karlsruhe)  
• Glutardialdehyd 25% for electron microscopy (Merck, Darmstadt) 
• Glycerol 99,5% (Gerbu, Gaiberg) 
• Glycine (AppliChem, Darmstadt) 
• HEPES (N-2-hydroxyethyl piperazine-n-ethanesulfonic acid) (Serva, Heidelberg) 
• Horse Serum (Gibco, Invitrogen,  
• IgG Sepharose? 6 Fast Flow (Amersham Biosciences, Freiburg) 
• Iodoacetamid (Sigma, Deisenhofen) 
• IPTG (Isopropyl-beta-D-thiogalactopyranoside) (Roche, Mannheim) 
• Lithium acetate (Sigma, Deisenhofen) 
• Magnesium chloride ? 6 H2O (Gruessing, Filsum) 
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• Maleic acid (Fluka, Buchs) 
• Methanol (Merck, Darmstadt) 
• NBT (p-Nitro-blue tetrazolium chloride) (Roth, Darmstadt) 
• PEG (polyethylene glycol) 6000 (Serva, Heidelberg) 
• Penicillin (Serva, Heidelberg) 
• Pharmalyte pH 3-10 (Amersham Biosciences, Freiburg) 
• Phenol (Carl-Roth GmbH and Co.,Karlsruhe) 
• Phenol red  (Merck,Darmstadt) 
• PMSF (Phenylmethylsulfonyl fluoride) (Roth, Karlsruhe) 
• Polyacrylamide solution 30 % (19:1 Acrylamide:Bisacrylamide) (Carl-Roth, Karlsruhe) 
• Ponceau S (Sigma, Deisenhofen) 
• Potassium acetate (Gerbu; Gaiberg, Germany) 
• PPLO broth (Difco Laboratories, Augsburg) 
• Quicksafe A Szintillation solution (Zinsser, Frankfurt) 
• SDS (Sodium dodecyl sulphate) (AppliChem, Darmstadt) 
• Silver nitrate (Sigma, Deisenhofen) 
• Sodium acetate   (J.T. Baker; Deventer, Holland) 
• Sodium chloride (J.T. Baker; Deventer, Holland) 
• Sodium hydroxide (Gruessing; Filsum) 
• Sodium sulfate (Agros Organics, Geel, Belgium) 
• Sodium thiosulfate (Agros Organics, Geel, Belgium) 
• Sucrose  (J.T. Baker, Deventer, Holland) 
• Standard I Medium (Merck, Darmstadt) 
• TCA (Trichloroacetic acid) (Riedel-de Haen, Seelze) 
• TEMED (N,N,N',N'- tetramethylethylenediamine) (Carl-Roth GmbH, Karlsruhe) 
• Trisodium citrate dihydrate, Roth, Karlsruhe 
• TRIS PUFFERAN® (Roth, Karlsruhe) 
• Triton X-100, SigmaUltra (Sigma, Deisenhofen) 
• Tween (Polyoxyethylene sorbitan monolaurate) (Sigma, Deisenhofen) 
• Urea (Carl-Roth GmbH and Co., Karlsruhe) 
• X-Gal (5-Bromo-4-chloro-3-indolyl-beta-D-galactopyranoside) (AppliChem, Darmstadt) 
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2.7.2 Reagents for biochemical and molecular biological methods 
• BCA Protein Assay  (Pierce; Rockford/IL, USA) 
• BioRad Protein Assay (BioRad Laboratories, Munich) 
• DIG-DNA Labeling Kit (Roche, Mannheim) 
• ECF™ Substrate for Western Blotting (Amersham Biosciences, Freiburg) 
• Novex Colloidal Blue? Stain Kit (Invitrogen, Karlsruhe) 
• High Pure PCR Product Purification Kit  (Roche, Mannheim) 
• MagneHis™ Protein Purification System (Promega GmbH, Mannheim) 
• Nucleobond PC100 Midiprep Kit (Machery and Nagel) 
• Plasmid Miniprep Kit Quantum Prep® (BioRad Laboratories, Munich) 
• QIAquick® Gel Extraction Kit (Qiagen, Hilden) 
• Quantum Prep™, Plasmid Miniprep Kit (BioRad Laboratories GmbH, Munich) 
 
2.7.3 Isotopes 
• [?-32P] ATP (3000 Ci/ mmol) (Amersham Biosciences, Freiburg) 
• [?-33P] dATP (3000 Ci/ mmol) (Amersham Biosciences, Freiburg) 
 
2.8 Laboratory articles/ consumer items 
• Cell culture flask (TPP), 500cm?,150cm? and 50cm?, polystyrol (Renner GmbH, Darmstadt) 
• Cell scraper (Corning Inc.; Corning, NY, USA) 
• Cellophane foil (Deti GmbH, Meckesheim) 
• Cover Fluid (Amersham Biosciences, Freiburg) 
• Immobilized pH-gradient (IPG) DryStrips (Amersham Biosciences, Freiburg) 
• Immobilon P PVDF-Membran, Millipore, Bedford (USA) 
• Milk powder Glücksklee, nonfat (Glücksklee GmbH, Munich) 
• Milk powder Naturaflor, nonfat (Töpfer GmbH, Dietmannsried) 
• Microfuge ultracentrifuge tubes, polyallomer 9.5?38 mm (Beckman-Coulter; Fullteron , CA, USA) 
• Nitrocellulose membranes  (Sartorius, Göttingen) 
• Nitrocellulose membranes  (Schleicher & Schuell, Dassel) 
• Nylon membranes  (Amersham Biosciences, Freiburg) 
• Sephadex G-25 and G-100  (Amersham Bioscience, Freiburg) 
• Ultracentrifuge tubes, polyclear 11?60 and 15?95 mm, Science Services GmbH, Munich) 
• Vivaspin 0.5 ml Concentrator, Vivascience 
• Xar X-ray film, Kodak 
• ZipTips C-18 (Millipore; Bedford, MA, USA) 
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2.9 Apparatuses 
2.9.1 Gel electrophoresis 
• IPGphor? and IPGphor? strip holder (13 cm) (Amersham Biosciences, Freiburg) 
• Hoefer Mighty Small-SE250- chamber mit gel pouring apparatus for 10 ? 8 and 10 ? 11 
cm glass plates (Amersham Biosciences, Freiburg) 
• Trans-Blot® SD Semi-Dry Electrophoretic Transfer Cell (BioRad Laboratories, Munich) 
 
2.9.2 Chromatography 
• Äktaexplorer™ 10 System, Hi-Trap™ Chelating column, Superloop 10 ml and 150 ml    
  (Amersham Biosciences, Freiburg) 
 
2.9.3 Other apparatuses 
• Biofuge pico (Heraeus Instruments, Osterode) 
• Biofuge fresco (Heraeus Instruments, Osterode)   
• Beckman Tl 100 Ultracentrifuge, TLA 45-Rotor (Beckman Coulter GmbH, Krefeld) 
• Branson Sonifier with Micro-Tip or Cuphorn  (Branson, Danbury; CT, USA) 
• DuPont Sorvall Centrifuge RC5C with SS-34, GSA and GS-3 rotors (Kendro Laboratory  
  Products GmbH, Langenselbold) 
• Eppendorf thermocycler (Mastercycler® Gradient) (Eppendorf GmbH, Hamburg) 
• Eppendorf Centrifuge 5402 (refrigerated) (Eppendorf, Hamburg) 
• Gene Pulse and Pulse Controller (BioRad,  Munich) 
• Mini Hybridization Oven (Oncor-Appligene;  Illkirch, France) 
• Speed-Vac-Concentrator (Bachofer Laboratoriumsgeraete; Reutlingen, Germany) 
• UV/ Visible Specrophotometer Ultrospec 3000 (Amersham Biosciences, Freiburg) 
• Microscopes: LEICA DMIRB, LEICA DMRXA 
• PhosphorImager (Amersham Biosciences, Freiburg) 
• PhosphorImager FLA 3000; (FUJIFILM) 
• Sharp JX-330 Scanner and Film Scanning Unit (Amersham Biosciences, Freiburg) 
• Stratalinker 1800 (Stratagene; CA, USA) 
• Szintillation Counter Tri-Carb 1500 (Packard Instrument; Frankfurt) 
• Thermomixer Comfort (Eppendorf, Hamburg) 
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2.10 Computer Software 
• Lasergene Program (DNA STAR, Inc. WI, USA) 
   - Sequence Editing & Analysis: for creating DNA or amino acid sequences;  converts      
      DNAsequences to amino acid sequences 
   - Restriction Analysis & Mapping: reveals restriction sites in a DNA sequence as list or   
     in other forms; restriction sites can be viewed in vector map or ORF map forms 
   - Sequence Project Management:  for aligning and evaluating sequenced DNA 
 
• Microsoft Office 97; Microsoft Corp. 
   - Microsoft® Excel 97: used for creating spredsheets and calculation of signal data 
   - Microsoft® Word 97: used for creating text 
 
• Photo Editing and imaging software:   
- Adobe Photoshop® 5.0: a bitmap program for editing digital images (Adobe Systems   
   Incorporated, USA) 
   - Adobe Illustrator® 10: a vector based imaging tool for creating illustrations (Adobe  
SystemsIncorporated, USA) 
 
• Internet browsers: 
   - Netscape CommunicatorTM 4.76; Netscape® Communications Corp. 
   - Microsoft® Internet Explorer 5.0; Microsoft Corp. 
   - Website of Medline Database: http://www.ncbi.nlm.nih.gov/entrez 
   - Website of M. pneumoniae database: ORFs, gene map, annotations, primer list: 
      http://www.uni-heidelberg.de/~pneumo 
 
•  Signal detection software tools: 
- Image Reader V1.8E; FUJIFILM:  reads Ips and fluorescence signals and converts the  
      image to a digital file 
   - Image Gauge V3.45; FUJIFILM:  converts the digital image created by Image Reader   
      to a *.tif file  
    - VisualGrid; used for evaluating signal from Western Blots and 2-D gels images;  
       "VisualGrid(R), Implemented by Markus Kietzmann with contributions from David  
       Bancroft and Igor Ivanov.  Copyrighted and Licensed by GPC Biotech AG 1998 - 2000" 
 
• Other softwares 
- BLAST program for database searching [Altschul, 1990] 
   - 373A Software Paket with SepEd v1.0.3 for editing DNA sequences (Applied Biosystem) 
   - Oligo 4.0: program for selection of sequencing and cloning  oligonucleotides  (National  
     Biosciences Inc.)
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3 Methods 
All methods which are not described in more detailed were done after the laboratory 
manual: Molecular Cloning [Sambrok et al., 2001].  
 
3.1 Microbiological Methods 
3.1.1 Standard cultivation of E. coli 
E. coli strains were either inoculated in liquid standard I medium or streaked on standard I 
agar (2% agar) plates and allowed to grow 14-16 h at 37 °C. Liquid cultures were grown 
14-16 h with agitation (100-130 rpm) at 37 °C. If required, antibiotics were added in 
concentrations as described above. A fresh overnight culture contained approx. 1-2 ? 109 
cells/ml. For further cultivation, a fresh overnight culture was diluted 1:100 with medium. 
The bacterial titer was determined by counting bacteria cells in a Neubauer chamber or by 
using a photometer to measure optical density of cell suspension (appoximate value: 1 
OD600 = 8 ?108 bacteria/ml).  
 
3.1.2 Standard cultivation of M. pneumoniae 
M. pneumoniae strain M129 (Wild type) 
M. pneumoniae cells were grown adherently in cell culture flasks. Precultured cells, either 
freshly prepared or frozen stocks were diluted 1:10 with serum-complemented, modified 
Hayflick medium. A 100 ml culture was incubated in a 500 cm2 cell culture flasks for 96 h 
at 37 °C. The medium for the transformants contained either gentamicin (80 µg/ml) or 
chloramphenicol (25 µg/ml). The cells were harvested when the medium changed the color 
from red to orange. 
 
M. pneumoniae mutant A3 (hmw2?) 
M. pneumoniae mutant A3 cells were grown non-adherently in 500 ml glass flasks. 
Precultured cells, either freshly prepared or frozen stocks were diluted 1:10 with serum-
complemented, modified Hayflick medium containing 20 µg/ml gentamicin. A 500 ml 
culture was incubated in 1000 cm2 glass flasks for 96 h with gentle agitation at 37 °C. The 
cells were harvested by centrifugation for 15 min at 8,000g at 4 °C. The medium for 
growing the transformants contained 20 µg/ml gentamicin and 25-50 µg/ml 
chloramphenicol. 
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3.1.3 Standard cultivation of Saccharomyces cerevisiae 
YPD-medium (5 ml) was inoculated with a large colony (diameter ca. 2-3 mm) of 
S. cerevisiae strains picked from a fresh plate (less than 2 months) and incubated for 16-18 
h with agitation (230-270 rpm) at 30 °C. By these conditions, the yeast culture will reach 
the stationary phase (OD600 > 1.5). For further cultivation, a fresh overnight culture was 
diluted and adjusted to OD600 = 0.2 – 0.3.   
 
3.1.4 Storage of E. coli  
For long-term storage, glycerol is added to a liquid overnight culture to 20% final 
concentration (v/v) and stored at -80° in aliquots. 
 
3.1.5 Storage of Saccharomyces cerevisiae 
A single colony was picked from the agar plate and resuspended very well in 200-500 ?l 
YPD medium (or appropriate selection medium). Glycerol (50 %) was added to this cell 
suspension (final concentration 25%), mixed and stored at -80 °C. Instead of a single 
colony, a fresh overnight culture could also be used. 
 
3.1.6 Storage of M. pneumoniae 
M. pneumoniae strain M129 (Wild type) 
After standard incubation, the medium was drained off and the adhering cells were washed 
once with fresh medium (containing appropiate antibiotics) and then scraped in 1-2 ml fresh 
medium and frozen at -80 °C. Such cultures could be stored at -80 °C for several years. 
 
M. pneumoniae mutant A3 (hmw2) 
After standard incubation conditions, each 50 ml of the bacteria culture is aliquoted and 
frozen at -80 °C. Such cultures can be stored at -80 °C for several years. 
 
3.1.7 Harvest of M. pneumoniae 
M. pneumoniae strain M129 (Wild type) 
After standard incubation, the medium was drained off and the adhering cells were washed 
three times with cold PBS, scraped and resuspended in 1-2 ml PBS. After centrifugation, 
PBS was drained off and the cell pellet was stored at -80 °C. The yield was about 70 mg 
cells (wet weight) or about 6 mg total protein from 100 ml bacteria culture.  
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M. pneumoniae mutant A3 (hmw2?) 
After standard incubation, the cells were harvested by centrifugation for 15 min at 8,000g 
at 4 °C. The cell pellet was washed by resuspending first with 400 ml cold PBS and 
centrifuged for 15 min at 8,000g at 4 °C. This was repeated twice with each 150 ml cold 
PBS. The final cell pellet was resuspended in 1-2 ml PBS and centrifuged for 5 min at 
8,500g at 4 °C. PBS was drained off and the cell was stored at -80 °C. The yield was about 
40 mg cells (wet weight) or about 3 mg total protein from 500 ml bacteria culture.  
 
3.1.8 Transformation of E. coli 
Preparation of competent E. coli (calcium chloride method) 
Standard I medium (3 ml) (containing appropiate antibiotics) was inoculated with a single 
E. coli colony from a fresh overnight plate and incubated for 14-16 h with agitation at 
37 °C. From this culture, 5 ml was further inoculated in 20 ml Standard I medium 
(containing appropiate antibiotics)  and incubated fro 14-16 h with agitation at 37 °C. From 
this culture again a 1:100 dilution was prepared in 50 ml Standard I medium and incubated 
with strong agitation (159 rpm) at 37 °C until the OD600 of the culture reached 0.7-0.8. 
After chilling the culture on ice for 15 min, the cells were harvested by centrifugation for 
15 min at 5,000g at 4 °C. The cell pellet was resuspended in 25 ml of ice-cold 0.1 M CaCl2 
solution and further incubated for 30 min. Thereafter, the cells were harvestd by 
centrifugation 15 min at 5,000g at 4 °C. The cell pellet was then resuspended in 2.5 ml of 
an ice-cold 0.1 M CaCl2 containg 10% (v/v) glycerol solution and divided in aliquots of 
200 µl, shock-freezed by liquid nitrogen and stored immediately at -80 ºC. 
 
Transformation 
Frozen competent E. coli cells (200 ?l) were thawed for 5-10 min on ice. After adding 0.1 
to 0.5 µg Plasmid-DNA (dissolved in 5 ?l TE) or 4 ?l of ligation product, the cell 
suspension was chilled on ice for 20 min, followed by a 30-sec incubation at 42 °C and 
immediatly chilled on ice for 1-2 min. Thereafter, 0.8 ml of prewarmed Standard I medium 
was given to the cells, incubated for 30 min with agitation at 37 °C, then 10 µl, 100 µl, 
200 µl and the rest (? 600 µl) of the cells were plated on Standard I agar plates containing 
the appropriate antibiotic and incubated for 12-16 h (sometimes upto 36 h) at 37 °C. 
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3.1.9 Transformation by electroporation of E. coli 
Preparation of electroporation-competent E. coli  
A fresh E.coli overnight culture (10 ml) was diluted 1:100 with 500 ml LB medium 
(containing appropiate antibiotic) and incubated with agitation at 37 °C until the OD600 of 
the culture reached 0.5 to 1.0 (corresponding to approx. 2-3 ? 108 cells). After chilling the 
culture on ice for 15-30 min, the cells were harvested by centrifugation for 15 min at 
4,000g and washed twice with ice-cold sterile water. Thereafter, the cells were washed 
twice with ice-cold 10% (v/v) glycerol and finally resuspended in 2 ml ice-cold 10% (v/v) 
glycerol. The cell suspension containing 1-3 ? 1010 cells/ml was divied in aliquots of 50 µl, 
shock-freezed by liquid nitrogen and stored immediately at -80 ºC. 
 
electroporation 
Frozen competent E. coli cells (50 ?l) were thawed for 5-10 minutes on ice. About 100 ng of 
plasmid DNA or 4 µl of ligation product was mixed with 50 ?l of competent cells and 
incubated on ice for 1 minute. Electroporation was done in 1 mm cuvettes with the Biorad 
GenePulser under the following conditions: field strength 1.25kV/cm, electric capacity 25 ?F 
and resistance 200 W. Thereafter, 1 ml cold Standard I medium was added immediately, the 
cell suspension was incubated for 1 h with agitation at 37°C and spreaded onto Standard I 
agar plates containing the appropriate antibiotic and incubated overnight at 37 °C. 
 
3.1.10 Blue/white selection 
By using cloning vectors like pBCSK + /KS, there is a possibility provided to recognize 
recombinant  bacteria clones by color of their colonies. E. coli strain TOP10 used for 
general cloning in the lab contains deletions in lacZ gene in the ?-peptide region, both 
chromosomal and episomal (F-factor), which leads to loss of ß-galaktosidase activity. This 
deficiency can be complemented by transforming this bacteria with pBC SK/KS plasmids, 
which encode an intact ?-peptide. 
Whenever possible vectors (pBCSK + /KS, pMT 85 etc.) and host cells (E. coli TOP10) 
were used, which permitted the blue/white selection. Bacteria cells were plated on 
Standard I agar plates with X-Gal (5-bromo-4-chloro-3-indolyl-?D-galactoside). The ß-
galactosidase splits the lactose derivative X-Gal, by which 5’-bromo-4-chloro-indolyl is 
produced, of which the oxidation is promoted by atmospheric oxygen to the blue 5,5’-
dibromo-4,4’-dichloro-indigo. The successful insertion of a DNA fragment into the cloning 
site of the plasmids leads to the destruction of the ?-peptide region. Bacteria carrying 
plasmids containing DNA insertions will not turn to blue color on agar plate containg 2% 
X-Gal (v/v in dimethyl formamid). 
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3.1.11 Transformation of M. pneumoniae M129 (WT)  
M. pneumoniae cells were incubated in 100 ml under standard growth conditions. Cells 
were washed three times with each 100 ml ice-cold HEPES/ Sucrose buffer, then scraped 
in 2 ml of the same buffer and centrifuged for 5 min at 8,500g at 4 °C. The cell pellet was 
re-suspended in 150 ?l Hepes /Sucrose buffer. 
For a standard transformation, 50?l cell suspension was mixed with 10 ?g plasmid (in TE) 
and 1 ?l 500 ?M tRNA. The suspension was filled up to a final volume of 80 ?l with 
Hepes /Sucrose buffer and incubated for 15 min on ice prior to electroporation. 
Electroporation was done in 1 mm cuvettes with the Biorad GenePulser under the 
following conditions: field strength 1.25kV/cm, electric capacity 25 ?F and resistance 100 
W. Thereafter, the cells were incubated on ice for an additional 15 minutes, and then 
suspended in 10 ml modified Hayflick medium without addition of antibiotic. After 
incubation for 2 h at 37°C, 1 ml of the transformation mix was diluted from 10-1 to 10-3 in 
10 ml modified Hayflick medium containing 80 ?g /ml gentamicin or 25-50 ?g /ml 
chloramphenicol and incubated for at least 4 days at 37 °C. 
 
3.1.12 Transformation of M. pneumoniae (mutant A3)  
The bacteria were grown as described above. Cells from a 500 ml culture are harvested by 
centrifugation for 15 min at 8,000g at 4 °C and washed by resuspending first with 400 ml 
ice-cold HEPES/ Sucrose buffer and centrifuged for 15 min at 8000g at 4 °C. This was 
repeated twice with each 150 ml ice-cold HEPES/ Sucrose buffer. The final cell pellet was 
resuspended in 1-2 ml of the same buffer and centrifuged for 5 min at 8,500g at 4 °C. The 
buffer was drained off and the cell was resuspended in 150 ?l Hepes/ Sucrose buffer. 
For a standard transformation, 50?l cell suspension was used and mixed with 10 ?g 
plasmid (in TE) and 1 ?l 500 ?M tRNA. The suspension was filled up to a final volume of 
80 ?l with Hepes /Sucrose buffer and incubated for 15 min on ice prior to electroporation. 
Electroporation is done in 1 mm cuvettes with the Biorad GenePulser under the following 
conditions: field strength 1.25kV/cm, electric capacity 25 ?F and resistance 100 W. 
?Thereafter, the cells are incubated on ice for an additional 15 minutes, and then suspended 
in 10 ml modified Hayflick medium without addition of antibiotic. After incubation for 2 h 
at 37°C, 1 ml of the transformation mix is diluted from 10-1 to 10-3 in 10 ml modified 
Hayflick medium containing antibiotic containg 20 ?g /ml gentamicin  and  25-50 ?g /ml 
chloramphenicol and incubated for at least 7 days at 37 °C. 
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3.1.13 Isolation of transformants  
After several days (between 4 to 7 days for WT or 7-14 days for the mutant A3) of 
incubation of the transformed mixture of M. pneumoniae cells at 37°C, colonies develope 
at the surface of the culture flask. The cells were scraped in the 10 ml growth medium, 
sucked into a syringe with a 0.9 mm needle and filtrated. The following three filters were 
used: 0.45 ?m, 0.2 ?m and 0.1 ?m. From both, the 0.2 ?m and 0.1 ?m filtration, dilutions 
were made in 2 ml medium from 10-1 to 10-3, and from each dilution, 200 ?l were plated 
on mycoplasma agar containing antibiotic (10 ml agar in Ø 9 cm petri dishes or 15 ml agar 
in Ø 13 cm petri dishes).  The plated cells were incubated at 37 °C until colonies developed 
(between 1 to 2 weeks).  Colonies were picked with a sterile, wooden toothpick and 
transferred into 1 ml medium in a reaction tube and incubated for further several days at 
37 °C. When the medium changes color from red to orange (usually within one week), the 
1 ml was then transferred into 10 ml and incubated at 37 °C until ready for passaging. 
 
3.1.14 Transformation of S. cerevisiae by the Lithium acetate (LiAc) method 
Preparation of LiAc-competent yeast cells and transformation 
Two-three single colonies of the yeast strain were inoculated into 5 ml of YPDA liquid 
medium and incubated for 16-18 h on a rotary shaker (200 rpm) at 30°C. The titer of the 
yeast culture was determined by pipetting 0.1 ml of cells into 0.9 ml of water in a 
spectrophotometer cuvette and measuring the OD at 600 nm. For many yeast strains a 
suspension containing 1?106 cells/ml will give an OD600 of 0.1. The OD600 of the overnight 
culture should be between 3 and 6. The overnight culture was diluted with 50 ml 
prewarmed YPDA to a final OD600 at 0.2-0.3 in a 250-ml flask and incubated on a rotary 
shaker (200 rpm) at 30°C. This culture will give sufficient cells for 10 transformations. 
When the cell titer is at least 2 ? 107 cells/ml or OD600 = 1, which should take about 4 h, 
the cells are harvest by centrifugation for 10 min at 3,000g. The cells were then wash in 25 
ml of sterile water, resuspend in 1 ml of 100 mM LiAc and transferred to a 1.5-ml 
microfuge tube. The cell suspension was centrifuged for 15 sec at 13,000g and LiAc was 
removed with a micropipette. The cell pellet was resuspended in a final volume of 500 µl 
(about 2?109 cells/ ml) and kept on ice.  
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The cell suspension was vortexed and divided in aliquots of 50 µl, centrifuged for 15 sec at 
13,000g and the supernatant was remove with a micropipette. The transformation mixture 
was made as followed and had to be kept in ice/water:   
240 µl PEG (50% w/v) 
  36 µl 1.0 M LiAc  
  25 µl SS-DNA (carrier DNA, Herring sperma DNA, 2.0 mg/ ml)* 
  50 µl water and plasmid DNA (0.1-10 µg) 
(* Carrier DNA (1 ml) was boiled for 5 minutes and quickly chilled in ice/water prior to use). 
The order is important, the PEG should be pipetted first, which shields the cells from the 
detrimental effects of the high concentration of LiAc. The transformation mixture was 
resuspended by vortexing vigorously for 1 min. The tubes were incubated in a 30 °C water 
bath for 30 min and the cells exposed to a heat shock for 20-25 min at 42 °C. The cell 
suspenion was centrifuged at 6-8,000g for 15 sec and the transformation mix is removed 
with a micropipette. One ml sterile water is pipetted into each tube, the pellet is 
resuspended by gently pipetting up and down. Twenty ?l, 200 ?l and the rest (about 750 
?l) of the transformation mix was plated on onto SD selective agar plates (-L, -U or –LU 
by cotransformation). The plates were incubated for 3 to 4 days at 30°C. 
 
3.1.15 Yeast drop test (applied for the pairwise test) 
S. cerevisiae strain PJ69-4? was cotransformed with a pair of bait and pray vector as 
described in 9.1.14. After cells were grown,  2-3 single colonies of this yeast strain were 
inoculated into 5 ml of -LU liquid medium and incubated for 16-18 h on a rotary shaker at 
200 rpm at 30°C. The titer of the yeast culture was determined by pipetting 0.1 ml of cells 
into 0.9 ml of water in a spectrophotometer cuvette and measuring the OD at 600 nm. The 
OD600 of the overnight culture should be between 3 and 6. The overnight culture is diluted 
with 1 ml sterile water to a final OD600 at 1.0. The cell suspension (100 µl) was further 
diluted from 10-1 to 10-4 in 1 ml sterile water. Each dilution (5 µl) was gently dropped on 
selective agar plates (-LU, -LUH and –LUHA) by pipetting. The plates were incubated for 
3 to 4 days at 30°C and the growth of the yeast cells was monitored.  
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3.2 Molecular biological methods 
3.2.1 Restriction of DNA 
DNA restrictions were done according to the standard protocols [Sambrock et al., 2001].  
The reaction conditions were corresponded to the recommendations of the enzyme 
manufacturers. In general, the enzyme concentrations was calculated for a reaction time of 
1 h. The completeness of the restriction was controlled on analytical agarose gels. The 
following methods were used to inactivate the enzymes: 
- Isolation of DNA with the PCR purification kit from Roche. 
- Phenol/chloroform extraction. 
 
3.2.2 Ligation of DNA  
For ligase reaction, only purified DNA fragments were used, either from gel extraction kit, 
PCR purification kit or phenol/chloroform extraction. The ligation of double stranded 
DNA molecules was done by T4 DNA ligase, applying 0.1-0.4 pmol DNA and 200 U T4 
DNA ligase (400 U/ ?l, NEB) in a reaction volume of 20 ?l. DNA with sticky ends was 
ligated for 2 h at RT and DNA with blunt ends was ligated for 14-16 h at 16 °C 
 
3.2.3 Converting sticky ends DNA to blunt ends 
Sticky end at 5’-overhang could be filled-in or sticky end 3’-overhang could be removed 
with T4 DNA polymerase under following standard conditions; 
3’-overhang removal:  
0,1 to 1 ?g DNA with 3’-overhang ends  
2 ?l 10 ? T4 DNA polymerase reaction buffer  
2 ?l 10 ? BSA 
1 ?l (3 U) T4 DNA polymerase (NEB) 
20 ?l final volume (H2O bidest)  
 
5’-overhang fill-in: 
0,1 to 1 ?g DNA with 5’-overhang ends  
2 ?l 10 ? T4 DNA polymerase reaction buffer  
2 ?l dGTP/ dCTP/ dTTP/ dATP (10 mM each)  
1 ?l (3 U) T4 DNA polymerase  
20 ?l final volume (H2O bidest)  
After an incubation period of 15 min at 12 °C, the restricted fragments were purified by a 
PCR purification kit or by phenol/choloroform extraction. 
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3.2.4 Phosphorylation of 5’-end of DNA  
Up to 300 pmol 5’-ends of DNA fragments can be phosphorylated in a 50-?l reaction 
containing 1? T4 DNA ligase buffer (1mM ATP, NEB) and 10 U T4 polynukleotide 
kinase (10 U/ml) by incubation for 30 min at 37°C. For blunt-end DNA fragments, 
preheating of the sample for 5 min at 70 °C prior to the start of the reaction are 
recommended (NEB, T4 polynukleotide kinase manual). 
 
3.2.5 Radioactive 5’-end labeling of oligonucleotides 
Oligonucleotides (5 pmol) were mixed in a final volume of 20 ?l with T4 polynucleotide 
kinase buffer, ddH2O, 30 pmol [?-32P] ATP and 10 U T4 Polynucleotide Kinase.  This mix 
was incubated for 30 minutes at 37°C prior to addition of 100 ?l Enzyme-Stop mixture.  
Labeled oligonucleotides were fractionated with a G-25 Sephadex-column.   
Standard protocol: 
  1 ?l oligonucleotides (5 pmol/ ?l) 
  2 ?l 10 ? T4  polynucleotide kinase buffer 
  1 ?l T4 polynucleotide kinase (= 10 U) 
   3 ?l ( = 30 ?Ci [?-32P] ATP) 
 13 ?l H2O bidest 
 
3.2.6 Polymerase chain reaction (PCR) 
For amplification of DNA fragments, polymerase chain reactions were done in an 
Eppendorff Thermocycler (Mastercycler® Gradient). Gene constructs for cloning 
experiments were amplified with the following proofreading polymerases: DeepVent DNA 
polymerase (NEB), Platinum Pfx DNA polymerase (Invitrogen), AccuPrime Pfx DNA 
polymerase (Invitrogen) or Phusion DNA polymerase (Finnzymes). A protocol for 
amplifying DNA is given below, some details were modified corresponding to the 
recommendations of the enzyme manufacturers.  
 
Reaction mixture 50 ?l 
Template DNA 0.01-0.1 µg 
10 ? polymerasebpuffer/ 5 ? polymerase buffer 5 ?l/ 10 ?l 
Primer 1 20-40 pmol 
Primer 2 20-40 pmol 
dNTP mixture (10 mM each) 1-1.5 ?l (200-300 µM) 
DNA polymerase 1-2.5 U 
bidest. H2O ad 50 ?l 
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PCR protocol: 
Cycle step Tempetature Time Cycle number 
preheating 94-98 °C hold (prior to start)  
Initial denaturation  94-98 °C 30 sec-2 min 1 
Denaturation 94-98 °C 5-30 sec   
Annealing 45-72 °C 10-30 sec 25-35 
Extension 68-72 °C 15-30 sec/ 1 kb (Phusion) 
       1 min/ 1 kb (Accuprime Pfx,   
                         Platinum Pfx, Taq) 
       2 min/ 1 kb (DeepVent) 
 
Final extension 68-72 °C 5-10 min 1 
 4 °C hold  
 
3.2.7 PCR mediated site-directed mutagenesis 
The aim of this experiment was to replace the UGA codon (tryptophan) by the UGG 
codon (stop codon in E. coli) and replace the ATG internal start codon of HMW2-s by 
ATT. The method, which was applied to exchange a single nucleotide was based on a 
PCR mediated site-directed mutagenesis [Zoller and smith, 1987; Barettino et al, 1994], 
by which the desired mutation was incorporated in the primers used for the PCR 
program. These primers are generally 25-35 bases long and carry the nucleotide which 
had to be changed in the middle of their sequences. The ‘mutation’ was finally 
incorporated into both DNA strands during PCR-cycles, by which the whole vector was 
amplified. The number of cycles for the PCR-mutagenesis was reduced to only 16 
cycles. The parental template DNA and the linear, mutagenesis-primer incorporating 
newly synthesized DNA were treated with DpnI (10 U) as follow: 
 17 ?l purified PCR sample 
              2 ?l 10 ? NEB4 buffer 
   1 ?l DpnI (10 U/ ?l, NEB) 
incubated for 1.5 h at 37 °C  
DpnI digested only the methylated parental template and hybrid DNA. The treated DNA 
sample (3-5 ?l) was used to transformed competent E. coli.  
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3.2.8 DIG (Digoxigenin-dUTP) -labeling of DNA by PCR 
DNA sequences used for Southern blot experiments were DIG-labeled during the PCR 
with the Taq DNA polymerase. The PCR program for this PCR was set up according to 
chapter 3.2.6. The reaction mixture was however modified:  
Premixture was prepared in 3-fold volumn and divided in 2 PCR reaction tubes. One of 
them was used for a control reaction with the standard dNTPs and another one for a 
reaction, where dTTP was replaced by DIG-dUTP. The replacement of dTTP by DIG-
dUTP during the PCR caused an increase of the molecular weight of the PCR-product.  
Therefore, the success of the DIG-labeling reaction could be monitored by agarose gel 
electrophoresis, where the DIG-labeled DNA migrates slower than the control DNA. 
 
Premixture 45 ?l 
Template DNA 0.05 µg 
10 ? Taq polymerase buffer (with MgCl2) 5 ?l 
Primer 1 40 pmol 
Primer 2 40 pmol 
Taq DNA polymerase 0.5 ?l (1?l if PCR product larger than 1 kb) 
H2O (bidest) ad 45 ?l 
 
Reaction 1: control PCR 
        45 ?l PCR premixture 
          2 ?l dNTP mixture (10 mM each) 
          3 ?l bidest. H2O 
 
Reaction 2: DIG-labeling 
        45 ?l PCR premixture 
          5 ?l PCR DIG probe synthesis mix (#158550, Roche)  
 
3.2.9 Colony hybridization (radioactive) 
This procedure facilitated the search for bacterial colonies containing recombinant 
plasmides by applying DNA hybridization techniques. For this propose, bacteria colonies 
were transferred on nitrocellulose filters and their DNA fixed to the filters. The prepared 
filters could be then hybridized with labeled probes. 
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Colony transfer 
A nitrocellulose membrane was marked, placed on an agar plate containing grown bacteria 
colonies. After one minute the filter was peeled off carefully. For a lysis of the cells, the 
membran was then briefly placed for 3 min on a 3 MM paper (on transparent foil) soaked 
with solution A. To denature the DNA, the filters is further placed for 5 min on 3 mm paper 
soaked with solution B, after that the nitrocellulose is neutralized by placing for 5 min on  3 
MM paper soaked with solution C, before it was air dried, then 0.05 µg positive control 
(plasmid DNA, PCR products or oligonucleotides containing sequence corresponding to the 
labeled probe) is mixed 1:1 to 0.8 M NaCl and dropped on one edge of the membrane. DNA 
was immobilized by automatic UV crosslinking (Stratalinker; 120 mJ). 
 
Colony hybridization  
The colony filters are prehybridized twice for each 2 h in hybridizing buffer (5 ? SSC, 1% 
SDS, 10 ml/ 1-2 filters) at hybridizing temperature (5-10 °C under the melting temperature 
of the oligonucleotids). Hybridization was followed with radioactive-labeled probes (? 106 
cpm) in 10 ml hybridization buffer (per 1-2 filters) for 14-16 h at the same temperature. 
The membranes were washed shortly with 10 ml wash buffer (0.05% SDS, 5 ? SSC), then 
for 10 min at RT with 40 ml wash solution. The detection of the signal was facilitated by 
Phosphor Imager Screens (see 3.5.6). 
 
3.2.10 Colony hybridization (DIG) 
Colony transfer 
A nitrocellulose membrane was marked, placed on an agar plate containing grown bacteria 
colonies. After one minute the filter was peeled off carefully. The membran was briefly 
placed for 15 min on a 3 MM paper (on transparent foil) soaked with solution B, for 15 
min on  3 MM paper  soaked with solution C, and finally for 10 min on  3 MM paper 
soaked with 2 ? SSC, before it was air dried, then 0.05 µg positive control (plasmid DNA, 
PCR products or oligonucleotides containing sequence corresponding to the labeled probe) 
is mixed 1:1 to 0.8 M NaCl and dropped on one edge of the membrane. DNA was 
immobilized by automatic UV crosslinking (Stratalinker; 120 mJ). 
Additional step before hybridizing with DIG-labeled probes, the colony filters had to be 
treated with proteinase K to digest all cellular debris which would cause high background 
by detection. For this perpose, the colony filters were placed on plastic foil, 1 ml of 2 mg/ 
ml (in 2 ? SSC) proteinase K per one membrane was spreaded over the membrane, then 
incubated for 1 at 37 °C h. The filters were placed between 2 Whatman paper (3MM) 
soaked with sterile water, and rolled with a heavy rolling pin to remove all cell debris. 
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Colony hybridization  
The colony filters were prehybridized for 1 h in 50 ml DIG-hybridization buffer (per 1-2 
filters) at 60 °C. Hybridization was followed with 0.1-0.2 µg DIG-labeled probe in 5 ml 
DIG-hybridization buffer (per 1-2 filters) for 14-16 h at 60 °C.  The Dig-labeled probe was 
denatured for 5 min at 95 °C and chilled on ice prior to addition to the hybridization buffer. 
The membranes were washed twice for 5 min with wash buffer 1 and twice for 15 min in 
wash buffer 2 at 60°C. The DIG-detection is described in 3.2.11. 
 
3.2.11 DIG-detection 
The following steps were done at room temperature.  Membranes were incubated for 1-2 
min in DIG-wash buffer, then blocked in 40-50 ml DIG 2 for 30 min-3 h.  Anti-DIG 
antibody (1 µl) was suspended in 10 ml DIG 2 and membranes were incubated in this 
solution for 45 min.  Membranes were then washed twice in DIG-wash buffer for 15 min 
and incubated in DIG 3 for 2-3 min. Probes were stained with NBT/BCIP in AP-buffer 
(10 ml AP-buffer plus 66 ?l NBT and 33 ?l BCIP) (usually from 5-15 min, or even up to 
16 h).  To stop the staining reaction, the AP-buffer was discarded, the membranes were 
washed with TE buffer and air dried. 
 
3.2.12 Colony Western blot 
The Colyny Western blot was used for a rapid identification of overexpressed fusion 
proteins in a polyclonal cell culture. For this perpose, LB agar plate containing bacteria 
colonies grown under selection pressure was chilled for 30 min at 4 °C. A nitrocellulose 
round filter was marked, placed on an agar plate. After one minute the filter was peeled off 
carefully, placed on a fresh LB agar plate containg 10 mM IPTG (colonies upward) and 
incubated for 2-4 hr at 37 °C. The induced bacteria are fumigated with chloroform for 
15 min and incubated with lysis buffer (6ml/ filter) for 14-16 h at RT. After washing with 
TBST, the filters were treated as described in chapter 3.3.9 (Immunoblot analysis). 
 
3.2.13 Southern blotting 
Standard protocol: 
Genomic DNA was diluted with loading  buffer  and  separated  in  a  1  %  agarose  gel  in 
E-buffer at 150 mA or 250 mA depending on gel size. DNA is visualized by staining with 
ethidium bromide (3 ?g/ml). 
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Prior to blotting the DNA onto nylon membranes, gels are incubated as follows: 
2 ? 15 min in 0.125 M HCl 
      30 min in denaturing solution (0.5 M NaOH ; 1.5 M NaCl) 
      30 min in neutralizing solution (1 M NH4Acetate ; 20 mM NaOH) 
The gel was blotted overnight by capillary transfer to a nylon membrane.  Two gel blotting 
papers (GB 005; Schleicher & Schuell) were soaked with neutralizing solution and placed 
on a flat surface.  The gel was laid on the wet gel blotting papers.  A nylon membrane was 
placed on top of the gel and covered with two soaked gel blotting papers.  A stack of dry 
paper towels is laid on top to draw the liquid and transfer the DNA onto the nylon 
membrane. On the following day, the membrane was dried and the DNA was crosslinked 
to the nylon by UV light exposure. Hybridization was done with DIG-labeled probes.  
 
Hybridization protocol (DIG) 
Southern blots were pre-hybridized once in 10 ml DIG-hybridization solution (per 100 
cm2) for 4 h at 60 °C. Hybridization was followed with 0.1-0.2 µg DIG-labeled probe in 
3.5 ml DIG-hybridization solution (per 100 cm2) for 14-16 h at 60 °C. The Dig-labeled 
probe was denatured for 5 min at 95 °C and chilled on ice prior to addition to the 
hybridization solution. The membranes were washed twice with wash solution 1 for 5 min 
and twice in wash solution 2 for 15 min at 60°C. The DIG-detection is described in 3.2.11. 
 
3.3 Biochemical and physical methods 
3.3.1 Preparation/ isolation of plasmids from E. coli 
Protocol: 
A bacteria culture (1.5 ml) was transferred into a 1.5 ml reaction tube and centrifuged for 
1 min at 13,000g.  The cell pellet was resuspended in 100 ?l SolA and incubated for 5 min 
at RT. SolB (200 ?l) was then added to the cell suspension and inverted several times until 
the lysate was homogenous and clear. Then 150 ?l SolC was added, the tube wss inverted 
five times and placed on ice for 10 min.  The precipitate is collected by centrifugation for 
20 min at 13,000g at 4 °C. The supernatant was transferred into a new reaction tube and 
precipitated by ethanol. 
Plasmid isolations from 100 - 200 ml cell suspensions were done with the "Nucleobond PC 
100 Midiprep Kit"  from Macherey and Nagel.  The isolation protocol was used as 
described in the manufacturer’s manual. 
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3.3.2 Preparation/ isolation of genomic DNA from M. pneumoniae 
M. pneumoniae cell were cultured in a 100 ml modified Hayflick medium. After 96 h, cells 
were washed twice with 1 ? PBS and centrifuged at 8,500g at 4 °C. The cell pellet was 
resuspended in 750 ?l Tris/EDTA buffer (50 mM Tris pH 8.0, 25 mM EDTA) and  19 ?l 
of an RnaseH solution (1 mg/ ml, final conc. 25 ?g/ml) was added and incubated for 
15 min at 37 °C. A 50 ?l of proteinase K (25 mg/ml) and 100 ?l of a 10 % SDS solution 
were added to lyse cells. The lysate was incubated for 1-2 h at 50°C or for 14-16 h at RT, 
then 300 ?l 5 M NaCl was added and mixed well by inverting the tube several times until a 
white precipitate had developed. The lysate was incubated on ice for 20 min-1 h. The 
precipitate was collected by centrifugation for 25 min at 13,000g at 4 °C. The supernatant 
was moved into a new reaction tube, 1 ml ice-cold isopropanol (100 %) was added and the 
DNA was precipitated by mild inversion of the tube.  The precipitated DNA was 
centrifuged for 15 min at 13,000g and washed twice with 70 % ethanol. DNA was air dried 
for at least 2 h, 300 ?l TE was added to the DNA pellet without pipetting up and down (to 
avoid shearing genomic DNA) and allowed to stand for 1-2 h at RT. During this time, the 
DNA will be slowly dissolved in the buffer. 
For Southern blot analysis, 20 ?l genomic DNA was digested by a restriction endonuclease in a 
final volume of 100 ?l and samples of 10 to 20 ?l was loaded onto agarose gels for further analysis. 
 
3.3.3 Phenol/ chloroform extraction 
Phenol was added to the liquid solution in a 1:1 ratio (at least 100 ?l of DNA sample). This 
suspension was vortexed and centrifuged for 5 min at 13,000g.  The water phase was 
transferred into a new reaction tube and equal volume TE was added to the phenol phase. 
The suspension was treated like before and the water phase was added to a new tube. An 
equal volume chloroform was added to the water solution and treated twice as described 
above.  Again the water phase was transferred into a new tube for ethanol precipitation.  
 
3.3.4 Ethanol precipitation 
To a given DNA solution 0.1 volume of a 3 M NaAc solution and 2.5 volumes ice-cold 
100 % ethanol  were  added. The  solutions  were  mixed  by  vortexing  and  incubated  for  
20-30 min at -20°C or -80°C (by small DNA or small amount incubate longer (1 hr or 
overnight) before centrifugation at 13,000g.  After centrifugation, the supernatant was 
discarded and the pellet was washed three times with 70 % ethanol.  The precipitated DNA 
was dried in a vacuum centrifuge. 
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3.3.5 Quantification of nucleic acids 
The extinction was measured in a final volume of 100 ?l in a quartz cuvette at 260 nm. 
1 OD260  is equivalent to 50 ?g/ml dsDNA, 40 ?g/ml ssRNA, 33 ?g/ml oligonucleotides. 
Measurements were carried out in UV/ Visible Spectrophotometer Ultrospec 3000.  
 
3.3.6 Purification of PCR products, Isolation of DNA fragment from agarose gel/ 
restriction reactions 
For the separation of full length DNA fragments from primers, buffer, nucleotides and 
enzymes, PCR reactions were purified with the High Pure PCR Product Purification Kit 
(Roche, Mannheim). This kit was also used to seperate DNA fragment from restriction 
enzymes and other addtives in restriction probes. For purification of DNA fragments from 
agarose gels, the Qiagen Gel Purification Kit was used. 
 
3.3.7 Immunization of rabbits 
For the immunization, 300 ?l of the coupled peptides were mixed well with 300 ?l 
Freund’s Adjuvant (complete for the first, incomplete for the subsequent immunizations) 
and injected into a rabbit.  About 0.25 to 0.6 mg proteins were used for each immunization. 
The immunization was repeated 3 times in intervals of 3 weeks, sample was taken a week 
after each immunization and the antibody reaction was monitired by Western blotting. If 
the reaction was satisfying, the rabbit was sacrified and blood of that rabbit was collected 
(~ 70 ml). The blood was incubated for 1 h at 37 °C and then at least 12 h at 4 °C. After 
centrifugation for 30 min at 5,000g at 4 °C, the clear supernatant of the serum was be 
taken, divided in aliquots and kept at -80 °C for a long-term storage or -20 °C prior to use. 
Dilutions of the serum for Western blotting were experimentally determined.  
 
3.3.8 Western-transfer 
Proteins were separated by SDS-PAGE (see 3.4.3). and transferred on nitrocellulose or 
PVDF membran by a BIO RAD blotting chamber (Model No.Trans-Blot SD) at 25 volts 
for 1 hr (or 1.5 hr for protein larger than  200 kDa). Three Whatman papers (GB 005; 
Schleicher & Schuell) are soaked with Schafer-Nielson buffer.  A nitrocellulose membrane 
was soaked shortly with Schafer-Nielson buffer and then laid on top of the wet papers. By 
using PVDF membrane, it had to be briefly soaked with 100% methanol before blotting. 
The resolving gel was placed on the membrane and covered with 3 wet Whatman paper.  
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3.3.9 Immunoblot analysis 
After Western transfer, the proteins were now immobilized on a nitrocellulose membrane 
and could be detected by specific antisera. Immunoblots with antisera were carried out in 
blocking buffer (5 % milk powder in 1 ? TBST). After staining the proteins with Ponceau, 
membranes were blocked in blocking buffer for 1 hr.  The first antibody was diluted in 
blocking buffer and incubated with the membrane for 1 hr.  Membranes were then washed 
three times (each 5-10 min) in 1 ? TBST, followed by incubation with the second antibody 
diluted in blocking buffer for 1 hr. The washing procedure was repeated.  For staining of the 
protein with NTB/BCIP, membranes were incubated in AP-buffer for 1 min prior to 
addition of the staining solution (10 ml AP-buffer plus 66 ?l NBT and 33 ?l BCIP). 
Thereby, alkaline phosphatase catalyzes the oxidation of NBT to indigo, by which a violett-
blue-colored  precipitate developed. The reaction was stopped by incubating the membranes 
in 20 mM EDTA. 
Immunoblots with anti-polyHis antiserum (#H1029, Sigma) were carried out in BSA. After 
staining the protein with Ponceau, membranes were blocked in BSA-blocking buffer (1 % 
BSA in 1 ? PBS) for 1 hr.  The anti-His antiserum was diluted 1:3000 in BSA-blocking 
buffer and incubated with the membrane for 2 hr.  Membranes were then washed three 
times in PBS/ Tween wash buffer (1 ? PBS, 0.05 % Tween20), followed by incubation with 
the anti-Goat-mouse diluted in PBS/ Tween wash buffer for 1 hr.  The washing procedure 
was repeated.  For staining of the protein with NTB/BCIP, membranes were incubated in 
AP-buffer for 1 min prior to addition of the staining solution for Western blots. 
 
3.3.10 Purification of His-tagged proteins  
Purification of fusion proteins with His tag is done by an immobilized metal affinity 
chromatography (IMAC), where matrices like Sephadex CL-6B or Superflow™ coated 
with Nitrilotriacetic acid (NTA) are generally used. NTA binds  Ni2+ ions [Hochuli, 1987, 
Qiagen manual], it has a tetradentate chelating group that occupies four of six sites in the 
nickel coordination sphere. The principle of this affinity chromatography is based on a 
selective connection of neighbouring Histidine with two free binding site of the Ni2+ ions, 
which are coupled with NTA. 
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By automated IMAC 
Automated purification of His-tagged proteins are carried out on an ÄKTAexplorer™ 10 
(Amersham Biosciences). All buffers and running soltions are filtered through 0.2 ?m filter. 
The purification under denaturing condition was done as follows; the sediment of an 
E. coli culture (500 ml) was lysed in 50 ml buffer A and mixed overnight at 4 °C with a 
magnet agitator. The bacterial suspension was then ultracentrifuged for 1 hr at 20,000g at 
4 °C and the supernatant was filtered through a filter with a 0.2 ?m pore size.  This cleared 
cell lysate was the loaded onto the column loaded with Ni2+ ions (5 ml HiTrap Chelating or 
5 to 10 ml Ni-NTA superflow in a XK16/20 column). This column was preincubated with 
buffer A and the lysate in buffer A was loaded with a superloop. The column was washed 
with 5 cv (column volume) buffer B. By further washing with buffer C (5 cv), the pH value 
was lowered to 6.3. The elution was done either by a stepwise gradient with 3 steps (10, 50 
and 100% buffers D, 5 cv each) or a linear gradient (0-100% buffer D in 20 cv). Fractions 
were collected with 0.5 to 1 cv. 
 
Gravity-flow chromatography using sepharose column  
Lysates were prepared from 100 ml E. coli culture. E. coli cells were centrifuged for 
10 min at 8000g at 4 °C, and the resulting pellet was lysed in 20 ml buffer A. The lysates 
were stirred over night at 4 °C in a glass cup. The lysate was centrifuged for 20 min at 
13,000g at 4 °C. To remove unlysed cells. The supernatant was collected and loaded onto a 
Nickel-bound sepharose column. 
 
Purification protocol: 
2 ml Chelating SepharoseTM  Flast Flow (Amersham Biosciences) were loaded into an 
empty column. The sepharose was equilibrated with 10 ml 0.2 M acetic acid, then the 
following solutions were loaded in the order as mentioned: 
10 ml (10 mM nickel sulfate in 0.2 M acetic acid) 
10 ml 0.2 M Acidic acid 
10 ml buffer A 
the lysate 
10 ml buffer A 
20 ml buffer B 
20 ml buffer C 
15 ml buffer D 
10 ml buffer E (five fractions were collected, each in 2 ml reaction flasks) 
10 ml buffer F (five fractions were collected, each in 2 ml reaction flasks) 
The purified proteins were normally in the first two to three fractions of buffer F. 
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Paramagnetic precharged nickel particles 
The paramagnetic precharged nickel particles were supplied with the MagneHis™ Protein 
Purification System (#V8500, Promega) containing all buffers required for purification under 
native conditions. For a purification under denaturing conditions, all buffers were adjusted 
with guanidium hydrochloride or urea to a final concentration at 6 M or 4-8 M, respectively. 
If the tagged protein contained disulfide bridges, up to 10mM DTT were used in all buffers. 
Lysates were prepared from either 5 ? 100 ml M. pneumoniae transformants or from 500 ml 
E. coli culture. The cell pellets were lysed in binding/wash buffer for denaturing conditions 
for 10–60 min (1ml of cultures should be resuspended in 200–600?l binding/wash buffer), 
then incubated with shaking for 10–20 min at RT on a rotary mixer or shaking platform. The 
magnetice particles were vortexed to a uniform suspension prior to use. 
MagneHis™ Ni-Particles (30 µl) were added to 1 ml of cell lysate, then pipetted up and 
down and mixed by pipetting approx. 10 times and incubated for 2 min at RT. The tube was 
placed in the appropriate magnetic stand for approx. 30 sec to capture the magnetic particles 
with the magnet. The supernatant was carefully removed with a pipette and the tube was 
removed from the magnetic stand. About 150 µl of binding/wash buffer were added to the 
magnetic particles mixed well by pipetting. The tube was placed again in the magnetic stand 
for approx. 30 sec, then the supernatant was carefully removed. The wash step was repeated 
twice for a total of 3 washes. For the elution of the His-tagged proteins, 100 ?l of elution 
buffer was added to the washed magnetic particles, and mixed and incubated for 1–2 min at 
RT. Thereafter, the tube was placed in a magnetic stand to capture the magnetic particles 
with the magnet. The supernatant that now contained the purified protein was removed by 
pipetting and the samples could be analyzed by SDS-PAGE or Western blotting. 
 
3.3.11 Purification of TAP-tagged HMW2 
Extracts were prepared from 30 ? 150 ml M. pneumoniae transformants, grown at standard 
growth conditions. The collected cell pellets were resuspended in 7.5 ml IPP150 buffers 
containing protease inhibitor Cocktails (Complete tablets, Roche), and sonified (Sonifier 
B-15, Cuphorn, Branson) for 8 ? 15 sec with 30 sec intervals at 4 °C. The extract was 
centrifuged at 25,000g for 30 min and the supernatant was transferred into a new tube and 
centrifuged at 100,000g for 1 h. After this centrifugation step three phases were visible in 
the tube: a lipidic phase floating on top, a pellet of cellular debris on the bottom, and a 
middle phase containing the extract. This last phase was recovered and used for the next in 
purification step or kept at -80 °C. 
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All the binding and elution steps were done in a 0.8 ? 4-cm Poly-Prep columns (Bio-Rad). 
One hundred microliters of IgG Sepharose beads (Amersham Biosciences) corresponding 
to 200 µl of bead suspensions, was transferred into the column. The beads were washed 
with 10 ml IPP150. Then the extract was transferred into the column containing the 
washed beads and rotated for 2 h at 4 °C. Elution is done by gravity flow and the beads 
were washed 3 times with each 10 ml IgG binding buffer and once with 10 ml of TEV 
cleavage buffer. Cleavage is done in the same column by adding 1 ml of TEV cleavage 
buffer and 100 units of TEV protease (Gibco). The beads were rotated for 2 h at 16 °C and 
the eluate was recovered by gravity flow.  
One hundred microliters of calmodulin beads (Stratagene), corresponding to 200 µl of bead 
suspension, was transferred into a column and washed with 10 ml of IPP150 calmodulin 
binding buffer. Calmodulin binding buffer (3 ml) and 3 µl of 1 M CaCl2 were added to the 
1 ml of eluate recovered after TEV cleavage. This solution was then transferred to the 
column containing washed calmodulin beads and rotated for 1 h at 4 °C. After the beads 
were washed with 30 ml of calmodulin binding buffer, the bound proteins were elute with 
1 ml of calmodulin elution buffer. Five elution fractions of 200 µl each were collected. The 
proteins were usually found in fractions 2 and 3. 
 
3.3.12 Determination of protein concentration 
BCA method  
Protein concentration is determined by the bicinchoninic acid (BCA) Protein Assay Kit 
(Pierce). This method is based on the reaction of biuret with Cu2+ ions in alkaline solution, 
where a blue-violet copper complex develops (biuret reaction) [Smith, 1985]. 
Reagent A (containing Na2CO3, NaHCO3, bicinchoninic acid and sodium tartrate in 0.1 M 
NaOH) was mixed in the ratio 50:1 with reagent B (4% CuSO4). One milliliter of the 
mixture was pipetted to 50 ?l of the protein sample and mixed well. After incubation of 
30 min at 60 °C, the absorbance was measured at 562 nm. Standards containing a range of 
50 to 400 ?g/ml protein (50, 100, 200, 300, 400 ?g/ml, bovine serum albumin) were used 
for generating a standard curve. 
 
Bradford method 
Assay materials including color reagent, protein standard, and instruction booklet were 
available from Bio-Rad Corporation. The assay is based on the observation that the 
absorbance maximum for an acidic solution of Coomassie Brilliant Blue G-250 shifts from 
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465 nm to 595 nm when binding to protein occurs [Bradford, 1976]. Both hydrophobic and 
ionic interactions stabilize the anionic form of the dye, causing a visible color change. The 
assay is useful since the extinction coefficient of a dye-albumin complex solution is 
constant over a 10-fold concentration range. The Bradford assay is very fast and is 
insensitive against various chemicals (eg. urea, SDS). Protein samples (50 µl) were added 
to 1 ml of the 1:5 diluted dye reagent and incubated for 5 min. The absorbance was 
measured at 590 nm. Standards containing a range of 50 to 400 ?g/ml protein (50, 100, 
200, 300, 400 ?g/ml, bovine serum albumin) were used for generating a standard curve.  
 
3.3.13 Protein precipitation 
TCA precipitation 
Precipitation of proteins with trichloroacetic acid (TCA) is a fast method, however proteins 
are strongly denatured. This makes it sometimes difficult to resuspend the complete pellet 
even in protein sample buffer. To precipitate proteins, 0.25 volumes of a 50% TCA 
solution were added to the protein sample and the proteins were allowed to precipitate for 
1 h on ice. The precipitated proteins were harvested by centrifugation for 20 min at 
13,000g at 4 °C. After washing once with 5 volumes of ice-cold 80% acetone, the tubes 
were set on their sides for about 10 min at RT to let acetone evaporated. The dried pellets 
were then resuspended in sample buffer and used for further analysis. 
 
Acetone precipitation  
It is a very mild method for protein precipitation and suitable for recovering proteins from 
most aqueous solvents and from SDS containing buffers. It is not recommended for 
proteins dissolved in urea or guanidine or for peptides. Acetone (3.3 volumes, precooled at 
-20 °C) were added to the protein or protein sample and mixed by vortexing and incubated 
for at least 1 h or overnight at -20 °C. The precipitated protein will be visible, usually as a 
flocculent, white particulate material. The proteins were collected by centrifugation for 
20min at 13,000g at 4 °C. The pellets were allowed to dry completely, until the acetone 
was completely removed. Each pellet was dissolved in sample buffer. 
Methanol/ chloroform precipitation 
This procedure for precipitating proteins from solution, including detergent solutions, was 
introduced by Wessel and Flügge [Wessel and Flügge,1984] to remove salt and detergents. 
Methanol (400 µl) were added to 100 µl sample solutions, mixed well by converting tubes 
several times and centrifuged for 10 sec at 9,000g, then 100 µl chloroform were added, 
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mixed well by converting tubes several times and centrifuged for 10 sec at 9,000g. For 
phase separation, 300 µl water were added, mixed vigorously by vortexing and centrifuged 
for 1 min at 9,000g. Three phases will be observed, a H2O/methanol phase, an interphase 
containing the proteins, and a chloroform phase. The H2O/methanol phase was removed 
carefully with a pipette without touching the interphase. Methanol (300 µl) were added to 
the interphase and the chloroform phase, mixed well by converting tubes several times and 
centrifuged for 2 min at 9,000g. The supernatant was removed as carefully as possible 
without disturbing pellet which containes the protein(s). The pellet was allowed to dry 
completely and was then dissolved in sample buffer. 
 
3.4 Gel systems 
3.4.1 Agarose gels 
To analyze plasmid DNA and DNA fragments, a horizontal Gelsystems with an agarose 
concentration between 0.8 to 2 % (standard DNA gel: 0.8 %) were used. DNA gels were 
prepared with 1 ? E-buffer. To control DNA migration, the samples were mixed with 
sample buffer (20%). The gels were run in E-buffer with a constant current (160 mA for 
30 ml gels, or 320 mA for 120 ml gels). 
 
3.4.2 SDS polyacrylamide gel electrophoresis (PAGE) 
Vertical tris-glycin gel systems composed of  stacking- (4.5 %) and resolving gels 
(between 7.5 % and 15 %) were used. Recipes for both gels are given below: 
 
Stacking gel:   4.5 % 
30% PAA   3 ml 
Stacking gel buffer  5 ml   
H2O    12 ml 
TEMED   20 ?l 
10 % APS   200 ?l 
final volume   20 ml 
 
Resolving gel:    7.5%  10 %  12,5 %  15 % 
30% PAA   15 ml  20 ml  25 ml  30 ml   
Resolving gel buffer  15 ml  15 ml  15 ml  15 ml 
H2O    30 ml           25 ml  20 ml             15 ml 
TEMED   60 ?l   60 ?l  60 ?l  60 ?l 
10 % APS   600 ?l   600 ?l  600 ?l  600 ?l 
final volume   60 ml 
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Solutions for the resolving gels were pipetted together as described above, but without 
addition of APS. The casting cartridge was assembled as described by the manufacturer. 
The required amount of APS was added to the solutions just before pouring the gel. The 
resolving gel solution was overlaid with isopropanol is and allowed to polymerize. The 
polymerization should be finished within 15-30 min. After that the stacking gels solution 
was overlaid and the combs were placed between the glass plates. The stacking gel should 
polymerize within 30-45 min. Vertical 2-dimensional gels were prepared without the 
stacking gel. After polymerization, the combs were removed carefully and the wells are 
rinsed with water to remove any unpolymerized acrylamide. 
To get preliminary information of the analysed proteins, a protein marker is routinely 
loaded onto the gel. The gel apparatus is connected to the power supply and run at constant 
current. Cooling was required by running at higher current to prevent the ‘smiling’ effect 
(curvature of the migratory band). The gels were normally stopped when bromophenol 
blue tracking dye had reached the bottom of the gel. 
 
3.4.3 One-dimensional (1-D) gel electrophoresis 
M. pneumoniae cells (ca. 70 mg wet weights) were resuspended in 500 ?l extraction buffer 
for SDS-PAGE. For measuring the protein concentration, the protein solution had to be 
diluted (1:20 – 1:50). The final sample was adjusted to concentration of 1 mg/ml with 
extraction buffer and 5 ? SDS sample buffer. After heating for 5 min at 95 °C, the cells are 
broken and 5-20 µl (per lane) of clear cell suspension was used for 1-D SDS gel 
electrophoresis. Procedures for preparing and running gels are described in 3.4.2. 
 
3.4.4 Two-dimensional (2-D) gel electrophoresis 
The two-dimensional (2-D) gel electrophoresis with immobilized pH gradient was done 
according to a manual from Görg [Görg et al., 1988, 1995,1999 and 2000]. The isoelectric 
focussing was done in the IPGphor™ chamber (Amersham Biosciences). The 18 cm long 
strips with an immobilized pH gradient from 3-10 (Amersham Biosciences) were used. 
 
Preparation of protein extract for 2-D gel electrophoresis 
Extracts were prepared from 100 ml M. pneumoniae cells grown at standard growth 
conditions. Cell pellets (about 70 mg wet weight) were resuspended in 500 lysis buffer and 
sonified (Sonifier B-15, cuphorn, Branson) for 8 ? 15 sec at 4 °C. To solubilize the 
proteins as completely as possible, the cell suspension was incubated for 1 h with agitation 
at RT. Insoluble components were separated by ultracentrifugation for 45 min at 55,000g 
at 20 °C. The clear supernatant was stored in aliquots at -80 °C and should not be thawed 
more than twice. The protein concentration was measured by the Bradford method and 
adjusted to a concentration from 2 and 5 mg/ml. 
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First dimension: Isoelectric focussing (IEF) with IPGphor™ 
IPG-IEF for 2-D electrophoresis can be simplified by the use of an integrated instrument, the 
IPGphor™ (Amersham Biosciences). The IPGphor™ includes a Peltier element for 
temperature control (between 18°C and 25°C) and a programmable power supply (8000V, 1.5 
mA). The central part of this instrument are so-called strip holders made from an aluminium 
oxide ceramic, in which IPG (immobilized pH gradient) strip rehydration with sample 
solution and IEF are done after the strip is placed into the strip holder. The IPGphor™ can 
handle up to 12 strip holders (length 7, 11, 13 or 18 cm). The strip holder platform regulates 
temperature and serves as the electrical connector for the strip holders. Besides easier 
handling, a second advantage of the IPGphor is the reduced time for focussing, because IEF 
can be done at rather high voltage (up to 8000 V). The IPGphor™ is programmable and can 
store nine different programs. A delayed start is also possible, which allows the user to load 
the strip holders with sample dissolved in rehydration buffer in the afternoon, then 
automatically start IEF during the night so that IEF is finished the next morning. 
The extract containg the appropiate amount of proteins was diluted with rehydration 
solution to a final volumn of 350 µl for 18 cm long IPG strips (Amersham Biosciences). 
The required number of strip holders were put onto the cooling plate/electrode contact area 
of the IPGphor™. The sample containing the rehydration solution was pipetted into the 
strip holder base. The protective cover sheets from the IPG strip was peeled off and the 
IPG strip was placed slowly (gel side-down) onto the rehydration solution, avoiding trap to 
air-bubbles. The IPG strips were covered with 1 ml of silicone oil, then the plastic cover 
was applied. Pressure blocks on the underside of the cover assure that the IPG strip keeps 
in good contact with the electrodes as the gel swells. The instrument was programmed 
(desired rehydration time, voltage gradient, temperature). After the IPG gel strips had been 
rehydrated (which requires six hours at least), IEF started according to the following 
programmed parameters. After IEF, those IPG gel strips, which were not used immediately 
for the run in the second dimension were kept for further use, were stored between two 
sheets of plastic film at -80 °C up to several months. 
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IPGphor™ running conditions for IPGs 3-10:  
Temperatur: 20°C, 0.05 mA/ strip 
  analytical:  preparative: 
V / h    18 cm   18 cm 
30 V      6 h     6 h 
60 V      6 h     6 h 
200 V      1 h     2 h 
500 V      1 h     2 h 
1000 V     1 h     2 h 
Gradient 1-8 kV    1 h     2 h 
8000 V   4 h   10 h 
 
Equilibration of the IPG gel strips 
The IPG gel strips were equilibrated twice, each time for 15 min in 2 ? 10 ml equilibration 
buffer. The equilibration buffer contained 6 M urea and 30% (v/v) glycerol to diminish 
electroendosmotic effects [Görg et al. 1988] which are thought to be responsible for 
reduced protein transfer from the first to the second dimension. DTT (100-200 mg) were 
dissolved in 10 ml of equilibration buffer (= equilibration buffer I). The focused IPG gel 
strips were taken out from the freezer and placed into individual test tubes. Bromophenol 
Blue solution were added to 10 ml Equilibration buffer I. The test tubes were sealed with 
parafilm and incubated for 15 min on a shaker, then the equilibration buffer I was 
discarded. Iodoacetamide (IAA) (460 mg) were dissolved in 10 ml of equilibration buffer 
(= equilibration buffer II, 260 mM iodoacetamide). Bromophenol Blue solution were 
added to the equilibration buffer II. The IPG gel strips were incubated with the 
equilibration buffer II for another 15 min on a shaker. Iodoacetamide removes excess DTT, 
which is responsible for the ‘point streaking’ in silver stained patterns [Görg et al. 1988]. 
The equilibrated IPG gel strips were slightly rinsed with deionized water for a second, then 
placed on a piece of filter paper at one edge for a few minutes to drain off excess 
equilibration buffer. The strip could be now applied onto the second dimension SDS gel.  
 
Second dimension: SDS-PAGE) 
The second dimension can be run on horizontal or vertical systems [Görg et al. 1988, 1995]. 
In this work, a vertical gel system was used. The electrophoresis chamber was filled with 
protein running buffer and the cooling (15°C) was turned on. The SDS gel cassettes (gel 
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size 20 ? 20 cm) were supported in a vertical position to facilitate the application of the first 
dimension IPG strips. After equilibration, The IPG gel strip was immersed in protein 
running buffer for a few seconds, placed on top of of a vertical SDS gel and overlaid with 
2 ml of hot agarose solution (75°C). The IPG strip was pressed carefully with a spatula onto 
the surface of the SDS gel to achieve complete contact. The agarose was allowed to solidify 
for at least 5 min. This procedure was repeated for the remaining IPG strips. The gel 
cassettes were inserted in the electrophoresis apparatus (Protean Xi chamber, Biorad) and 
the electrophoresis started. The SDS-PAGE gels could be run for 4-5 h or overnight. 
 
Running conditions for one vertical SDS gel (15 °C): 
    1 h 200 V, 20 mA, 30 W 
3-4 h 800 V, 40 mA, 50 W 
 
Overnight running conditions for one vertical SDS gels (15 °C): 
18 h 100-150 V, 15 mA, 50 W 
 
The run was terminated when the Bromophenol Blue tracking dye had migrated off the 
lower end of the gel. The cassettes was opened carefully with a spatula. A spatula was also 
used to remove the agarose overlay from the polyacrylamide gel. The gel was peeled off 
the glass plate carefully, lifted by the lower edge and placed in a tray containing fixing 
solution. Fixing and protein staining were then continued. 
 
3.5 Visualization of biomolecules and imaging tools 
3.5.1 Nucleic acids 
DNA fragments in agarose gels are visualized by staining with ethidium bromide. 
Ethidium bromide is a fluorescent dye that intercalates between bases of nucleic acids and 
allows a very convenient detection of DNA or RNA fragments in gels. The gel was stained 
after electrophoresis by soaking 10 min in a dilute solution of ethidium bromide (3 µg/ ml), 
and then rinsed well with water. To visualize DNA, the gel was placed on a ultraviolet 
transilluminator. Examination or photography of DNA should be taken shortly after the 
end of electrophoresis because the DNA bands will diffuse within the gel. 
Ethidium bromide can also be incorporated into the gel or added to the samples of DNA before 
loading, however binding of ethidium bromide to DNA has some influence on the DNA mobility.  
Methods 
 
 75
3.5.2 Coomassie Blue staining 
After electrophoresis the gel was soaked in Coomassie staining solution for 45 min with 
gentle agitation at RT. The gel was then destained by soaking in the destaining solution 
with gentle agitation. The destaining solution should be changed several times. The 
destaining was continued until the protein bands are seen without background staining of 
the gel. The gel can be stored for some time in deionized water. It might be convenient to 
carefully transfer the gel to a sealable bag and dried for longer-term storage. 
 
3.5.3 Colloidal Coomassie staining 
Colloidal Coomassie staining was used because it is more sensitive than normal Coomassie 
staining, and the proteins can be analysed by mass spectrometry. 
 
With Colloidal Coomassie Kit 
The Colloidal Coomassie staining was done with the Colloidal Coomassie kit from 
Invitrogen. It is based on the method from Neuhoff [Neuhoff et al., 1988]. After 
electrophoresis, the gel was soaked in fixing solution for at least 2 h or overnight. After 
rinsing with distilled water, the gel was further incubated in Colloidal Coomassie staining 
solution mixed as described in the manual of the manufacterer for 3-12 h with gentle 
agitation. The gel was destained by rinsing with deionized water until the protein bands 
were seen without background staining of the gel.  
 
With home-made Colloidal Coomassie stain solution  
After electrophoresis, the gel was soaked in fixing solution (40% ethanol, 10% acetic acid) 
for 1-2 h or overnight. After rinsing with distilled water for 2 ? 10 min, the gel was further 
incubated in Colloidal Coomassie staining solution overnight with gentle agitation. The gel 
was destained by rinsing with deionized water until the protein bands were seen without 
background staining of the gel. 
 
3.5.4 Silver staining according to Blum  
It is a standard silver staining method modified for 2-D gels [Blum et al., 1987]. It is 
relatively rapid and sensitive (?1 ng). Since proteins are not crosslinked with 
glutaraldehyde, it is also compatible with a subsequent mass spectrometric analysis, 
although it is not as suitable as Colloidal Coomassie.  
All steps were done with gentle agitation at RT. All solutions are freshly made with 
deionized water. For staining one acrylamide gel (20 ? 20 ? 0.075 cm), about 500 ml of the 
following solutions were required. 
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Purpose Solution (in 500 ml deionized water) Time 
Fixing 40% ethanol, 10% acetic acid > 2h or overnight 
Wash 30% ethanol 3 ? 20 min 
Sensitizer 0.1 g Na2S2O3 (0.02%) 1 min 
Wash  deionized water 3 ? 20 sec  
Silver staining 1 g AgNO3 (0.2%) + 125 ?l (0.03%) formaldehyde 
37% 
20 min 
Wash deionized water 2 ? 20 sec 
Development 15 g Na2CO3 (3%) + 250 ?l (0.05%) formaldehyde 
37% 
2-5 min or until 
protein spots reach 
required sensitivity 
Wash deionized water 3 ? 20 sec 
Stop 5 g (1%) glycine 10 min 
Wash deionized water 3 ? 20 sec 
- Do not touch the gel with fingers. Always wear gloves or use forceps. 
- This method can also be used for staining RNA in PAA gels. 
- alternative fixation for small proteins: 50% methanol and 10% acetic acid 
 
3.5.5 Silver staining according to Heukeshoven and Dernick 
This staining method is particulary used for visualizing basic proteins [Heukeshoven and 
Dernick, 1988]. By this method, proteins are crosslinked with glutaraldehyde, so that 
protein spots can not be used for analysis by mass spectrometry. 
All steps were done with gentle agitation at RT. All solutions are freshly made with 
deionized water. For staining one acrylamide gel (20 ? 20 ? 0.075 cm), about 500 ml of the 
following solutions were required. 
Purpose Solution (in 500 ml deionized water) Time 
Fixing 40% ethanol, 10% acetic acid 30 min 
Sensitizer 30% ethanol, 64.5 g Na-acetate 5?H2O (or 39 g Na-
acetate), 10 ml glutardialdehyde, 1 g Na2S2O3 
1 h 
Fixing/ Wash 30% ethanol, 5% acetic acid > 1 h or overnight 
Wash deionized water  6-8 ? 15 min 
Silver staining 0.5 g AgNO3 + 250 ?l formaldehyde 37% 30 min 
Wash deionized water 2 ? 20 sec 
Development 15 g Na2CO3 + 125 ?l formaldehyde 37% 1-3 min or until 
protein spots reach 
required sensitivity 
Wash deionized water 2 ? 20 sec 
Stop 5 g (1%) glycine 10 min 
Wash deionized water 3 ? 20 sec 
- Do not touch the gel with fingers. Always wear gloves or use forceps. 
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3.5.6 Ponceau staining 
This staining is a quick and easy method to visualize proteins after transferring to 
nitrocellulose membranes. Ponceau is a reversible protein dye allowing one to check the 
quality of the transfer. The blot was stained in the Ponceau solution for 5 min with gentle 
agitation. The Ponceau solution is reusable for several times. The blot was destained by 
rinsing in distilled water, until the protein bands showed up well. If the transfer was 
efficient, the proteins could be seen as pale pink bands. The molecular weight markers 
could be permanently marked using a pen even when the membrane was still wet. To get a 
permanent record of the gel, the ponceau stained blot can be copied. 
 
3.5.7 Phosphor Imager screens 
The Phosphor Imager system was developed by Molecular Dynamics for qualitative and 
quantitative analysis of radioactive probes.  The system is approximately ten times more 
sensitive than x-ray film [Phosphor Imager user manual, 1999, Molecular Dynamics]. The 
commercially available "Imaging Plates: IPs" are made up of a crystal layer composed of 
BaFBr:Eu2+, contained within an organic binder.  Rays, which are emitted from high 
energy sources, e.g. x-rays, UV-rays, gamma rays, beta particles, excite an electron within 
the Eu2+-ions, which then shifts from the valence band into the conduction band.  The 
excited electron is trapped in the "F-center" of the BaFBr--complex and the Eu3+ remains in 
its oxidized condition.  The excited BaFBr--complex possesses a distinct absorption at 
600 nm.  By exciting the complex with a Helium-Neon Lasers (630 nm), the electron 
returns into the valence band. Thus, the Eu3+ atoms are again reduced to Eu2+.  During this 
process, a photon (390 nm) is emitted [Johnston et al., 1990]. 
The intensity of the luminescence is measured in relation to the position of the scanning 
laser beam and the output is saved as a digital image, yielding a quantitative representation 
of the initial energy-emitting source.  
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3.6 Computer based evaluation of data 
3.6.1 Image Quant and Image Reader 
These are software tools that functions in combination with the phosphor imager scanners;  
Image Quant in combination with the phosphor imager of Molecular Dynamics, and Image 
Reader V1.8E in combination with the phosphor imager from FUJIFILM. The tools 
transcribes the scanned image to digital data, delivering a tif image file in 16 bit format. 
 
3.6.2 VisualGrid 
The software program “VisualGrid™, Implemented by Markus Kietzmann with 
contributions from David Bancroft and Igor Ivanov, Copyrighted and Licensed by GPC 
AG Genome Pharmaceuticals Corporation 1998 – 1999” was applied for the analysis of the 
image *.tif files. 
Protocol: 
Western blots or 2-D gels were scanned and save as *.tif or *.bmp, then inverted by using 
the software program Adobe Photoshop to a dark background. A virtual grid of 2 ? 2 
squares was placed over the Western blot signals or protein spots from 2-D gels, so that 
two signals, which were to be compared, are in each square. For each signal, a mask was 
set, which defined the spot-area to be measured by the program. 
Aside from the average signal, the  program  calculated  background  and  various  quantile 
values of the signal and the  background. Of  all  the  calculated  values,  only  the  average 
value was used for further analyses. 
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4 Results 
4.1 Expression of HMW2 
To isolate sufficient material of HMW2 for doing structural and biochemical studies, the 
HMW2 protein was expressed in Escherichia coli. 
 
4.1.1 Expression of the His-tagged HMW2 in E. coli 
a) Cloning and expression of the C-terminal His-tagged HMW2 in E. coli 
The gene hmw2 fused 6?his tag at the 3’ end was constructed and used for overexpression 
in E. coli. It was cloned into the NcoI/BglII site of the vector pQE60 (Qiagen), which 
added a sequence for a 6?his tag to the 3’ end of the cloned gene. E. coli strain XL1-blue 
(Stratagene) was transformed with the gene construct. 
The hmw2 gene contains four UGA triplets, coding for tryptophan in M. pneumoniae but 
for a stop codon in other organisms (Fig. 4.1). Therefore, to express HMW2 in other 
organisms than M. pneumoniae, all UGA codons of the gene hmw2 were changed to UGG 
[Boonmee, unpublished]. 
 
 
 
Fig. 4.1: Schematic illustration of the HMW2 protein. The positions of UGAs numbers shown here 
are amino acid positions. 
 
The success of the mutagenesis could be  monitored by analyzing the translation products 
of the stepwise mutated hmw2 gene in E. coli by Western blot. After conversion of all four 
UGA codons, the full-length HMW2 protein could be detected in a band indicating a molar 
mass of 216 kDa (Fig. 4.2). 
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Fig. 4.2: Western blot analysis of expressed full-
length HMW2 in E. coli and M. pneumoniae WT 
was used as a control (7.5% SDS-PAA gel).  
?-HMW2-Cterm, dilution1:1000. 
lane 1 = E. coli 
lane 2 = M. pneumoniae 
 
The full-length HMW2 protein was synthesized at very low concentrations and seemed to 
be degraded very fast in E. coli. It was only visible after Western blotting but not by 
staining with Coomassie Blue. It was not possible to isolate sufficient amount of HMW2 
under standart condition and therefor I tried to optimize conditions for the expression. 
 
Optimization of the expression of the C-terminal His-tagged HMW2 in E. coli 
Variation of the Inducing time 
The expression of the His-tagged HMW2 in E. coli was done under standard condition as 
followed: the diluted overnight culture (?1:20 ; OD600 = 0.2) was grown for two hours, 
then IPTG was added at a final concentration of 1 mM and incubated for four more hours. 
Since HMW2 seemed to be degraded during the four hours of induction, the induction time 
was reduced to two hours. To compensate for the shorter induction period, the noninduced 
bacteria were now grown for four hours instead of two, to increase the number of cells. 
Total protein extracts of E. coli containg the His-tagged HMW2 expressed within two and 
four hours were compared (Fig. 4.3). Total protein lysat were seperated on a 7.5% SDS-
PAA gel, blotted on nitrocellulose membran and probed with an antiserum which was 
directed against the HMW2-C-terminal region (?-HMW2-Cterm). 
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Fig. 4.3: Western blot analysis of HMW2 synthesized 
in E. coli (7.5% SDS-PAA gel). The induction time 
was compared between four hours and two hours.  
?-HMW2-Cterm, dilution 1:1000. 
1 = four hours  
2 = two hours 
The Western blot analysis revealed that the amount of fusion protein expressed within two 
hours was less than that from the four hours induction, but the degradation of the fusion 
protein was reduced. But even the after two hours induction many degraded HMW2 
proteins could be still detected. This indicated that HMW2 was not very stable in E. coli. 
In addition, the amount of HMW2 was very low, since the protein could be only detected 
by Western blotting but not by staining the gel with Coomassie Blue or silver stain. 
 
Changing the host strain 
To improve the yield of HMW2 in E. coli, several host strains were tested. The 
QIAexpress System (Qiagen), to which pQE60 vector belongs, recommens the E. coli 
strain M15[pREP4] which permits high-level expression. In our lab, E. coli strain 
XL1 Blue (Stratagene) is normally used. It harbours a single chromosomal copy of the 
lacIq gene, producing enough lac repressor to efficiently block transcription. This E. coli 
strain is ideal for storing and propagating pQE plasmids because it does not contain 
additional plasmid like the strain M15[pREP4]. Other E. coli strains that also have a lacIq 
phenotype are JM109 and TG1. These strains (XL1 Blue, JM109 and TG1) can be used as 
expression hosts for expressing nontoxic proteins, but they may be less efficient than the 
M15[pREP4] strain and expression is regulated less tightly than in strains harboring the 
pREP4 plasmid. If the expressed protein is toxic to the cell, ‘leaky’ expression before 
induction may result in poor culture growth or in the selection of mutants which grow 
faster than bacteria containing the correct plasmid. To test differences in expression, the 
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E. coli strain XL1-blue, M15[pREP4], JM109 and TG1 were transformed with the cloned 
his-tagged hmw2 and the expression of the His-tagged HMW2 in these strains was 
monitored by SDS-PAGE and Western blotting (Fig. 4.4). A ‘leaky’ expression of the 
fusion protein was observed in all strain. E. coli strain M15[pREP4] showed the most tight 
control of the expresssion, since one could see that the fusion protein is less expressed in 
the uninduced sample. Therefore, this strain was chosen for expression of the HMW2 
fusion protein in further experiments. 
 
Fig. 4.4: Western blot analysis of HMW2 expressed in various E. coli strains (12.5% SDS-PAA gel). 
1 = XL1-blue;  2 = M15[pREP4];  3 = JM109;  4 = TG1;  5 = BL21;   
+ = induced; ? = uninduced; for control with nontransformed E. coli see Fig. 4.5. 
 
Reducing temperature for growth and induction 
Since the results on expression of HMW2 were still not satisfactory, several growth 
parameter were changed in particular temperature and time of induction. E.coli 
M15[pREP4] containing the hmw2 construct was grown overnight at 37°C in YT medium 
containing 2% glucose. The overnight culture was diluted to OD600 = 0.2 and grown at 
37 °C in YT medium containing 1% glucose until the culture reached an OD600 = 1. YT 
medium containing 1% glucose was added to dilute the E. coli culture to OD600 = 0.4. They 
were grown for two hours at 15 °C, then IPTG was added to final concentration of 0.1mM. 
The bacteria were incubated overnight (? 20 hours) at 15 °C. The expression of the HMW2 
fusion protein was monitored by Western blot analysis using ?-HMW2-Cterm to detect the 
fusion protein (Fig. 4.5). No significant change in reduction of protein degradation was 
observed between cell induced at 37 °C or 15 °C. It seemed that the yield of HMW2 fusion 
protein was higher in the sample from E.  coli grown at 15 °C than E. coli grown at 37 °C. 
Therefore, I decided to express this protein at 15 °C. 
Results 
 
 83
 
 
 
 
 
Fig. 4.5: Western blot analysis of HMW2 expressed 
in E. coli strain M15[pREP4] (7.5% SDS-PAA gel). 
The inducing temperature was compared. 
0 = E. coli M15[pREP4]. 
– = E. coli containing HWM2 (not induced) 
1 = E. coli containing HWM2 induced at 37°C 
2 = E. coli containing HWM2 induced at 15°C 
MP = M. pneumoniae WT 
 
c) Purification of the C-terminal His-tagged HMW2 fusion protein 
Solubility tests of cell pellets containing the HMW2 fusion protein were done with various lysis 
buffers (native/ denaturing conditions). As seen by SDS-PAGE, the fusion protein was 
insoluble applying native conditions. To test the various purification procedures, the pellet from 
500 ml of E. coli culture was used. The purification of the His-tagged HMW2 was successful 
only by using paramagnetic, precharged nickel particles (MagneHis™ Ni-Particles, Promega) 
under denaturing condition (6 M Guanidium hydrochloride). The success of the purification 
was monitored by SDS-PAGE and Western blotting using ?-HMW2-Cterm (Fig. 4.6). 
Although the purification was effective, the amount of isolated expressed protein was so low 
that renaturation experiments to see polymerization of HMW2 could not be done succesfully. 
 
 
 
 
 
Fig. 4.6: Western blot analyses of various 
fractions from the purification of His-tagged 
HMW2 in E. coli (12,5% SDS-PAA gel)  
(?-HMW2-Cterm, dilution1:1000). 
MP = M. pneumoniae WT (control) 
Wh = whole cell extract 
E = eluat 
W = wash 
F = flow through 
P = pellet from the cell lysat. 
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4.1.2 Expression of the His-tagged HMW2 in M. pneumoniae 
HMW2 was unstable and degraded very fast in E.coli, so that it was impossible to isolate 
enough material for further structural studies. The condition in E.coli might be not optimal 
for the stability of HMW2. Therefore, expression in its original host M. pneumoniae was 
chosen to overcome this problem. 
 
a) C-terminal fusion of a poly His tag 
Cloning of the 3’ end his-tagged hmw2 construct 
The expression of the His-tagged HMW2 should be regulated by the expression unit of the 
clpB gene from M. pneumoniae (this unit will be called throughout this thesis clpB 
promotor, since the only signal conserved in the unit is the -10 region of the promotor). 
Since attempts to ligate the small (300 bp) fragment containing the clpB promotor and the 
large (5.8 kbp) fragment containing the whole gene hmw2 failed, a short EcoRI fragment 
of the hmw2 gene encoding the first 128 aa (384 bp) was ligated to a PCR product of the 
clpB promotor. The gene hmw2 (4 UGGs) cloned in the vector pQE60 was used as a 
source for generating this construct. This construct contained the gene hmw2 followed by 
additional six histidine codons at the 3’ end. The new construct containing the clpB 
promotor upstream of the ATG start codon of hmw2 was then amplified by PCR. Codons 
for additional three histidines were added in a primer used for the PCR, so that the final 
PCR product contains a gene coding for nine histidines at the 3’ end. The obtained PCR 
product was restricted with BamHI and cloned into the BamHI site of the IS256R element 
of Tn4001mod of the vector pKV74. This vector contains a modified transposon 
Tn4001mod [Hedreyda et al., 1993], which can be used as carrier for integrating foreign 
DNA into the genome of M. pneumoniae The cloning strategy is illustrated in Fig. 4.7.  
E. coli colonies which were transformed with the ligation product grew very slowly and 
the size of the colonies was unusual small. No positive clones were found after searching 
almost 2,000 colonies by colony hybridization. It was previously observed that a gene 
hmw2, of which all four UGA codons were changed to UGG was not very well expressed 
and seemed to be degraded very fast in E.coli (Fig. 4.2). The full-length HMW2 protein is 
probably toxic for E.coli and could therefor increase the generation time and cause the 
formation of those unusual small colonies which made a finding of positives clones even 
more difficult. Therefore, a clone habouring the modified gene hmw2 under the control of 
the clpB promotor might not be easily identified, since the clpB promotor can not be 
regulated, causing a constitutive production of HMW2 in E.coli. 
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Fig. 4.7: Schematic illustration of the synthesis of the gene hmw2 fused to DNAfragment encoding 
nine histidines at the 3’ end and of cloning it into the vector pKV74. 
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Hence, to inhibit synthesis of HMW2 in E. coli, a BclI fragment of the new hmw2 
construct which contained two UGGs was exchanged against a BclI fragment of the 
construct of hmw2 which contains two UGAs. The cloning of the PCR products of the clpB 
promotor and the his-tagged hmw2 was done as explained above. This time, six positive 
clones out of 450 clones were found by colony hybridization. Fig. 4.8 shows a scheme of 
the final hmw2 construct in pKV74. 
 
 
 
 
Fig. 4.8: The final construct of gene hmw2 in pKV74. 
 
Expression of the C-terminal His-tagged HMW2 in M. pneumoniae 
The modified hmw2 was integrated into the genome of  M. pneumoniae WT by transposon 
insertion with Tn4001mod. By monitoring the expression of the C-terminal His-tagged 
HMW2 in M. pneumoniae, a single protein of about 27 kDa (which I will call HMW2-s), 
instead of the expected 215 kDa, was observed in protein extracts of transformants, which 
reacted   positively   with  ? - poly  His  antiserum  (Fig. 4.9).  By  Western  blotting  using  
?–HMW2-Cterm, two protein bands were observed in the low molecular mass region, a 
protein of 25 kDa and a 27 kDa. The latter corresponded to the single protein band in 
Western   blot   probed   with   ? - poly  His   antiserum  which  represented  the  expressed  
His-tagged HMW2 in M. pneumoniae. The 25-kDa protein band corresponded to the 
HMW2-s of the wild type M. pneumoniae. 
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Fig.4.9: Western blot of M. pneumoniae WT(1), M. pneumoniae mutant A3 (2) and a selected 
WT transformant (3). Five microgram of each total protein extract was seperated on a 10 % SDS-
PAA gel (antisera: ?-HMW-Cterm 1:1000; ?-Histidine 1:3000). 
 
A detailed analysis of the introduced his-tagged hmw2 gene showed a deletion of four 
nucleotides at position 4708-4711 of the gene hmw2 preventing the synthesis of the mature 
full-length HMW2 protein (Fig. 4.10) but this frame shift mutant turned out to be very 
helpful for the isolation of a pure preparation of the the HMW2-s to be used for 
biochemical characterizations of this protein (see chapter 4.2). 
 
 
 
Fig. 4.10: Schematic drawing of the gene hmw2 fused with a DNA sequence encoding nine 
histidines. The numbers above the bar give the position of the four bp deletion by the nucleotide 
numbers. 
Results 
 
 88
b) N-terminal fusion of a poly His tag 
As an alternative construct, the His tag was fused to the N-terminus of HMW2. The 
expression of the N-terminal His-tagged HMW2 was regulated by the promotor of the clpB 
gene from M. pneumoniae. 
For this propose, a sequence coding for methionine followed by 9 histidine was added to the 
5’ end of the hmw2 EcoRI fragment. The clpB promotor was amplified by PCR and ligated 
with 5’ end of an EcoRI fragment of the hmw2 gene (384 bp). The ligation product of both 
gene fragments was amplified by PCR and cloned into the EcoRI site of the vector pQE60 
resulting in a construct containing the complete gene hmw2 with two UGA codons. 
The final construct contained the clpB promotor followed by a sequence coding for one 
methionine and nine histidines upstream of the hmw2 gene. It was amplified by PCR using 
primers adding a BamHI restriction site to both ends of the final PCR product. The PCR 
product with blunt ends was cloned into the SmaI site of the IS256R element of Tn4001mod 
of the vector pKV104 [Hahn et al., 1999]. The cloning strategy is illustrated in Fig 4.11.  
Recently, new plasmids were developed in our lab (pCT461 and pMT850) and the gene 
construct of the modified hmw2 was recloned into these new vectors. The vectors were much 
smaller than the pKV vector. Their integration in the genome was stable, because the 
transposase was not part of the transposon, and recloning of the inserted transposon was simple. 
The insert was cut out of the construct cloned in pKV104 vector by BamHI and recloned 
into the BamHI site of both new vectors. M. pneumoniae WT was transformed with the 
gene construct in pMT850. Sine the pCT461 plasmid contains a chloramphenicol-
resistence gene, it allowed a convenient selection of the cloned gene in M. pneumoniae 
hmw2 mutants which were already gentamicin-resistant.  
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Fig. 4.11: Schematic illustration of the synthesis of the gene hmw2 fused with a DNA fragment 
encoding nine histidine at the 5’ end and of cloning into the pKV104. 
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It was shown by Western blotting that the HMW2 fusion protein was produced in the 
transformant of M. pneumoniae mutant A3, but the amount of the protein was too low to 
be detected with anti-polyHis antiserum (Fig. 4.12). The HMW2 protein was not expressed 
not very well by the M. pneumoniae clpB promotor, although it was shown by 
transcriptional analysis that this promotor belongs to one the strongest promotors of 
M. pneumoniae [Weiner et al., 2000]. The expression of HMW2 in M. pneumoniae might 
be somehow related with the cell status or growth phase. Since the level of expression was 
so low, a preparative purification of the HMW2 protein was not possible. 
 
 
 
Fig. 4.12: A) Western Blot analysis of total protein extracts of the selected transformant of 
M. pneumoniae WT using an antiserum directed against His tag and the 573aa N-terminal region of HMW2. 
+ = His-tagged   fusion   protein   used   as  a   positive   control   ;    WT   =   M. pneumoniae  WT ;  
a = transformant of M. pneumoniae WT  
     B) Western Blot analysis of total protein extracts of selected M. pneumoniae mutant 
A3 transformants using ?-HMW2-N573aa.  A3  =  M. pneumoniae  mutant  A3 ;  
WT  =  M. pneumoniae  WT ;  1-6  =  transformants  of  M. pneumoniae  mutant  A3 
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4.2 Determining the N-terminus of HMW2-s 
The function of HMW2-s is still unclear, as well as the mode of its synthesis. It could be 
generated by processing full-length HMW2 or by an internal new start within the hmw2 
gene. Although the protein analysis of the described deletion mutant (previous chapter, 
Fig. 4.9 and 4.10) favored an internal new start and made the possibility of HMW2-s being 
a processing product of HMW2 rather unlikely. As a first step, the N-terminus of HMW2-s 
was determined by Edman sequencing. 
 
4.2.1  Purification of the C-terminal His-tagged HMW2-s from M. pneumoniae 
For the N-terminal sequencing approach, the protein had to be purified from 
M. pneumoniae, blotted on PVDF membrane and stained with colloidal Coomassie Blue or 
amido black. The purification of His-tagged HMW2-s was successful by applying 
denaturing conditions (6 M guanidium hydrochloride) and using paramagnetic, precharged 
nickel particles. The success of this purification procedure was monitored by Western 
blotting using antiserum directed against the C-terminal region of HMW2 (Fig. 4.13). As 
can be seen on Western blots, the purification was effective, since none of the His-tagged 
HMW2-s could be detected in the flow-through or in the washing-fraction. The eluatant 
was precipitated by methanol-chloroform [Wessel and Fluegge, 1984]. After seperation by 
12.5% SDS-PAGE, the protein was transferred on a PVDF membrane and stained by 
colloidal Coomassie Blue. The N-terminal sequencing analyses were done both by 
Dr. H. Heid (DKFZ, Heidelberg) and by Dr. H. Hippe (Chromatec GmbH, Greifswald). 
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Fig. 4.13: A) Western blotting of different fractions from the purification of HMW2-s (12,5%  
SDS-PAA gel). Wh = whole cell extract; S = supernatant; F = flow through; 
W = wash; 3-5; 8-9 = number of collected fraction. (?-HMW2-Cterm, 1:1000) 
B) 12.5% SDS-PAA gel of the purified HMW2-s, blotted on PVDF membran and  
stained with Coomassie Blue. The arrows point to HMW2-s. 
 
However, the Edman sequencing was not successfull, despite optimizing the isolation 
procedures, repeating the experiments several times, and giving the protein to two different 
laboratories for an Edman sequencing. We concluded that the N-terminus of this HMW2-s 
might be chemically blocked. 
 
4.2.2 Construction, expression and purification of three recombinant derivatives of 
HMW2-s and their application as size markers for HMW2-s 
As an alternative method, I tried to determine the N-terminus of HMW2-s by mass 
spectrometry (MS), but the predicted N-terminal region for HMW2-s contained many 
arginines (R) and lysines (K), which caused the productions of too many small peptide 
fragments that could not be analyzed by mass spectrometry (MS). The molecular mass of 
HMW2-s is about 25,000 Da, as determined by its migration in a SDS-PAA gel. Three 
different recombinant HMW2-s-like proteins was synthesized. They had a predicted 
molecular weights of 22,927 (23,750); 24,692 (25,515)  and 27,888 (28,711), the number 
in the bracket shows a predicted molecular weight after adding 6?His tag to their C-
termini. I will call them throughout my thesis 24 kDa, 26 kDa and 29 kDa, respectively. 
Their C-termini were kept constant but the N-termini were different (Fig. 4.14). We 
expected one of them should migrate very close to the HMW2-s. A comperison of 
Results 
 
 93
migration of the recombinant proteins and of HMW2-s should give a rather precise 
information on the N-terminus of HMW2-s. One difference between these recombinant 
proteins and the HMW2-s is that the HMW2-s derived from the experiment in chapter 
4.1.2 contained nine Histidines at its C-terminus. This caused a difference of about 412 Da 
because of the additional three Histidines.  
 
MPYPYPWFYPQQKQEDSSNQIRHLFEQQLQFMQQRYENELTELR  1 
MLFPPLFKINGNDMNYPYPYPWFYPQQKQEDSSNQIRHLFEQQLQFMQQRYENELTELR  2 
MAVEQQYQAEITRLKTRNADLEKNDNKHLFPPLFKINGNDMNYPYPYPWFYPQQKQEDSSNQIRHLFEQQLQFMQQRYENELTELR  3 
 
Fig. 4.14: Amino acid sequences of the N-terminal regions of the three recombinant HMW2-s-like 
proteins. The molecular mass of HMW2-s is about 25,000 Da according to its migration in a SDS-PAA 
gel. Positions of a possible trypsin cleavage are marked in pink and blue: K = Lysin, R = Arginin., 1 = 
recombinant protein 24 kDa, 2 = recombinant protein 26 kDa, 3 = recombinant protein 29 kDa. 
 
Genes coding for these three recombinant proteins were amplified by PCR and cloned into 
NcoI/ BglII site of vector pQE60, which added the sequence for a His-tag (6?histidines) to 
the C-terminus of a cloned gene. E. coli strain XL1-blue (Stratagene) were transformed 
with the three gene constructs. Their expression was under control of a lac operon and 
therefore inducible with IPTG. After adding IPTG to the E. coli culture, the bacteria were 
further incubated and harvested after 4 hours. The expression of fusion proteins was 
monitored by SDS-PAGE (Fig. 4.15). 
 
Fig. 4.15: Coomassie Blue stained gels (12.5% SDS-PAA  gel ) of total protein extract of E. coli containing 
three recombinant proteins. 1 = recombinant 24 kDa, 2 = recombinant 26 kDa, 3 = recombinant 29 kDa. 
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All three fusion proteins were expressed at a very high level, which facilitated their 
purification and MS-analysis. They were purified by IMAC using a nickle-charged resin 
under denaturing conditions (6 M guanidium hydrochloride). The migration of the purified 
fusion proteins was compared with each other and the natural HMW2-s by SDS-PAGE and 
Western blotting, respectively (Fig. 4.16). The recombinant 24 kDa protein migrated 
similarly as HMW2-s, indicating that the N-terminus of both proteins were not far apart. 
 
 
Fig. 4.16: (A) Coomassie Blue stained SDS-PAA gel of the three different recombinant proteins. 
       (B) Western blot of three recombinant HMW2-s-like proteins and a new recombinant 
HMW2-s protein containing the same sequence as the His-taggd HMW2-s from M. pneumoniae; 
1 = recombinant protein 24 kDa; 2 = recombinant protein 26 kDa; 3 = recombinant protein 
29 kDa, WT/C = M. pneumoniae WT transformant with his-tagged HMW2-s , WT = M. 
pneumoniae WT, * = wild-type HMW2-s, ** = 9x his-tagged HMW2-s. 
 
4.2.3 Mass spectrometry (MS) analysis of the obtained peptide fragments 
The three recombinant HMW2-s proteins and the purified His-tagged HMW2-s from 
M. pneumoniae were analyzed by MS (Dr. T. Ruppert, ZMBH, Heidelberg). The mass 
spectrometric analyses were done by A. Bosserhof and Dr. T. Ruppert. The signal from the 
His-tagged HMW2-s isolated from M. pneumoniae was relatively weak when compared to 
the three recombinant HMW2-s-liked proteins. However, one peptide fragment which did 
not correspond to a predicted  fragment derived from tryptic proteolysis was observed (Fig. 
4.17). An additional variation of this peptide fragment was also found and had been 
identified as an oxidized species of this peptide fragment by MALDI-TOF (matrix-assisted 
laser desorption ionization–time-of-flight) mass spectrometry. The oxidized peptide 
fragment (* red) appeared as a slightly later peak in the MS compared with the authentic 
peptide fragment (* black) (Fig. 4.17D). 
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Fig. 4.17: Mass spectrogram of all recombinant proteins.  
A = MS of recombinant 24 kDa; B = MS of recombinant 25 kDa;  
C = MS of recombinant 29 kDa; D = MS of the His-tagged HMW2-s from M. pneumoniae extract.  
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The oxidation site has been determined to be the N-terminal methionine residue by 
sequencing of this peptide fragment by MALDI-TOF mass spectrometry, where the 
methionine was oxidized to methionine sulfoxide. The presence of methionine sulfoxide is 
commonly observed in gel electrophoresis [Person et. al, 2001]. Signals for peptides 
containing a single partially oxidized methionine residue will appear in the mass spectrum 
at mass values corresponding to both the protonated non-oxidized molecular weight (MH+) 
and shifted by +16 u mass (+Mox) [Person et. al, 2001]. An oxidized methionine in this 
peptide fragment indicated that the N-terminus of HMW2-s is methionine (4.18). 
Fig. 4.18: The peptide fragement containing oxidized amino acid from His-tagged HMW2-s from 
M. pneumoniae (see Fig. 4.17 D, * red) was sequenced. Mass spectrogram shows amino acid 
sequence of this peptide fragment. 
 
Similar pattern of peptide fragments were observed analyzing the three recombinant 
HMW2-s proteins (see Fig. 4.17). The sequence of the recombinant 24 kDa protein was 
almost identified with the sequence of HMW2-s  from M. pneumoniae, except two amino 
acids were missing (Fig. 4.19). 
 
MPYPYPWFYPQQKQEDSSNQIRHLFEQQLQFMQQRYENELTELR     1 
MLFPPLFKINGNDMNYPYPYPWFYPQQKQEDSSNQIRHLFEQQLQFMQQRYENELTELR    2 
MAVEQQYQAEITRLKTRNADLEKNDNKHLFPPLFKINGNDMNYPYPYPWFYPQQKQEDSSNQIRHLFEQQLQFMQQRYENELTELR    3 
 
Fig. 4.19: Amino acid sequences of N-terminal regions of the three recombinant HMW2-s-like 
proteins. The molecular mass of HMW2-s is about 25 kDa according to its migration in a SDS-
PAA gel. Positions of a possible trypsin cleavage are marked in pink and blue.The peptide 
fragment of the N-terminus found in MS-analysis is marked in  green.  K  =  Lysin ;  R  =  Arginin.  
1 = recombinant protein 24 kDa 2 = recombinant protein 26 kDa 3 = recombinant protein 29 kDa. 
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4.2.4 Comparison of the peptide fragment patterns between the His-tagged HMW2-s 
from M. pneumoniae and recombinant HMW2-s protein of the same size  
To prove the result from the MS analysis and to determine unambigously the N-terminus 
of HMW2-s, a new recombinant protein was constructed, which should have exactly the 
same sequence as the His-tagged HMW2-s from M. pneumoniae. This new recombinant 
protein was prepared as described above (see 4.1.2). It was expressed in E. coli at a very 
high level. By MS analysis, it showed exactly the same peptide fragment pattern as the 
His-tagged HMW2-s from M. pneumoniae but with stronger signal (Fig. 4.20). This 
confirmed that the N-terminus of the His-tagged HMW2-s, which was isolated from 
M. pneumoniae, was correct. Therefore, the molecular weight of the native HMW2-s 
(without His tag) is 23,204. 
 
 
Fig. 4.20: MS analysis of the new recombinant (A), it showed exactly the same peptide fragment 
patterns as the His-tagged HMW2-s from M. pneumoniae (B) but with stronger signal.  
* = the oxidized peptide fragment. * = the authentic peptide fragment. 
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4.3 In vivo synthesis of HMW2 s - 
As described in chapter 4.2, the N-terminus of HMW2-s was identified. It starts with a 
methionine, which suggested that HMW2-s is produced by an internal new start rather than 
by proteolytic cleavage. To answer this question precisely, the following constructs of the 
gene hmw2-s were made: hmw2-s with 300 bp nucleotide upstream of the identified ATG 
start codon and the same construct with a modified (ATT) internal start codon. Both 
constructs contained a sequence coding for mRFP and a 7?His tag at their 3’ end (Fig. 4.21). 
 
 
 
Fig. 4.21: Schematic illustration of the hmw2-s gene constructs described in this chapter. For 
comparison, the complete hmw2 gene is added. 
 
4.3.1 Construction of a HMW2-s fusion protein 
If HMW2-s can be synthesized independently from the complete HMW2, then only the 
corresponding DNA sequence at the 3’ end of the gene hmw2 should be sufficient to 
encode HMW2-s. Therefore, a sequence coding for HMW2-s with additional 300 bp 
upstream   from  the  start  codon  of  HMW2-s  was  cloned  into  a  BamHI / SmaI  site  of  
pMT-Red vector (Fig. 4.22). Those 300 nucleotides were chosen as expression unit for the 
HMW2-s. The pMT-Red vector is a modified mini transposon, which can be used as 
carrier for integrating foreign DNA into the genome of M. pneumoniae. It provided a gene 
coding for mRFP (a monomer form of red fluorescence protein) followed by a 7?His tag, 
so that the complete gene construct contained a sequence coding for the hmw2-s and an 
expression unit consisisting of 300 bp upstream of hmw2-s and the mrfp gene modified 
with a 7?his tag at its 3’ end. The modified hmw2-s was integrated into the genome of M. 
pneumoniae WT by transposon insertion. 
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Fig. 4.22: Schematic illustration of 
cloning the artifical hmw2-s gene 
with additional 300 nucleotides 
upstream from its start codon. The 
gene was cloned into the BamHI/ 
SmaI site of pMT-Red vector. 
 
The expression of HMW2-s was monitored by Western blotting. A protein of about 52 kDa 
was observed in all transformants, which reacted positively with poly-His antiserum 
(Fig. 4.23). The observed molar mass of 52 kDa agreed very well with the expected molecular 
weight (49,391) of the fusion protein consisting of HMW2-s, mRFP and a 7?His tag. 
 
 
 
Fig. 4.23: Western blot analysis of total protein extracts of the selected M. pneumoniae WT 
transformant haboring a hmw2-s gene construct (12.5 % SDS-PAA gel). Name of antisera and the 
dilution used are given below the picture.Expected protein bands are indicated by arrows.  
WT = M. pneumoniae WT, 1 = transformant of M. pneumoniae WT haboring hmw2-s gene 
construct;  + = positive control (a fusion protein with His tag).  
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The results of this analyses showed that HMW2-s can be synthesized under in vivo 
condition without the sequence of gene hmw2 and verified the hypothesis of an internal 
new start within complete gene hmw2. 
 
4.3.2 Construction of a HMW2-s fusion protein with a modified (ATT) internal ATG 
start codon 
As a negative control for the previous experiment (4.3.1), a modified hmw2-s gene was 
synthesized. It contained exactly the same gene fragment as described in Fig. 4.22. The 
only difference was that the internal ATG start codon was changed into ATT. For this aim, 
the plasmid pQE60 haboring an insert of the gene hmw2 was used for further genetic 
manipulations. The next step was to mutate of the ATG start codon for HMW2-s, which is 
located at codon position 1620 and change it to ATT. This was done by PCR mediated 
site-directed mutagenesis, by which the desired mutation is incorporated in the primers 
used for the PCR amplification. These primers are generally 25-35 bases long and carry the 
nucleotide which has to be changed in the middle of their sequences (Fig. 4.24). The 
‘mutation’ was finally incorporated into both DNA strands during PCR-cycles. 
 
 
 
Fig. 4.24: Schematic illustration of the primers used in mutagenesis-PCR. The primers bind 
complementary at the gene hmw2 and contain the desired point mutation in the middle of their 
sequence. 
 
This plasmid containing the modified gene hmw2 with ATT codon instead of ATG was 
then used as template for the PCR of hmw2-s. The PCR product containing a sequence 
coding for HMW2-s and additional 300 bp upstream from its modified (ATT) start codon 
of HMW2-s was cloned into the BamHI/ SmaI site of pMT-Red vector. The modified 
hmw2-s was integrated into the genome of M. pneumoniae WT by transposon insertion. It 
was shown by Western blot analysis of the total mixture of all transformants that an 
HMW2-s fusion protein was not produced (Fig. 4.25A), although the modified hmw2-s 
was integrated in genome of M. pneumoniae (Fig. 4.25B), which was confirmed by 
Southern blot analysis. Genomic DNAs of the transformants were digested with the 
restriction enzyme XmnI, seperated on 1% agarose gel and transferred overnight to a nylon 
membrane. The membran was incubated with a Digoxygenin-labeled probe of the mrfp 
gene. The blot showed that the transformants contained the gene construct (Fig. 4.25B).  
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Fig. 4.25: A) Western blot analysis of total protein extracts of the M. pneumoniae WT mixture 
transformants haboring a hmw2-s gene construct with a modified (ATT) start codon (1 and 2). 
Expected protein bands are indicated by arrows.  
     B) Southern Blot analysis of the mixture transformants of M. pneumoniae WT. A DIG-
labeled PCR product of mrfp was used for detection. WT = M. pneumoniae WT;  
1-2 = transformants mixture + = positive control (pMT-red) 
 
As expected for the analysis of a mixture of transformants, many different DNA fragments 
were showed and not a single band. Since the DNA containg the modified hmw2-s gene 
was proven to be correct by sequencing, we concluded from the negative results of the 
Western blot, that the methionine at position 1620 is indeed crucial for the synthesis of 
HMW2-s. The experimentally identified translation products of hmw2 and its truncated 
derivatives, hmw2-s (+ATG) and hmw2-s (-ATG) are summarized in Fig. 4.26. 
 
 
 
Fig. 4.26: Schematic drawing of the hmw2 constructs used for the analysis of HMW2-s and the 
recording of the identified proteins. 
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4.4 Characterization of the M. pneumoniae mutant A3 
The hmw2 gene was identified as an important genetic locus, P65 operon, associated with M. 
pneumoniae cytadherence by transposon mutagenesis with Tn4001 [Krause et.al,1997]. It 
contains four genes in the following order: MPN309 (orfp65), MPN310 (hmw2, previously 
orf216), MPN311 (orfp41), and MPN312 (orfp24)? flanked by a promoter-like and a terminator-
like sequence (Fig. 4.27). MPN310 encodes the protein HMW2. Each transposon insertion 
mapped to orfp216 (hmw2) affected the level of expression of all genes of the P65 operon.  
 
 
 
Fig. 4.27: Organization of the Mycoplasma pneumoniae P65 operon. 
 
Six mutants with defects in gene hmw2 were isolated, analyzed and their sites of insertion 
into the M. pneumoniae genome identified [Krause et.al,1997]. The M. pneumoniae A3 
used (in this work) was kindly provided by Prof. Krause (University of Georgia, USA). To 
confirm the identity of the mutant and to characterize it in more detail the following 
experiments have been done: 1) determination of the site of insertion of Tn4001 within 
MPN310; 2) analysis of turnover of proteins which might interact with HMW2 by Western 
blotting and comparative two-dimensional (2-D) gelelectrophoresis. 
 
4.4.1 Determination the site of insertion of Tn4001 in the genome of the 
M. pneumoniae mutant A3 
The site of insertion was analyzed by cloning and sequencing the DNA fragment carrying 
the transition between either end of Tn4001 and the genomic DNA. For this purpose, 
genomic DNA of M. pneumoniae A3 was restricted with restriction endonuclease HindIII. 
This enzym cuts the IS-element (IS256L) at nucleotide position 1027. The restricted 
genomic DNA was first ligated into the vector pBC, which was linearized with HindIII, and 
the ligation products used to transform E. coli strain TOP10. The obtained  colonies were 
transfered to nitrocellulose membranes and screened for positive clones by hybridizing the 
                                                
? The names in brackets refer back to the nomenclature [Krause et. al, 1997], while the capital letters MPN indicate 
the gene numbers according to the re-annotation of the M. pneumoniae genome sequence [Dandekar et.al, 2000]. 
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membranes at 60 °C for 16 hours with a DIG-(Digoxygenin) labeled PCR product (1234 
bp) of the IS-element (IS256L). Plasmids of the clones showing a positive signal were 
analyzed with HindIII. The clones, which contained only one HindIII-fragment besides the 
vector were sequenced with the primers 7221 and 8050. The sequence analysis revealed an 
integration site at genome position 370306-370307 within the hmw2 gene (gene position 
4839-4840), confirming that we are indeed working with M. pneumoniae A3 (Fig. 4.28). 
 
 
 
Fig. 4.28: Location of Tn4001 insertion in M. pneumoniae A3. Triangles point to Tn4001 
insertions. The nucleotide sequences at both junctions of mycoplasma and Tn4001 DNA were 
examined. Uppercase letters correspond to the sequence of gene hmw2, while the nucleotide 
number corresponding to the junction site in genom of the hmw2 mutant is indicated (370306). 
Lowercase letters in the blue box correspond to the nucleotide sequence of IS256L of Tn4001. The 
arrow above the box show the direction of the IS256L. The 6-bp doublication of genomic DNA, 
the consequence of the transposon insertion, is underlined.  
 
4.4.2 Comparison of the expression profiles of selected genes in M. pneumoniae WT 
and M. pneumoniae mutant A3 by Western blot analysis 
It has been shown previously that in M. pneumoniae A3, HMW1 and HMW3, when 
compared with WT, appeared in lower concentrations [Krause et al., 1982]. This 
observation was explained by a reduced half life of these proteins in the absence of 
HMW2. In this present work, I extended analyses to such proteins, which, based on the 
result of the two-hybrid analysis (for detail see next chapter), could be possible candidates 
for interacting directly with HMW2. The relative difference in concentration of the 
following proteins (table 4.1) in whole protein extracts of M. pneumoniae WT and A3 
were determined by evaluating the signal intensities of specific protein bands in Western 
blots (Fig. 4.29) with the program Visual Grid. It allowed manual adjustment for the grid 
position overlayed on the images. It gave intensity values of the measured spots, so that I 
could analyze relative quantitative changes of individual protein spots based on their 
intensity value (Fig. 4.30). 
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Table 4.1: List of antisera used in Western blot analysis of M. pneumoniae WT and A3  
MPN 
number 
gene/protein length of 
recognized 
amino acid (aa) 
Position of 
recognized 
amino acid (aa) 
Antiserum 
Number 
dilution 
MPN227 EF-G 82 - 66708 1:3000 
MPN310 HMW2-Cterm 320 1459-1778 88256 1:1000 
MPN310 HMW2-N573aa 573 1-573 MX-94 1:5000 
MPN447 HMW1 122 135-257 84267 1:5000 
MPN452 HMW3 118 44-162 65376 1:5000 
MPN309 P65 18 167-185 66578 1:3000 
MPN426 P115 13 971-982 35 1:1000 
MPN297 H10_orf 149 150 1-150 MX-95 1:5000 
MPN311 P41 254 49-302 86630 1:500 
MPN312 P24 126 74-199 85952 1:250 
MPN141 P1 68  45790 1:1000 
MPN142 P90 223  43558 1:1000 
MPN142 P40 146  42326 1:1000 
? Triton X-100 
insoluble Fraction 
? ? 60631 1:5000 
 
Elongation factor G was used as a measure for equal protein concentration in both protein 
extracts. The protein HMW1, HMW3 and the P65 operon-encoded proteins P65, P41, P24 
were included in this analysis as controls for proteins which were already known to be 
differently expressed in M. pneumoniae A3 [Krause et al., 1982, 1997].  
 
Total protein extracts of M. pneumoniae WT and A3 were separated in 12.5%, 10% or 
7.5% SDS-PAA gels, depending on the expected size of the proteins, transferred to 
nitrocellulose membranes and tested with the corresponding monospecific antisera (Table 
4.1). The concentrations of the extracts were adjusted, so that the same amount of protein 
was always compared. As internal standard, the elongation factor G was included in the 
analyses. The almost identical signals indicated that the protein concentration in both 
extracts were very similar (Fig. 4.29). 
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Fig. 4.29: Western blot analyses of expression profiles of selected genes in M. pneumoniae WT 
and M. pneumoniae A3. Names of antisera and dilution used are given below each blot. Expected 
protein bands are indicated by arrows. 
 
The gene hmw2 encodes two proteins, one with the molecular mass of about 216 kDa and 
another one of about 25 kDa. The latter one is synthesized from an internal AUG codon in 
the same reading frame as HMW2 (For details see chapter 4.2). The antiserum which was 
made against the C-terminal end of HMW2 [Proft, 1994] recognized the complete HMW2 
Results
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and another protein of about 25 kDa. Both protein bands were not present in extracts of 
M. pneumoniae A3 (Fig. 4.29, upper panel). 
 
Fig. 4.30: Summary of the intensity values of selected protein from M. pneumoniae WT and A3. 
Fourteen antisera were used in this experiment (Table 4.1). 1 = monomer, 2 = trimer, 3 = multimer, 
4 = average value of signal intensity of five selected protein bands (Fig. 4.29, arrows) 
 
Using antiserum directed against the N-terminal region of HMW2, a very faint protein 
band with a slightly reduced molecular mass compared to wild type HMW2 was observed 
(Fig. 4.29, upper panel). This reduction was caused by the insertion of Tn4001 in the gene 
hmw2 at gene position 4839-4840 (Fig. 4.28). This led an early termination of the HMW2 
protein due to a switch of the reading frame. Annotation of the DNA sequence predicted 
that the HMW2 of the mutant A3 should be 206 amino acids shorter causing a reduction of 
molecular mass of about 20 kDa, as was indeed observed in SDS-PAA gels. 
The specific antiserum against P41 reacted strongly with a 47-kDa protein in 
M. pneumoniae WT profile (Fig. 4.29, upper panel). The Western blot analyses confirmed 
the published results on the reduction in concentration or absence of the proteins HMW1, 
HMW3, P65, P41 and P24 (Table 4.2).  
The most significant new results concerned the proteins P1, P40 and P90. These proteins 
could not be detected indicating that they were rapidly degraded in the absence of HMW2. 
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 These finding support results from two-hybrid experiments (for detail see chapter 4.5), 
which suggested that P1 and HMW2 interact indirectly with each other. 
The results concerning the proteins from the Triton X-100 insoluble fraction and the gene 
products of MPN297 were not so clear. In M. pneumoniae WT, three different forms of the 
proposed 17-kDa protein of MPN297 were found with molar masses of 17 kDa, 51 kDa 
and about 200 kDa. The two latter proteins could be multimeric forms of the original gene 
product. While the proposed monomeric  form  was  prevalent  in  M. pneumoniae  A3,  
the  
51-kDa protein, maybe a trimer, was distributed almost equally in both samples, but the 
200-kDa protein was only visible in M. pneumoniae WT. The interpretation of these result 
is difficult, but we have here the first example, where a protein that interacts directly with 
HMW2 (for details see chapter 4.5) is not fast degraded in the absence of HMW2. 
Finally, the general comparison of the Triton X-100 insoluble fractions confirmed that 
some proteins were underrepresented in M. pneumoniae A3. But their identity was not 
further determined. 
 
Table 4.2: Summary of Western blot analyses of expression of selected proteins in 
M. pneumoniae A3 
MPN number gene/ 
protein 
Signal in 
Western blot 
remarks 
MPN309 P65 ++ P65 operon, upstream from hmw2 
MPN311 P24 ? P65 operon, downstream from hmw2 
MPN312 P41 ? P65 operon, downstream from hmw2 
MPN452 HMW3 +  
MPN447 HMW1 + interacting partner from two-hybrid pilot 
experiment (see chapter 5.5) 
MPN426 P115 0 interacting partner from two-hybrid pilot 
experiment (see chapter 5.5) 
MPN297 MPN297 0 interacting partner from two-hybrid pilot 
experiment (see chapter 5.5) 
MPN141 P1 ? localizes at tip structure 
MPN142 P90 ? localizes at tip structure 
MPN142 P40 ? localizes at tip structure 
0 = reduction not significant; ++  = slightly reduced;  +  =  strongly reduced; ? = not detectable 
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4.4.3 Comparison of the expression profiles of selected genes in M. pneumoniae WT 
and M. pneumoniae mutant A3 by two-dimensional (2-D) gel electrophoresis 
It was shown by Western blot analyses that the expression of many proteins was effected 
in M. pneumoniae cells lacking HMW2. Some of those proteins were known to directly 
interact with HMW2, but also proteins were identified in this study, like P1, P40 and P90, 
of which changes in protein concentration depending on the presence of HMW2 have not 
been observed before. To find other possible interacting proteins, 2-D gel electrophoresis 
was applied to compare changes of protein concentration between total soluble protein 
extracts of M. pneumoniae WT and M. pneumoniae A3. Two-dimensional gel 
electrophoresis was chosen for several reasons: 1) the protein spots of two gels can be 
compared by image overlay; 2) it represents a global analysis visualizing about 50% of the 
expressed protein of M. pneumoniae; 3) many of the protein spots have been identified and 
can be traced to their corresponding gene; 4) the analyses are highly reproducible. 
For the comparative 2-D gel anlysis, 80 µg of total protein extracts of M. pneumoniae WT 
and A3 were separated in the first dimension by charge using an immobilized pH gradient 
from 3-10 and then according to their molecular mass in the second dimension by SDS-
PAGE. The gels were silver stained for viewing the protein spots. Image analysis was done 
using Adobe Photoshop software version 5.0 and signal intensities were measured with the 
program Visual Grid (GPC Biotech AG). It allows manual adjustment for the grid position 
overlayed on the images. The useful feature of this software is that it calculates intensity 
values of the gray-level intensity of the spots, so that one can analyze the change of protein 
spots quantitatively based on their intensity value. 
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By overlapping both protein profiles, the difference between both strains could be easily 
determined. All protein spots with significantly changed signals were marked and 
numbered (Fig. 4.31). Assignment of those protein spots to gene products were based on 
data from a previously published M. pneumoniae proteome analysis [Ueberle et al., 2002]. 
All gene products that were reduced in M. pneumoniae A3 are listed in table 4.3. 
Four protein spots (A, B, C, D) of the 2-D gel of M. pneumoniae WT were selected and 
their intensities compared with same protein spots from the 2-D gel of M. pneumoniae A3. 
These four proteins showed only minor change in their signal intensities and were therefor 
used as standards to establish the baseline. The factor for the baseline was set at 1.42. If the 
factor of two spot intensities was above this baseline, the differences in the corresponding 
protein spots were considered as significant. 
From the proteins tested by Western blotting (table 4.2) only the reduction of HMW3 
could be confirmed by the 2-D gel approach (Fig. 4.31, spot Nr.2). One could clearly see in 
the 2-D gels that HMW3 is present in the WT protein extract but absent in the protein 
extract of M. pneumoniae A3. The usefulness of EF-G as internal standard for comparing 
protein concentrations were also confirmed, since the measured factor was 1.21, which was 
below the set baseline of 1.42. 
From a total of 31 analyzed protein, I identified 12 which had values above the baseline. 
Most of those were enzymes involved in different metabolic activities  (Table 4.3). The 
possible connection between a decrease in protein concentration and absence of HMW2 
will be speculated in the discussion section. 
The other proteins from the Western blot analyses (Table 4.2). were not separated well 
enough or could not be analyzed for technical reasons. One has to consider that proteins 
with more than three transmembran segments and isoelectric points above 10.5 were not 
seperated by the conditions applied. 
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4.5 Interaction of HMW2 with other proteins in M. pneumoniae 
According to our present knowledge, the HMW2 protein plays a central role in the 
formation of a cytoskeleton-like structure [Krause, 1996].  It seems to be the most 
important component of the M. pneumoniae cytoskeleton [Krause, 1996]. The 
characterization of non-cytadhering transposon-insertion mutants of M. pneumoniae 
confirmed both the interaction among HMW proteins (HMW1, HMW2, HMW3), 
especially HMW2, and their involvement in cytadherence [Krause, 1996]. During my 
diploma thesis, I established the yeast two-hybrid system with the aim to identify 
interaction partners of HMW2. The gene hmw2 was divided into four fragments (Fig. 4.32) 
and individual fragments were used as baits for screening a gene bank of M. pneumoniae 
for binding partners. The M. pneumoniae gene bank was cloned in Saccharomyces 
cerevisiae by M. Kögl (RZPD, Heidelberg). 
 
 
 
Fig. 4.32: Total profile of the protein HMW2. The positions of the four UGA codons are given in 
red. For the two-hybrid analysis, the protein was divided into four fragments (named hmw 2-1 
to 4). The  numbers below the arrows give the size of each fragments in numbers of amino acids. 
 
4.5.1 Results from the two-hybrid screen with HMW2 
Two-hybrid screens with HMW2 protein fragments 1 and 2 were not successful because of 
self-activation of both baits occured (activation of reporter gene without interaction of bait 
and pray). Positive interactions were found when using HMW2 fragment 3 (HMW2-3) as a 
bait [Boonmee, 2000]. Possible binding partners found by the two-hybrid screens as 
binding partners of HMW2-3 are given in Table 4.4. 
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Table 4.4: The table summarizes the screening results of hmw2-3 against the 
M. pneumoniae gene bank. 
Gene number of 
interacting protein and 
ORF name 
Length of 
protein (aa)
a
 
Genome position of 
DNA insert
b
 
amino acid position 
within  protein (aa)
c
 
MPN 447  HMW1-CTerm. 1018 543786-543369 859-998 
MPN 426  P115 982 513876-513361 223-394 
MPN 297  H10_orf149 149 351965-352261 11-109 
MPN 298  H10_orf119 119 352402-352672  6-96 
a) Length of whole protein 
b) Fragments of M. pneumoniae genomic DNA were cloned randomly into the pray-vector pGAD424. The 
number shows the corresponding genome positions of DNA fragments found from the screen.  
c) Amino acid position of peptide fragments encoded by DNA sequences as shown in column b. They show 
the interacting region within the whole protein in column a. 
 
4.5.2 Confirmation of two-hybrid screen from the pilot experiment by pairwise tests 
To confirm these two-hybrid screen results, selected proteine/ peptide fragments (Table 
4.5) were fused to the carboxyl terminus of the Gal4 activation domain (Gal4-AD) and also 
to the carboxyl terminus of the Gal4 DNA-binding domain (Gal4-BD). The C-terminal 
region of P1 and HMW2 fragement 4 (HMW2-4) were added in this pairwise test to prove 
their interaction with other proteins. 
 
Table 4.5: Protein/ peptide fragments used in the pairwise tests. 
MPN 
number 
Name of 
protein/ peptide 
fragment  
Total length 
of protein (aa) 
Length of fragments 
used in pairwise 
test(aa) 
position of 
amino acids  
MPN 310 HMW2-3  1818 498  944 - 1442 
MPN 447 HMW1-Cterm. 1018 399 619 – 1018 
MPN 426 P115 983 983 1-983 
MPN 297 H10_orf149 149 149 1-149 
MPN 298 H10_orf119 119 119 1-199 
MPN 141 P1-CTerm. 1606 370 1156-1525 
MPN 310 HMW2-4 1818 406 1413-1818 
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The yeast two-hybrid strain PJ69-4? was co-transformed with plasmids encoding bait and 
pray fusions of those proteins and the interaction between the fusion proteins was 
monitored by plating on –LUHA agar (Fig. 4.33). All potential pairwise interactions 
between those proteins were investigated. They were also tested
 
for non-specific 
interaction with control
 
plasmids.  
 
 
 
Fig. 4.33: Example of a negative and positive result in a yeast pairwise test. S. cerevisiae 
containing only a bait-(pGBDU) and a pray-(pGAD424) vector was used as a negative control. As 
positive control, known interacting proteins were used as bait and pray. She2 and She3 proteins 
were found to interact with each other [Bohl et al., 2000], and therefor were used as positive 
control in this experiment. Bait vector containing the gene she2 and a pray  vector containing the 
gene she3 were co-transformed in S. cerevisiae and grown on selective agar medium. 
 
 
a) MPN310, C-terminal region (HMW2 fragment 3) 
Pairwise tests using HMW2-3 as bait and pray are presented in Fig. 4.34. No activation of 
the reporter genes were observed when HMW2-3 was tested with plasmid vectors 
containing only GAL4 domains (Fig. 4.34, upper panel). I observed no interaction of 
HMW2-3 with either P115, the gene product of MPN298, the C-terminal region of P1, 
HMW2-4 or with itself. 
P1 in GAL-AD was auto-active, so that no pairwise test could be done. No yeast clone 
grew after co-transformation of MPN298 (in GAL4-BD vector) with HMW2-3 (GAL-AD 
vector), although experiments were repeated and optimized. Therefore, no pairwise test 
could be done using this gene construct. 
However, co-transformation of HMW2-3 with HMW1-C-term and the gene product of 
MPN297 activated the reporter gene, indicating direct interaction of HMW2-3 with both 
proteins. The interaction between HMW2-3 and HMW1 was found with HMW2-3 in the 
GAL-BD vector and HMW1 in GAL-AD vector, which agreed with the results from the 
previous two-hybrid screen. HMW1 in GAL-BD activated the reporter gene by itself so 
that it could not be used in a GAL4-based two-hybrid system. Therefore, interaction 
between HMW2-3 and HMW1 could not be confirmed when proteins were tested with 
exchanged GAL4 domains. 
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Co-transformation of HMW2-3 with MPN297 also resulted in an activation of reporter 
genes. This interaction was observed with HMW2-3 in the GAL4-BD vector and MPN297 
in the GAL4-AD vector. By exchanging plasmid, interaction between HMW2-3 and 
MPN297 could not be confirmed because of a weak auto-activation of MPN297 in the 
GAL-BD vector (Fig. 4.37, upper panel). 
 
 
 
Fig. 4.34: Yeast two-hybrid reporter gene activation in a pairwise test using HMW2-3 as bait and 
prey. All positive cultures are based on the activation of two independent reporters: His3 and Ade2. 
Presence of colonies indicates activation of the His3 and Ade2 reporters. Proteins which were 
tested against HMW2-3 are listed on the left. Constructs in pray  vectors are indicated in gray and 
those in bait vectors are in black. The interaction with itself is shown in italic. 
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b) MPN447 (HMW1-C-terminal region) 
Pairwise tests using HMW1 as bait and pray are presented in Fig. 4.35. HMW1-C-terminal 
region cloned in the GAL-BD vector was autoactivated (Fig. 4.35, upper panel) and 
therefore could not be used for this purpose. However, two pairwise combinations were 
observed in the direct mating test with HMW1-C-terminus in GAL-AD vector. It was 
shown that the HMW1-C-terminal region interacted in vivo with HMW2-3 and the C-
terminal region of P1. Data from two-hybrid experiments indicated also that interaction 
between both proteins might take place at their C-termini. 
 
 
 
Fig. 4.35: Yeast two-hybrid reporter gene activation in a pairwise test using HMW1-C-terminal 
region as prey. The construct of hmw1-C-terminal region in a bait vector was found to show auto-
activation (ability to cause nonspecific activation of reporters). All positive cultures are based on 
the activation of two independent reporters: His3 and Ade2. Presence of colonies indicates 
activation of His3 and Ade2 reporter. Constructs in pray  vectors are indicated in gray and those in 
bait vectors are in black.  
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c) MPN426 (P115) 
Pairwise tests using P115 as bait and pray are presented in Fig. 4.36. No interactions with 
any proteins were detected when full-length P115 was part of the GAL-BD vector. 
HMW2-3 did not interact with P115, which disagreed with the results from the initial two-
hybrid screen. The difference between the previous two-hybrid screen and this experiment 
was that in this experiment full-length P115 was used. In the two-hybrid screen pilot 
experiment, the initial interaction was found with a peptide fragment which contained only 
the coil-coil domains of P115.  
 
 
 
Fig. 4.36: Yeast two-hybrid reporter gene activation in a pairwise test using P115 as bait and prey. 
All positive cultures are based on the activation of two independent reporters: His3 and Ade2. 
Presence of colonies indicates activation of His3 and Ade2 reporter. All constructs used were tested 
for their ability to cause nonspecific activation of reporters and were found not to do so. None of 
interactions with P115 were found in this test. Constructs in pray  vectors are indicated in gray and 
those in bait vectors are in black. The interaction with itself is shown in italic. 
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d) MPN297 
Pairwise tests using gene product of MPN297 as bait and pray are presented in Fig. 4.37. 
MPN297 is weakly auto-activated in GAL-BD vector (Fig. 4.37, upper panel), so the 
interaction between MPN297 and HMW2-3 could not be confirmed in the manner of 
exchanging plasmid. However, a pairwise test in which full-length MPN297 was used as 
pray, showed that MPN297 binds to the HMW2-3. This result corresponded to the 
screening result from the previous two-hybrid screen with HMW2-3. Furthermore, it was 
shown in the pairwise test that MPN297 was able to interact with itself. So this result 
indicated that they could form a dimer or polymer in vivo. 
 
 
 
Fig. 4.37: Yeast two-hybrid reporter gene activation by MPN297 protein pairs. Typical results 
observed on media lacking adenine. Constructs in pray  vectors are indicated in gray and those in 
bait vectors are in black. The interaction with itself is shown in italic. 
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e) MPN298 
Pairwise tests using gene product of MPN298 as bait and pray are presented in Fig.  4.38. 
No interaction with any other proteins, even with HMW2-3, was detected when MPN298 
was used in the pairwise test. It did not confirm the data from two-hybrid screen with 
HMW2-3. The gene MPN298, therefore, seems rather to be a false-positive result from the 
two-hybrid screen. Transformations of yeast cells with MPN298 in the GAL4-AD vector 
was not succesful although many parameters were optimized. Therefore no experiment 
could be done with this gene construct. 
 
 
 
Fig. 4.38: Yeast two-hybrid reporter gene activation in a pairwise test using MPN298 as bait and 
prey. No positive interaction was detected. Constructs in pray  vectors are indicated in gray and 
those in bait vectors are in black. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Results
 
 121
f) MPN141 (P1-C-terminal region) 
Pairwise tests using P115 as bait and pray are presented in Fig. 4.39. It was shown 
previously that there are interactions between P1 and HMW1 of M. pneumoniae [Layh-
Schmitt et al., 2000]. However, it was not possible to determine, which part of the P1 
protein interacts with which part of the HMW1 protein. 
Therefore, P1, the main adhesin of M. pneumoniae, was tested for its interaction with 
proteins from the list (table 4.4) in the yeast two-hybrid system. The C-terminal region of 
P1 (amino acid residues 1156-1525) was fused to Gal4-AD and Gal4-BD. The P1 in 
GAL4-AD vector was strongly auto-activated and could not be used in the pairwise test. 
However, P1 in GAL-BD interacted clearly with the HMW1- C-terminal region and also 
interact weakly with MPN297. 
 
 
 
Fig. 4.39: Yeast two-hybrid reporter gene activation in a pairwise test using P1-C-terminal region 
as bait. The construct of P1-C-terminus in a pray vector was found to show auto-activation (ability 
to cause nonspecific activation of reporters). All positive cultures are based on the activation of two 
independent reporters: His3 and Ade2. Presence of colonies indicates activation of His3 and Ade2 
reporter. Constructs in pray  vectors are indicated in gray and those in bait vectors are in black. 
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g) MPN310 (HMW2 fragment 4) 
Pairwise tests using HMW2-4 as bait and pray are presented in Fig. 4.40. No interaction 
with any other proteins was detected when HMW2-4 was used in the pairwise test. 
However, it was shown from the pairwise test that HMW2-4 could bind to itself. So one 
could assume that HMW2-4 is responsible for dimer- or polymer formation of the 
complete HMW2 or HMW2-s in vivo, since HMW2-s is the subfragment of the HMW2-4 
(HMW2-s +208 aa upstream of the N-terminus). 
 
 
 
Fig. 4.40: Yeast two-hybrid reporter gene activation in a pairwise test using HMW2-4 as bait and 
prey. All positive cultures are based on the activation of two independent reporters: His3 and Ade2. 
Presence of colonies indicates activation of His3 and Ade2 reporter. Proteins which were tested 
against HMW2-4 are listed on the left. Constructs in pray  vectors are indicated in gray and those in 
bait vectors are in black. The interaction with itself is shown in italic 
 
.
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4.5.3 Summary of the results of the pairwise tests 
Results from two-hybrid screening using HMW2-3 as bait should be confirmed in these 
pairwise experiments. Two interactions were confirmed: interaction of HMW2-3 with the 
HMW1-C-terminal region and with MPN297. Two other interactions proposed on basis of 
the previous screen were shown to be rather false-positive results: interaction of HMW2-3 
with P115 and MPN298. Nevertheless, some potential interaction pairs were newly identified 
from pairwise tests, namely the interaction of P1 with the HMW1-C- terminal region and with 
MPN297. Two proteins were found to have ability to form homopolymers, MPN297 and 
HMW2-4. The data from yeast two-hybrid pairwise tests are summarized in Table 4.6. 
 
Table 4.6: Summary of the results of pairwise approaches 
        pray 
bait 
pGAD424 HMW2-3 HMW1-C P115 MPN297 MPN298 P1-C HMW 2-4 
pGBDU neg neg autoactive neg neg neg autoactive neg 
HMW 2-3 autoactive autoactive POS++ autoactive POS++ 0 autoactive autoactive 
HMW 1-C autoactive autoactive autoactive autoactive autoactive autoactive autoactive autoactive 
P115 neg neg autoactive neg neg 0 autoactive neg 
MPN297 autoactive autoactive autoactive autoactive POS++ autoactive autoactive autoactive 
MPN298 neg neg autoactive neg 0 0 autoactive neg 
P1-C neg neg POS++ neg POS+ 0 autoactive neg 
HMW 2-4 neg neg autoactive neg neg 0 autoactive POS++ 
POS++= positive, strong interaction (growth on –LUHA), 
POS+  = positive, weak interaction (growth on –LUH),    autoactive = growth on –LUHA without 
interaction,    
autoactive = growth on –LUH without interaction,                          0 = transformation not successful. 
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4.6 Isolation of protein complexes containing the HMW2 fusion protein 
It was shown (see chapter 4.5) that HMW2 interacts with several other proteins. To 
confirm these results by another independent method, I isolated in vivo protein complexes 
containing HMW2 from M. pneumoniae by applying the TAP-tag purification method 
[Puig et al., 2001]. 
 
4.6.1 Cloning and expression of the N-terminal TAP-tagged HMW2 
The hmw2 gene was modified with the tap tag to facilate the isolation of HMW2 
containing protein complexes. A DNA fragment encoding the TAP tag was fused to the 5’ 
end of the gene hmw2 (Fig. 4.41). 
 
 
Fig. 4.41: Schematic illustration of the construction of hmw2 gene fused with N-terminal TAP tag. 
 
The expression of the tap-tagged hmw2 was regulated by the clpB promotor from 
M. pneumoniae. The plasmid pBS1761 carrying the DNA sequence encoding the N-
terminal TAP (N-TAP) tag (kindly provided from Dr. Jansen, ZMBH Heidelberg) was 
used as template for amplifying the N-terminal TAP tag by PCR. The PCR product was 
then ligated to the 3’ blunt end of the PCR product of the clpB promotor. The DNA 
fragment containing both sequences was then amplified again by PCR using the ligation 
product as template. The PCR product containing the clpB promotor followed by the N-
terminal TAP tag was then ligated with an EcoRI fragment containing the 5’ end of the 
hmw2 gene (384 bp). The PCR product derived from this ligation reaction containing the 
clpB promotor, followed by the TAP tag and N-terminal hmw2 (EcoRI fragment) was then 
ligated into the EcoRI sites of pQE60 containing gene hmw2 (original sequence with 4 
UGA codons. The entire modified hmw2gene was amplified by PCR and the PCR product 
with the expected size was cloned into the SmaI site of the transposon Tn4001, which is 
part of the plasmid pKV104. The cloning strategy is illustrated in Fig. 4.42. 
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Fig. 4.42: Strategy for cloning the gene fusion of hmw2-N-tap-tag into the plasmid pKV104. 
 
After transforming M. pneumoniae WT and the M. pneumoniae A3, the expression of the 
TAP-tagged HMW2 could be shown. By Western blotting using antiserum against the N-
terminal HMW2, a 235-kDa protein and a 215-kDa protein were observed in protein 
extracts of M. pneumoniae WT transformants and only a 235 kDa protein in 
M. pneumoniae A3 transformants (Fig. 4.43). The 235 kDa protein corresponded to the 
expected size of the TAP-tagged HMW2. In addition, the IgG-binding domain (in TAP 
tag) was detected by Western blotting using serum from a mycoplasma-free rabbit as a 
source of IgG. It reacted positively with the 235 kDa protein in both transformants, 
confirming the presence of the TAP-tagged HMW2 in these cells. 
Results 
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Fig. 4.43: Western   blot   analysis   of  expressed  TAP - tagged  HMW2 in  M. pneumoniae  cells. 
( 7,5  %  SDS - PAA  gel ).  1 =  M. pneumoniae  WT  ;  2  =  M. pneumoniae  WT  transformant  ;  
3 = M. pneumoniae mutant A3 transformant; 4 = M. pneumoniae mutant A3. Anti-HMW2-N573aa 
antiserum and serum from a mycoplasma-free rabbit were used to detect the protein. 
 
4.6.2 Pilot experiments concerning cell breakage and protein solubility 
Various tests were done to fine appropiate conditions for the purification of the TAP-
tagged HMW2 and possible protein complexes containing the TAP-tagged HMW2 protein. 
 
Cell breakage 
The M. pneumoniae WT transformant Nr.1 was resuspended with the buffer recommended 
for general purification of TAP-tagged protein (IPP150: 10 mM Tris-Cl, pH 8.0, 150 mM 
NaCl, 0.1% Nonodet (NP-40)) [Puig et al., 2001]  and then the cells were broken by 
sonification, french press or shaking with glass beads (1 mm , or 0.1 mm diameter). After 
centrifugation, the distribution of the TAP-tagged HMW2 in supernatant and pellet was 
monitored by SDS-PAGE and Western blotting (Fig. 4.44). The TAP-tagged HMW2 was 
partly found in the supernatant of cell extracts prepared by sonification, but only traces of the 
fusion protein were detected in the supernatant after preparing with both size of glass beads. 
The TAP-tagged HMW2 could also not be detected in the supernatant from cell extracts 
treated with french press. Therefore, based on the results from these experiments, sonification 
was chosen as method for preparing cell extracts for the purification of protein complexes. 
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Fig. 4.44: Coomassie Blue stained gel (A) and Western Blot (B) of total protein extract of 
M. pneumoniae mutant A3 transformant containing TAP-tagged HMW2. Various methods for cell 
breakage were tested. (10 % SDS-PAA gel). 
1 = sonification    T = untreated total protein extract 
2 = french press    S = supernatant 
3 = glass beads (1 mm diameter) P = pellet 
4 = glass beads (0.1 mm diameter) 
 
Protein solubility 
The HMW2 protein is a relative large protein and not soluble in buffer without detergents 
or chaotropic substances. Therefore, IPP150 buffer was modified by adding different 
components in final concentrations as indicated: 5 M potassium chloride, 1% digitonin, 
0.5% NP-40, 0.5% Tween-20, 0.5% SDS, 2% DMSO. The M. pneumoniae WT 
transformant (TAP-tag+)was resuspended with those buffers and the individual cell 
suspensions were sonicated and separated in pellet and supernatant by ultracentrifugation. 
Supernatant and pellet of each cell suspension were loaded on a 7.5 % SDS-PAA gel. 
Distribution of the TAP-tagged HMW2 was monitored by Western blotting (Fig. 4.45). 
The fusion protein was only soluble in buffers containing 5 M potassium chloride or 0.5% 
SDS. 
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Fig. 4.45: Western Blot of a total protein extract of M. pneumoniae mutant A3 transformant 
containing TAP-tagged HMW2 (7.5% SDS-PAA gel). Various modifications of the IPP150 buffer 
were compared. 1 = 5M potassium chloride; 2 = 1% digitonin; 3 = 0.5% NP-40; 4 = 0.5% Tween-
20; 5 = 0.5% SDS; 6 = 2% DMSO; S = supernatant; P = pellet 
 
Binding affinity of the TAP-tagged HMW2 to IgG beads under selected buffer conditions 
IPP150 buffers containing 5M potassium or 0.5% SDS were used to treat the cell extract of 
M. pneumoniae A3 transformant as described. Cell extract treated with an unmodified IPP150 
buffer was used as a control. The supernatant was incubated with Dynabeads MyOne® Carboxylic 
Acid (Dynatech) coupled with rabbit-IgG (Sigma-Aldrid). All fractions of each step were 
monitored by Western blotting (Fig. 4.46) using antiserum against the N-terminal region HMW2. 
 
Fig. 4.46: Western blotting of fractions from the first-step-purification test of TAP-tagged HMW2 
using buffer containing 5M potassium chloride (A) or 0.5% SDS (B) (7.5% SDS-PAA gel). 
+ = M. pneumoniae WT; – = M. pneumoniae mutant A3; Wh = whole cell extract; P = pellet; 
S = supernatant; F = flow through; W = wash; E = eluat; M = magnet beads after elution. 
 
The TAP-tagged HMW2, dissolved in either one of the modified IPP150 buffers, was detected 
in the flow-through and in the washing buffers but not in eluat fraction. This indicated that the 
IgG-Protein A interaction did not tolerate these buffer conditions. Similar experiments with 
IPP150 buffer without addition of detergents or high salt were also not successful. 
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Test of the TAP-tagged HMW2 solubility in buffer with different concentrations of SDS 
Previous tests showed that TAP-tagged HMW2 was soluble in 0.5% SDS. However, this 
concentration was too high and inhibited binding of the fusion protein to IgG-beads. To 
find the lowest concentration of SDS, by which TAP-tagged HMW2 is still soluble, the 
following three concentrations of SDS were tested: 0.05%, 0.15%, 0.45%. After treating 
cell extracts with those buffers, the distribution of the TAP-tagged HMW2 in supernatant 
and pellet was monitored by SDS-PAGE and Western blotting (Fig. 4.47). 
 
 
Fig. 4.47: Western Blot of a total protein extract of M. pneumoniae mutant A3 transformant 
containing TAP-tagged HMW2 (10% SDS-PAA gel). The following concentrations of SDS were 
tested to solubilize the  TAP-tagged  HMW2.  S  =  supernatant ;  P  =  pellet ;  1  =  0.05  %  SDS ;  
2 = 0.15 % SDS; 3 = 0.45 % SDS; 4 = 0.5 % NP-40. 
 
 
Most of the TAP-tagged HMW2 was soluble in buffer contating 0.15% SDS. It has been 
reported that the IgG-Protein A interaction is taking place in the presence of up to 500 mM 
NaCl, 1% NP-40 and low concentrations of SDS (0.1%) [Puig et.al, 2001]. Therefore, I 
applied similar conditions for the purification of the TAP-tagged HMW2, since this protein 
is soluble at SDS-concentration of about 0.15%. 
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4.6.3 Purification of the TAP-tagged HMW2 under optimized conditions 
Although it was reported that IgG-Protein A interaction is taking place in the presence of 
up to 500 mM NaCl, 1% NP-40 and 0.1% SDS [Puig et.al, 2001], buffer conditions for 
each purification step using TAP-tag strategy had to be carefully tested. Detergents (e.g. 
SDS and NP-40) and high salt concentrations (above 300 mM NaCl) inhibit TEV-protease 
activity (Invitrogene, technical service). Binding affinity of calmodulin beads is disturbed 
in the presence of SDS, however, buffers containing up to 1 M NaCl and 0.1% NP-40 can 
still be used (Stratagene, technical service). Therefore, buffer components for each 
purification step were individually optimized and adapted to keep the protein complex 
soluble without destroying it. Considering these aspects, a buffer containg 10 mM Tris-
HCl (pH 8) and 250 mM NaCl was used as basic buffer for further purification steps. By 
adding the chemicals (see “Materials and Methods“) and detergents, individual buffers for 
each step were prepared. The following concentrations of detergents were used: 
 
Cell lysis 0.1% SDS 1% NP-40 
First step binding: IgG beads 0.1% SDS 1% NP-40 
Washing IgG beads ? ? 
Elution with TEV protease ? ? 
Second step binding: calmodulin beads ? 0.1% NP40 
Elution with EGTA ? 0.1% NP40 
 
As starting material for the purification of the HMW2 containing protein complex(es), cells 
from a 4500 ml culture of M.pneumoniae A3 transformant with tap-tagged hmw2 were 
used, which yieled about 350 mg of total protein (about 25 mg total protein). As negative 
control, the mutant A3 containing no TAP-tagged HMW2 was also purified under same 
conditions. After applying IgG Sepharose (Amersham Bioscience) in the first purification 
step and washing the calmodulin beads (Stratagene) in the second step, one milliliter of 
calmodulin elution buffer was added to the calmodulin beads. Five elution fractions of 200 
µl each are collected, 100 µl of each fractions were precipitate (methanol/chloroform), 
separated on SDS-PAA gels and visualized by silver staining (Fig. 4.48). 
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Fig. 4.48: Silver stained gel (10% SDS-PAA gel) of fractions (1-5) from the purification of TAP-
tagged HMW2 containing protein complexes. Protein bands (indicated with arrows) were cut and 
identified by mass spectrometry. 
– = fraction from the purification of M. pneumoniae mutant A3 
+ = fraction from the purification of M. pneumoniae mutant A3 transformant containing 
      TAP-tagged HMW2. 
 
 
After the purification with calmodulin beads, one could see that the purification was 
effective. No background from any protein band was seen in the negative control, but 
several proteins remained in the sample containing TAP-tagged HMW2. These proteins 
could potentially interact with the HMW2 protein. Four protein bands were cut out from 
fraction Nr.2 and identified by mass spectrometry (MS). The identified proteins are 
summerized in table 4.7. 
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Table 4.7: Proteins which were co-purified with TAP-tagged HMW2. 
Sample MPN 
number 
ORF calculated 
MW  
Molar mass 
on SDS-PAA 
gel 
Annotation 
 
MPN160 VXpSPT7_
orf377 
42,162 85,000 MG147 homolog; conserved 
hypothetical 
band A 
MPN573 D02_orf543 57,589 85,000 heat shock protein GroEL 
band B no result ? ? ? ? 
MPN665 K05_orf394 42,590 47,000 elongation factor TU (tuf) 
MPN015 D12_orf285 32,762 47,000 MG011 homolog; conserved 
hypothetical 
 
 
band C 
MPN140 E07_orf324 36,461 47,000 ORF4, P1 operon; DHH family 
phosphoesterases 
MPN430 A05_orf337 36,246 36,000 Glycerladehyde-3-phosphate 
dehydrogenase (Gap) 
MPN015 D12_orf285 32,762 36,000 conserved hypothetical, 
MG011 homolog 
MPN392 
 
F11_orf327 35,169 36,000 Pyruvate dehydrogenase E1- 
beta subunit (PdhB) 
 
 
 
band D 
MPN140 E07_orf324 36,461 36,000 orf4, P1 operon; DHH family 
phosphoesterases 
 
The molar masses of some proteins identified on the bands A-D did not always 
corresponded to the predicted molecular weight based on the DNA sequence of the gene. 
Possible reasons could be post-translational modifications of these proteins or a 
dimerization (e.g. by MPN160). 
 
About 100 µl of the fraction Nr.2 were divided into four aliquots and were separated on a 
10%  SDS-PAA gel, the proteins were transferred to nitrocellulose membrane and probed 
with four selected antisera directed against: EF-Tu (as a positive control), HMW2, HMW1 
and the gene product of MPN297. Since there were only small amounts of protein in the 
samples, the Western blot had to be developed with the more sensitive “Extracellular fluid” 
(ECF) reagent which is based on chemofluorescence. The signal from the blot probed with 
?-EF-Tu was easily observed, however only traces of TAP-tagged HMW2, HMW1 and 
the gene product of MPN297 could be detected (Fig. 4.49). 
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Fig. 4.49: ECF Western blots of fraction Nr.2 (10% SDS-PAA gel) from the purification of TAP-
tagged HMW2 containing protein complexes. Names of antisera and dilution used are given below 
each blot. Identified protein bands are indicated by arrows.  
 
Fraction Nr.3, which showed a similar protein pattern like fraction Nr.2 in silver stained gels 
was also analyzed by ECF Western blotting. Again, the fraction Nr.3 were divided into four 
aliquots and separated on 10%  SDS-PAA gel, proteins were transferred to nitrocellulose 
membrane and probed with four selected antisera directed against: HMW2, P1, P90 and P115. 
In these analyses, P115 showed the strongest signal, and again, HMW2 was seen only as a 
faint band. In addition, traces of P1 and P90 could be observed in this fraction (Fig. 4.50). 
 
 
Fig. 4.50: ECF Western blots of fraction Nr.2 (10% SDS-PAA gel) from the purification of TAP-
tagged HMW2 containing protein complexes. Names of antisera and dilution used are given below 
each blot. Identified protein bands are indicated by arrows.  
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4.7 Localization of HMW2 in M. pneumoniae using a new anti-HMW2 antiserum 
Several cytadherence-associated proteins HMW1, HMW2, HMW3, P1, P90, P40, P30, and 
P65 have been reported to be localized at the attachment organelle [Balish et al., 2003; 
Jordan et al., 2001; Krause, 1996; Krause and Balish 2001; Layh-Schmitt and 
Herrmann,1994; Stevens and Krause 1991, 1992]. Subcellular location of most of them have 
been also determined by immunocytochemistry, including P1, P30, P40, P90 [Layh-Schmitt 
and Herrmann,1994], P65, HMW1 [Stevens and Krause,1991, 1992]. However, the cellular 
sublocalization of the important protein HMW2 has still not been convincingly shown.  
So far, the localization of HMW2 at the tip was indicated by fluorescence microscopy with M. 
pneumoniae, which has been transfomed with a gene fusion expressed a green fluorescence 
HMW2 (HMW2-GFP) [Balish et al., 2003]. But this did not provide the conclusive evidence 
for co-localization of HMW2 with the rod, because this method is not sensitive enough for a 
precise localization. The correlation between the rod structure and HMW2 can only be done 
precisely by immunoelectron microscopy. The positive fluorescence signal at the tip did only 
indicate that  HMW2 might be somehow connected with the tip structure. There are two 
HMW2 specific antisera available (Fig. 4.51), one of them recognizes the first 29 amino acids 
of the N-terminal end [Regula, 1999] and another one directed against 319 amino acids of the 
C-terminal region of HMW2 [Proft, 1994]. Attempts to define the subcellular location of 
HMW2 in M. pneumoniae cells using those antisera in immunoelectron microscopy failed, 
since none of these antisera gave satisfying results. 
 
 
Fig. 4.51: Schematic drawing of HMW2. Antibody against the C-terminal region of HMW2 is 
shown here in pink and the antibody against the N-terminal region is shown in red bar with a 
porpotional scale and position. The numbers above the pink and red bars are positions of amino 
acid of HMW2 recognized by the antibody. 
 
The possible explanation was the well-known low specificity of antisera against coiled-coil 
structure forming proteins. Even if these antisera react very strongly in Western blotting 
analyses. In addition, the antiserum against the C-terminal region recognized two proteins, 
HMW2 and HMW2-s. Therefore, in case of positive results, it would not be clear, whether 
HMW2 or HMW2-s was colocalized. By using the program coils of percoils 
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(www.expasy.org) to determine score value of coiled-coild domains within HMW2 protein 
sequence, it was shown that non coiled-coil regions are found in the N-terminal part of 
HMW2. Therefore, a reactive new antigen was produced which contained 573 amino acids 
of the N-terminal region of HMW2. This antiserum should recognize larger regions of 
HMW2 and be more specific. 
 
4.7.1 Construction of a HMW2 fusion protein for generating a new antiserum 
For antiserum production, the antigen had to be as pure as possible and available in 
sufficient amounts. The hmw2 gene contains 4 UGA triplets, coding for tryptophan in M. 
pneumoniae (Fig. 4.1) but  for a stop codon in other organisms. Therefore, for expression 
of HMW2 in other organisms, all UGA codons of gene hmw2 were changed to UGG 
[Boonmee, unpublished]. 
It was observed that after converting the first two UGA codons, the resulting HMW2 
fragment showed the highest expression (Fig. 4.52). The corresponding protein, 573 amino 
acids, was considerably larger than the previous antigen used for producing anti-HMW2 
antiserum (29 amino acids). Due to its size and its high expression level, this truncated 
HMW2 was chosen as antigen for the generation of a new antiserum. 
 
 
 
 
 
 
Fig. 4.52: Coomassie Blue stained gel of total 
protein extracts of E. coli tranformed with 
hmw2 genes which contained 1, 2, 3 and 4 
UGA codons. (10% SDS-PAA gel). Number of 
* indicates position of fusion protein on each 
lane. The arrow points to the protein used as 
antigen. 
1 = HMW2 4UGA (20 kDa) 
2 = HMW2 3 UGA (32 kDa) 
3 = HMW2 2 UGA (68 kDa) 
4 = HMW2 1 UGA (185 kDa) 
 
 
A vector construct of pQE60 with gene hmw2 (2 UGGs) was used as a template for amplifying 
the 5' end of the 1722 bp DNA fragment of the gene hmw2 (which I will call hmw2-AG) which 
terminated at the third UGA codon of the gene. The construction was first cloned into the 
pQE9 vector which provided a his tag to the 5’ end of the fused gene (Fig. 4.53). 
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Fig. 4.53: Schematic illustration of the cloning of the hmw2-AG into the  pQE9 vector. 
 
However, the fusion protein was expressed at a very low level (Fig. 4.54), compared to the 
fusion protein from the mutagenesis experiment which had no N-terminal His tag. We 
concluded that,in this case, expression of this protein might be negatively influenced by the 
N-terminal His tag. 
 
Fig. 4.54: Coomassie Blue stained gel (A) and Western blot (B) of the N-terminal HMW2 (573 aa) 
expressed in pQE9 vector in E. coli. (10 % SDS-PAA gel) (?-HMW2_573aa, dilution 1:3000). 
Arrows   indicate   expected   fusion    protein .   Five    different    clones   were    tested   ( 1 – 5 ) ,  
– = transformed E. coli , uninduced.  
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Therefore, I decided to fuse the His tag to the C-terminus of HMW2. To improve the 
specific binding of our His-tagged protein, we added three more histidines to the C-
terminal end of HMW2-AG. An existing vector pQE60 with gene hmw2 (2 UGGs) was 
used again as a template for this purpose. E. coli XL1-blue strain was transformed with the 
ligation product. A search for the right clone was done by monitoring protein expressions 
of each clone. This time, the fusion protein was expressed at a high level and therefor 
could be produced in large quantities for purification and immunization (Fig. 4.56). 
 
4.7.2 Purification of the HMW2-AG fusion protein by IMAC 
Some proteins overexpressed intracellularly in E. coli are frequently sequestered into 
insoluble inclusion bodies. Therefore, to find proper conditions for an efficient purification 
of HMW2-AG fusion protein, the solubility of the fusion protein was determined. An 
advantage of His-tagged proteins is that, if they are found in insoluble inclusion bodies, 
they can be easily solubilized with chemicals such as 6 M guanidium hydrochloride or 8 M 
urea or with a variety of detergents and be purified on Ni-NTA matrices.Samples of cell 
pellets containing the HMW2-AG fusion protein were resuspended with various lysis 
buffers (native/ denaturing conditions). Distributions of the fusion protein were monitored 
in SDS-PAGE. Under native conditions, most of the fusion protein still remained in the 
insoluble fraction, therefor a denaturing buffer containing 4M urea was chosen for all 
processes. Purification of His-tagged HMW2-AG was done by with ÄKTAexplorer™ 10 
systems (Amersham Biosciences), using a 5-ml HiTrap Chelating column (Amersham 
Biosciences) loaded with nickel ions. The ÄKTA explorer™ was connected to a computer 
installed with the control program UNICORN™, by which all parameters for each 
purification steps could be modified. The program displayed actual run status and current 
flow path, so one will have a real-time overview of the system and separation (Fig. 4.55), 
followed by automatic generation of the purification report with extensive data evaluation 
wizard and reporting options. 
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Fig. 4.55: Flow-chart of purification of N-terminal HMW2 by ÄKTAexplorer™. 
 
Samples of eluated fractions which were shown in the program to contain the fusion 
protein were each loaded on a SDS-PAA gel and visualized by staining with Coomassie 
Blue (Fig. 4.56). Purifaction was very effective, so that no further purification steps were 
necessary. Six milligrams of the His-tagged HMW2-AG had been isolated from 500 ml of 
E. coli liquid-culture. The purified protein was precipitated with aceton to get rid of urea, 
which would interfere with the immunization. 
 
 
Fig. 4.56: Coomassie Blue stained gel of fractions from each purification step of HMW2-AG (10% 
SDS-PAA gel). – = whole cell extract of E. coli without the fusion protein; + = whole cell extract 
of E. coli containing HMW2-AG; P = pellet; S = supernatant; F = flow through; 5-13 = number of 
collected fraction. 
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4.7.3 Tests of the new antiserum 
For each immunization 0.6 milligram of His-tagged HMW2-AG was used (for details see 
“Material and Methods”). After each boost, specificity of the antiserum was tested by 
Western blotting. Antisera of all boosts were compared with each other and also with the 
previous N-terminal antiserum (Fig. 4.57). 
 
 
 
 
 
 
 
Fig. 4.57: Western blot analysis of a whole cell 
extract of M. pneumoniae WT (a) and of the 
M  pneumoniae A3 (b) using various antisera 
directed against N-terminus of HMW2 protein. 
N = antiserum directed against 29 aa [Regula, 1999] 
1 = antiserum directed against 573 aa, first boost 
2 = antiserum directed against 573 aa, second boost 
3 = antiserum directed against 573 aa, third boost 
 
The highest intensity of a reaction with HMW2 was monitored when probed with an 
antiserum derived from the third boost. This serum can be diluted at least 1: 10,000 and 
still gave a strong signal (Fig. 4.58). 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 4.58: Western blot analysis of a whole cell 
extract of M. pneumoniae WT (a) and the purified 
N-terminal HMW2 fusion protein (b) using the new 
antiserum taken after the third boost. 
Furthermore, this antiserum showed no cross-reaction with any other proteins of M. pneumoniae 
whole protein extracts, indicating that this newly produced antiserum was very specific. 
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4.7.4 Localizing HMW2 in M. pneumoniae with a new anti-HMW2 antiserum  
The new anti-HMW2 antiserum was then used for localization of HMW2 in 
M. pneumoniae cells by immunoelectron microscopy. This was done by Dr. Hegermann 
(AG Prof. Meyer, Goettingen). A reaction at the proximal region of the rod was observed 
in labelling experiments of ultrathin cryosections with this new antiserum (Fig. 4.59). 
 
 
 
 
Fig. 4.59: Immuno-gold labelling of ultrathin cryosections of M. pneumoniae with a new anti-HMW2 
antiserum. Signals in proximal region of rod was detected. R: rod (taken from Hegermann, 2003). 
 
 
No signal in so called whole-mount-preparations was observed, neither by cells with intact 
cytoplasma membrane nor by cells after removing their cytoplasma membrane. This leads 
one to assume that HMW2 is not exposed on the surface and is also not a part of the 
peripheral cytoskeleton [Hegermann, 2003]. 
The positive reaction near the proximal region of the rod suggested a participation of 
HMW2 in the structure of the rod or a participation in the formation of the circular 
structure at the proximal end of the rod (Fig. 1.3). 
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5 Discussion 
5.1 Expression of HMW2 
Expression in E. coli 
Protein expression in E. coli provides the possibility to obtain large quantities of a desired 
protein which can be used for a wide range of studies including vaccine production, 
structural, biochemical and cell biological studies. E. coli is most commonly used as a host 
for the expression of recombinant proteins, although a foreign protein, when expressed, 
often forms an insoluble product, termed an inclusion body or undergoes degradation by 
proteases. Most of those problems arise from misfolding of the expressed protein, being a 
main obstacle for expressing protein in large amount in E. coli. This might be caused by 
some noxious properties of the gene product (e.g. instability, misfolding, toxicity to the 
host, degradation of the ‘foreign’ mRNA etc.) [Ausubel et al., 2003]. 
The full-length HMW2 protein was expressed in E. coli in so small quantities so that it was 
only visible by Western blotting. Since a single subfragment of 573 amino acids covering 
the complete N-terminal region of HMW2 could be expressed very well, it must be either 
the size of the protein and the extended coiled-coil structure which prevents effective 
translation or stability in E. coli or some sequences in the C-terminal half of HMW2. An 
indication of instability is the high background of protein bands with lower molar masses 
observed in SDS-PAA gels combinded with Western blot analyses. This background 
indicates that HMW2 was degraded very fast in E.coli, although a variety of growth 
parameters was tested, which may provide a greater yield of non-degraded fusion protein 
in the soluble fraction. Several theories have been advanced to explain the susceptibility of 
certain proteins to degradation (e.g. the N-end rule [Varshavsky, 1997]), the function of the 
majority of proteases, and regulation of proteolysis within cells. 
Difficulties in expressing large proteins with extended coiled-coil domains have also been 
observed. For example, attempts to purify full-length Tpr? from various mammalian 
tissues, or to isolate the full-length N- and C-terminal domains from bacterial or insect 
expression systems, did not yield sufficiently high amounts of undegraded protein [Brettel, 
Hase, Herrmann, Krohne, and Cordes, unpublished data; Hase et.al, 2001]. 
The expression of HMW2 in E. coli was regulated by the lac control region. It was 
observed in Western blot analyses of the expressed HMW2 that this system was not 
                                                
? protein containing predicted coiled-coil domains. It is a component of nuclear pore complex (NPC)-
attached intranuclear filaments [Hase et.al, 2001]. 
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controlled tightly enough. Expressing the HMW2 protein occurred without induction by 
adding IPTG. In addition to reducing the bacterial growth temperature and induction time, 
a much tighter controlled expression unit e.g. the “tet system” [Lutz and Bujard, 1997]) 
could help to reduce degradation of foreign protein expressed in E. coli keeping expression 
turned off until the clone has been grown up to a relative high titer and allowing them only 
one or two hours of protein synthesis. 
 
Expression in other organisms 
Like mitochondria, Mycoplasma species utilize the UGA codon to encode tryptophan 
[Inamine et al., 1990] rather than to serve as a stop codon. In general, Mycoplasma genes 
containing one or more UGA codons will not be expressed due to premature termination in 
commonly used expression systems that strictly adhere to the universal genetic code. An 
exception is the very limited readthrough of the UGA stop codon in Escherichia coli and 
Salmonella enterica serovar Typhimurium [Parker and Wiley, 1989; Roth, 1970]. 
Interestingly, although UGA also functions as a termination codon in Bacillus subtilis, the 
efficiency of UGA readthrough in this Gram-positive bacterium is relatively high due to 
the presence of a tRNA that reads the UGA termination codon as tryptophan [Lovett et al., 
1991]. Therefore, UGA readthrough in B. subtilis happens much more often than that in 
other members of the family Enterobacteriaceae [Karow et al., 1998]. 
Furthermore, B. subtilis strains with mutations in the structural gene (prfB) for release factor 2 
(RF2) showed increased readthrough levels by overcoming UGA-mediated termination 
[Karow et al., 1998]. Based on those observations, Kannan and Baseman expressed in B. 
subtilis the specific UGA-containing genes encoding the P30 adhesin (one UGA) of 
Mycoplasma pneumoniae and methionine sulfoxide reductase (two UGAs) of Mycoplasma 
genitalium [Kannan and Baseman, 2000]. Due to natural UGA suppression, these Mycoplasma 
genes were expressed as full-length proteins, but with a relatively low efficiency.Expression of 
the P30 adhesin in E. coli resulted in two bands, one migrating to the expected position and 
another one indicating a higher molar mass [Kannan and Baseman, 2000]. 
Similar experiences have been made with other genes of Mollicutes. Multiple protein 
bands were observed expressing Mycoplasma hyorhinis genomic fragments in E. coli 
[Notarnicola et al., 1990]. The Spiroplasma gene encoding spiralin contains no UGA 
codons but also generated multiple recombinant proteins in E. coli [Mouches et al, 1985]. 
Expression of a set of multiple proteins exceeding the coding capacity of a cloned genomic 
fragment from Mycoplasma capricolum has also been described for E. coli [Andersen et 
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al., 1984]. Differences in UGA codon usage and initiation sites for translation in E. coli 
may account for these variations in protein size [Notarnicola et al., 1990]. 
Besides expression in baterial hosts, expression of HMW2 in Dictyostelium discoideum 
might also be another alternative choice for expression of coiled-coil-rich proteins 
[Schwarz et.al., 1999]. Dictyostelium discoideum is being used as a model organism to 
investigate the involvement of the actomyosin? cytoskeleton in a variety of cellular tasks. 
Two novel, unconventional myosins were identified in this organism, MyoK and MyoM 
[Schwarz et.al., 1999]. This organism was used to express myosins succesfully [Schwarz 
et.al., 1999]. Since HMW2 has some sequence similarity to the tail region of myosin II 
heavy chain [Krause et al., 1997], HMW2 might be more stable when expressed in 
Dictyostelium discoideum than in E. coli. 
 
Codon usage 
As mentioned above, differences in codon usage among organisms cause to a variety of 
problems concerning heterologous gene expression, since not all 61 codons are used 
equally. The so-called major codons are those that are used in highly expressed proteins, 
whereas the minor or rare codons tend to be in genes expressed at a low level. Which of 
the codons are the rare ones depends strongly on the organism. The codon usage of E. coli 
and M. pneumoniae is presented in Table 7.1 (Appendices). For more information on the 
low usage codons of both organisms see Table 7.2. 
Usually, the frequency of the codon usage reflects the abundance of their cognate tRNAs. 
Therefore, when the codon usage of the target protein differs significantly from the 
average codon usage of the expression host, this could cause problems during expression 
such as: decreased mRNA stability (by slowing down translation); premature termination 
of transcription and/or translation (which leads to a variety of truncated protein products); 
frameshifts, deletions and misincorporations (e.g. lysine for arginine) and inhibition of 
protein synthesis and cell growth [Kane, 1995]. 
As a consequence, the observed levels of expression are often low or there will be no 
expression at all. Especially in cases were rare codons are present at the 5’-end of the 
mRNA or in clusters expression levels are low and truncated protein products are found. 
Several codons that have been associated with translation problems in E. coli are: arginine 
(AGG, AGA, CGA, CGG), leucine (CUA), isoleucine (AUA), proline (CCC) and glycin 
(GGA). For instance, the presence of more than 8-9 of the two rarest Arg codons, AGG 
                                                
?  a protein complex composed of actin and myosin. It is a constituent of muscle fibre and is responsible for 
muscular contractions. 
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and AGA, particularly back-to-back as a tandem repeat, has prevented over-expression of 
the SurE? proteins of Pyrobaculum aerophilum [Mura et al., 2003].  
Interestingly, there are significant differences in the codon usage of the hmw2 gene (table 
7.1, Appendices) when compared to the codon usage of E. coli. The most significant 
difference concerns the CGG codon (coding for arginine). The frequency of this codon in 
the hmw2 gene was 10.4 fold higher than in E. coli. In addition, the following codons from 
the hmw2 gene also differ significantly from the average codon usage of E.coli: AAG 
(lysine, 6.1 fold), CAA (glutamine, 6.1 fold), UUA (leucine, 3.8 fold), CUG (leucine, 2.6 
fold), GAA (glutamine, 2.1 fold) and UUG (leucine, 2 fold). These seven codons represent 
60.7 % of the complete set of codons from the hmw2 gene.  
Moreover, the codon which is most predominantly presented in the gene hmw2 (245 out of 
1818 codons) is the CUA codon (coding for leucine). It is distributed over the entired 
sequence of hmw2, particularly in the middle region of the gene (Fig. 7.1, Appendix). They 
are frequently found to be located near each other (e.g. at gene position 2059 and 2074; 
2854 and 2860; 3097 and 3118; 3280 and 3298). It was shown that the truncated parts of 
hmw2 gene could be expressed very well in E.coli (chapter 4.2 and 4.7). Those regions of 
hmw2 contain different rare codons, where the CUA codon is dominating in the middle 
region of the sequence. Based on this observation, both the predominance of the leucine 
codon CUA in hmw2 sequence and the significant differences of codon present in hmw2 
gene and the average codon usage in E. coli might be the reasons for poor expression of 
the HMW2 full-length protein in E. coli. 
To improve the expression levels of HMW2 in E. coli, several approaches could be taken: 
• Replacing codons that are rarely found in highly expressed E. coli genes with more 
favourable codons throughout the whole gene. 
• Co-expressing the genes encoding for a number of the rare codon tRNAs. There are 
several commercial E. coli strains available that encode a number of tRNAs with rare 
codons gene [Carstens and Waesche, 1999; Schenk et al., 1995; Wakagi et al., 1998]. 
• Examining the second amino acid after the start methionine. In endogenous E. coli 
proteins not all codons are used to the same extend as the second triplet (following the N- 
terminal methionine). The most used one is AAA lysine (13.9%) while other codons are    
not used at all. Looman and colleagues showed that the expression efficiency of a modified 
lacZ gene varies at least 15 fold, depending on the codon at the second position. Thus, 
choosing the right codon in this position, e.g. changing it into one that is moreoften used in 
E.coli, could improve expression levels [Looman et al., 1987]. Later on, by establishing the 
Discussion 
 
 145
N-end rule, Varshavsky showed convincingly that the half-life of a protein is strongly 
induced by the amino acid at the second position [Varshavsky, 1997], which is in 
agreement with the observation of Looman. 
• Minimizing the GC content at the 5’-end. A high GC content at the 5’-end of the gene of 
interest usually leads to the formation of secondary structure in the mRNA. This could 
result in interrupted translation and cause lower levels of expression. Thus, higher 
expression levels could be obtained by changing G and C residues at the 5’-end of the 
coding sequence to A and T residues without changing the amino acids [Voges et al., 2004]. 
• Addition of a transcription terminator (or an additional one if one is already present). 
• Addition of a fusion partner. Fusion of the N-terminus of a heterologous protein to the C-
terminus of a highly-expressed fusion partner often results in high level expression of the 
fusion protein, e.g. a His-tagged derivative of bacteriophage Lambda head protein D 
(GpHD) [Forrer and Jaussi, 1998] or an N-terminus sequence of human interleukin 1beta   
(HIL-1beta) [Lee et al., 1999]. 
• Using protease-deficient host strains. The use of host strains carrying mutations which 
eliminate the production of proteases can sometimes enhance accumulation of the desired 
protein by reducing proteolytic degradation. E. coli strain BL21, the work horse of E. coli 
expression, is deficient in two proteases encoded by the lon (cytoplasmic) and ompT 
(periplasmic) genes. 
 
5.2 Internal start in hmw2 gene 
The existance of HMW2-s was first observed in Western blots of total protein extracts 
from M. pneumoniae when probed with an antiserum which was directed against the C-
terminal region of HMW2 [Proft, 1994]. This monospecific antiserum was made by 
immunization of rabbits with a 320 amino acids long peptide from the C-terminal region of 
HMW2 (position 1459-1778). It reacted with a 216-kDa protein and a 25-kDa protein 
(HMW2-s) in Western blot experiments of total protein extracts from M. pneumoniae WT 
but monospecific antibodies directed against a peptide from the N-terminal region of 
HMW2 reacted only with a 216-kDa protein and not with HMW2-s. 
The complete loss of HMW2-s in M. pneumoniae A3 (hmw2-), of which the hmw2 gene 
was inactivated by a transposon insertion close to the 3’ end of the gene hmw2, raised the 
possibility that HMW2-s might be a product of an internal translation initiation [Krause et 
al., 1997]. It was argued that two different ATG codons near the 3’ end of hmw2 at 
nucleotide positions 4735 and 4858 could initiate start of translation to generate, in frame 
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with HMW2, a polypeptide of 25 kDa. Exhaustive attempts to determine the N-terminal 
end or to obtain amino acid sequences from internal regions were unsuccessful [Krause et 
al., 1997]. In this work, the N-terminus of HMW2-s was sucessfully identified. The result 
of mass spectrometric analyses revealed that HMW2-s starts with methionine, which is 
encoded by the ATG codon at position 4858. Results from chapter 4.3, together with 
observations about HMW2-s in different hmw2 mutants are summarized in Fig.5.1. 
 
 
Fig. 5.1: Summary of HMW2 and HMW2-s proteins synthesized in M. pneumoniae from natural and 
artifical hmw2 genes (see chapter 4.3). WT = M. pneumoniae WT; A3 = M. pneumoniae mutant A3. 
 
It was shown in chapter 4.3 that HMW2-s can be produced despite deleting 2/3 from the  
hmw2 gene. This supports strongly the hypothesis of an internal new start within the hmw2 
gene. The DNA sequence of the 18 nucleotides upstream from ATG start codon of 
HMW2-s seemed to play critical role for the expression of HMW2-s (Fig. 5.1, A3). A 
detailed analysis of the sequences in this DNA region showed a potential promotor region 
(-10) of a M. pneumoniae gene (Fig. 5.2). The characteristic features are the conserved -10 
region, absence of a conserved -35 region, and a short leader mRNA without a pronounced 
ribosomal binding site. 
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Fig. 5.2: The proposed promotor region for hmw2-s. 
 
The sequence TAAAAT of the -10 region is also found in the promotors of the genes 
MPN083 (lipoprotein), MPN446 (rps4), MPN449 (unknown), MPN454 (unknown), MPN 
455 (ctaD), MPN 560 (arcA), MPN592 (lipoprotein) and MPN309 (p65). The sequence 
TAAGCA of the -35 region is identical to those of MPN455 (TTAGCA), MPN401 
(TTGGCA) and again, the MPN309 (TTTGCA). These data provide additional support 
that HMW2-s is indeed synthesized by an internal start codon. Moreover, the proposed 
promotor region shows similarity to the promotor of the P65 operon, of which the gene 
hmw2 is part of. Interestingly, this internal start codon seemed to be specifically used by 
M. pneumoniae only, since HMW2-s has never been observed in protein extracts from 
E.coli containing the full-length, UGA free hmw2 gene (see chapter 4.1). 
Internal translational start site also occurs in other organisms, for instance in the clpA gene 
of E. coli [Seol et al., 1994, 1995]. The clpA gene has dual translational start sites encoding 
two polypeptides with different sizes, 84 kDa and 65 kDa; referred to as ClpA84 and 
ClpA65, respectively. The smaller polypeptide is derived from the internal start site [Seol 
et al., 1994]. It has been suggested that ClpA65 may play an important role in the 
regulation of the ClpA84 level and hence in the control of ATP-dependent protein 
breakdown in E. coli [Seol et al., 1995]. 
Although the HMW2 homologue (MG218) is expressed in Mycoplasma genitalium, a 
protein corresponding to HMW2-s has not been identified in that organism 
[Dhandayuthapani et al., 1999]. Interestingly, the C-terminal region of the M. genitalium 
homologue of HMW2 lacks a predicted trivalent coiled coil region (Fig. 5.3) possibly 
obviating a HMW2-s-like molecule in this organism. However, the roles of HMW2 and 
HMW2-s in the biogenesis of the attachment organelle remain poorly defined. To 
understand the function of HMW2-s, it would be desirable to have a mutant with a 
complete functional HMW2 but incapable to synthesize HMW2-s. 
 
 
 
Fig. 5.3: Schematic illustration of the HMW2 homologous protein of M. genitalium (yellow) and 
comparison with the HMW2 of M. pneumoniae (pink). The C-terminal region (marked with blue) 
of the M. genitalium homologue of HMW2 lacks a predicted trivalent coiled-coil region. 
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5.3 Effects of HMW2 on the stability of other proteins from M. pneumoniae  
The rationale behind the comparative analyses of protein profiles from M. pneumoniae WT 
and hmw2? mutants was that proteins which normally interact directly with HMW2 are 
rapidly degraded if the interacting partner protein HMW2 is absent. 
 
Comparative Western blot analyses: 
By comparative Western blot analyses, changes in the concentration of 12 selected proteins, 
candidates for the interaction with HMW2 (Table 4.1) in M. pneumoniae mutant A3 were 
compared with those from WT. The concentration of five from these proteins (HMW1, 
HMW3, P65, P41 and P24) have been previously reported to be reduced in the mutant A3 
[Krause et al., 1982, 1997]. My data support these earlier notions. The most significant new 
results concerned three proteins of the P1 operon (P1, P40 and P90). They could not be 
detected in the protein extracts of the mutant A3. This indicated that they might undergo a 
rapid degradation in the absence of HMW2. These results supported data from two-hybrid 
pairwise tests of HMW2 with P1, suggesting that P1 and HMW2 interact at least indirectly 
with each other by HMW1, which was able to bind to both P1 and HMW2. The loss of all 
proteins of the P1 complex in hmw2- mutants might be a consequence of the missing 
binding partner HMW1 which has a high turnover rate in the absence of HMW2. Without 
HMW2, the P1 complex probably can not be formed and inserted properly in the 
membrane, making those proteins useless for the bacterium and are therefore degraded. 
The concentrations of two other proteins, which reacted positively in the two-hybrid screen 
pilot experiment, P115 and the gene product of MPN297, was also determinded in the 
mutant A3. No significant changes of their concentrations was observed. P115 was part of 
an enriched protein complex containing HMW2 indicating that P115 might interact 
directly or indirectly with HMW2. The protein encoded by MPN297 was shown by two-
hybrid experiments to directly interact with HMW2. Although its concentration was not 
reduced, higher multimeric forms observed in the WT profile could not be observed in the 
mutant A3. Since this protein was found to interact also with itself, it could be speculated 
that HMW2 might affect the polymerization of this protein, and therefor monomeric and 
trimeric forms of this protein accumulated in the mutant A3 but higher multimers were not 
formed. These results suggest that P115 and the gene product of MPN297 might have at 
least two functions, of which one is independent of HMW2 and therefor their 
concentrations are not significantly affected by the absence of HMW2.  
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Comparative 2-D gel electrophoresis 
For a more comprehensive analysis of the effect of HMW2 on other proteins of 
M. pneumoniae, 2-D gel electrophoresis was selected as a method. Changes of protein 
concentration of individual proteins from M. pneumoniae WT and M. pneumoniae A3 in 
total soluble protein extracts were monitored. 
Twelve proteins from a total of 41 analyzed proteins were found to have a significant 
decrease in their concentrations in the mutant A3 (Table 5.1). Most of those were enzymes 
involved in different metabolic activities. Five of the identified proteins with significant 
reduction were also found in the Triton X-100 insoluble fraction. The connection of the 
different enzymes to HMW2 is not clear at all. It could be argued that these enzymes are 
organized in the bacterium forming the so called enzoskeleton? [Norris et al., 1996] and 
that HMW2 does participate in this organization. 
 
Table 5.1: Proteins with significant differences in concentration in M. pneumoniae WT 
and A3 detected by comparative 2-D gel electrophoresis 
Presence in the Trition X-100  
insoluble fragment 
Absence in the Triton X-100  
insoluble fragment 
MPN 
Number 
Annotation MPN 
Number 
Annotation 
MPN082 Transketolase 1 (TklB), MPN050 Glycerolkinase (glpK) 
MPN321 Dihydrofolate reductase (DhfR), MPN051 Glycerol-3-phosphat-dehydrogenase 
MPN452 HMW3  MPN062 Purinnucleosid-phospholyrase (deoD) 
MPN456 Conserved hypothetic putative 
lipoprotein 
MPN191 RNA-polymerase alpha-core-subunit 
(rpoA) 
MPN674 1-Lactate dehydrogenase (Ldh) MPN533 Acetatkinase (ackA) 
  MPN479 Acylcarrier-proteinphosphoesterase 
  MPN600 ATP-Synthase alpha chain (atpA) 
  MPN631 Elongationfactor Ts (tsf) 
 
HMW3 was the only protein of those compared by Western blotting (see also 4.4.1), the 
reduction of which could be also confirmed by the 2-D gel approach. The other proteins 
from the Western blot analyses were probably not separated well enough or could not be 
analyzed for technical reasons. The following limitting factors of the 2-D gel approach 
have to be considered: 
                                                
? Metabolic pathways form multi-enzyme complexes which channel substrates and which connect 
membranes and nucleic acids to create the extensive, cross-linked, intracellular structure termed 
‘Enzoskeleton’. This enzoskeleton includes eukaryotic-like cytoskeletal structures and elements such as the 
MukB and FtsZ proteins. The enzoskeleton was proposed to be regulated by calcium and by protein 
phosphorylation during adaptation to different environments and during the cell cycle [Norris et al., 1996]. 
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About 50 % of M. pneumoniae proteins have a basic isoelectric point. With the standard 2-
D gel electrophoresis, as described by Görg and coworker, a pH range from 3 to 10, under 
special conditions to pH 12, can be covered [Görg et al., 1995]. But the basic section is not 
focussed as well as the acidic section. So, in practical terms, identifications of strongly 
basic proteins with a pI above 10, are still a problem applying standard 2-D gel 
electrophoresis. Furthermore, the silver staining according to Blum does not reliably work 
with basic proteins, i.e. these will be stained only after a long exposure or the staining will 
be incomplete and does not show a correct comparison. 
The separation of particular small proteins (< 6 kDa) und large proteins (> 100 kDa) is also 
difficult by standard 2-D gel electrophoresis. Small proteins move with the protein front 
and will not be separated into single spots. They are normally incompletely fixed in the gel 
and will be washed out [Ueberle, 2001]. Moreover, the accumulation of Sodium 
dodecylsulfat ions in the gel can cause poor resolution [Harry et al., 2000]. Therefore, for 
the separation of small proteins special gel systems are required, which separated only 
proteins with molar masses below 25 kDa. 
High molecular proteins are also usually underrepresented in 2-D gels. They are lost in 2-D 
gels for several reasons: they are badly solubilized under the conditions of separation 
according to charge in the first dimension. Based on their electrophoretic mobility, they focus 
very slowly and appear only as a strip, or due to dilution effects, are not visible even with the 
sensitive silver staining method [Ueberle et al., 2002]. For instance, HMW1, pI 3.79 and a 
molar mass of 112,200 Da, and HMW2, pI 9.78 and a molar mass of 215,600 Da, are barely 
detectable, although, based on pI and molecular mass, they should be very well separated. 
Another group of proteins, which are also well-known to be underrepresented in 2-D gels, are 
membrane proteins. The separation of membrane proteins is most critical in 2-D gel 
electrophoresis. Besides their usually basic pI-values, they are poorly solubilized in the used 
aqueous buffers due to their hydrophobicity. Membrane proteins with more than three 
predicted transmembran domains are normally not separated in 2-D gels [Ueberle et al., 2002]. 
Despite these limiting factors, it was shown here that the 2-D gel electrophoresis is a 
suitable method gaining in one experiment a fast overview on the protein compositions of 
most of the soluble proteins of a cell. Although 2-D gel electrophoresis provides very 
reproducible protein patterns, it gives however small variations which arise from gel to gel. 
Two-dimensional gel electrophoresis is time consuming, labor intensive and gel-to-gel 
variations is a major source of error. This makes it sometimes difficult to distinguish real 
biological differences from variations caused by technical problems. These disadvantages 
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were solved to some extend by the ETTAN- DIGE system (Amersham Biosciences) 
recently introduced as an improved method for doing comparative 2-D gel electrophoresis. 
This system uses size and charge-matched, spectrally resolvable fluorophore to pre-label 
protein samples to be compared individually, but separating them on a single 2-D gel. This 
allows comparing proteins from different sources e.g. from a wild type and a mutant of a 
given species with a much better accuracy and sensibility [Alban, 2003]. 
 
5.4 Proteins interacting with HMW2 in the two-hybrid pairwise tests 
The yeast two-hybrid system detects direct interactions between pairs of proteins expressed in 
yeast, and as a consequence the reporter genes may be activated even by weak or transient 
interactions that might not be detectable by other physical methods such as co-
immunoprecipitation. This system was used in this work to test direct interactions between all 
49 possible pairs of the seven proteins/ peptide fragments. All these proteins were suspected 
to potentially interact with HMW2 based on circumdtantial evidence from other experiments. 
Several candidates, suggested from pilot experiments of the two-hybrid screen with 
HMW2 fragment 3 (HMW2-3), were tested and some of their interactions were confirmed 
again by the pairwise test: interaction of HMW2-3 with the C-terminal fragment of HMW1 
(MPN447)  and with the MPN297 encoded 17-kDa protein. By applying the pairwise test, 
no interactions between HMW2-3 and two other candidates, P115 and the gene product of 
MPN298, were observed. This indicated that both proteins retrieved from the two-hybrid 
screen were probably false-positive results.  
Two additional proteins, the C-terminal region of P1 and HMW2 fragement 4 (HMW2-4) 
were also tested in this two-hybrid pairwise experiment to prove their interaction with 
other proteins. P1 was observed by comparative protein analyses of M. pneumoniae WT 
and the mutant M. pneumoniae A3 (hmw2
?
) to have a significantly higher turnover rate in 
the mutant A3. Although P1 did not to directly interact with HMW2-3 (or HMW2-4), but it 
was shown to interact with both HMW1 and, again, the gene product of MPN297, 
indicating an indirrect interaction of P1 with HMW2. 
In this study, two proteins, the gene product of MPN297 and HMW2 fragment 4, were 
observed to interact with themselves, forming different kinds of homopolymers. These 
results support earlier observations that HMW2 showed a much higher molar mass by SDS-
PAGE in the absence of reducing agents [Stevens and Krause, 1990; Krebs et al., 1995]  
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MPN447 (Cytadherence accessory protein (HMW1) 
The cytadherence accessory protein HMW1 is one of the proteins proposed to be involved 
in formation of cytoskeleton-like structures in M. pneumoniae. It was shown to be located 
 on the mycoplasma cell surface but lacks typical secretion signal, transmembrane 
sequences or significant homology to any proteins found beyond the mycoplasmas [Balish 
et al., 2001; Dirksen et al., 1996]. HMW1 has been localized to the attachment organelle 
[Seto et al., 2001, Stevens and Krause, 1991] as well as to the trailing filament [Stevens 
and Krause, 1991], depending on the experimental approach.  
HMW1, as well as HMW2, HMW3, P65 and P200, have been found almost exclusively in 
the Triton X-100 insoluble fraction [Regula et al., 2001]. The loss of HMW1 in the mutant 
M6 (hmw1
-
) is correlated specifically with HMW2 instability, the failure of HMW2 to 
localize to the attachment organelle, and the absence of an electron-dense core  [Willby et 
al., 2004]. The C-terminal domain of HMW1 was reported to be essential for the proper 
localization of HMW1 to the attachment organelle [Willby et al., 2004], for its function in 
cell morphology [Hahn et al., 1998], for its accelerated turnover in the absence of HMW2 , 
and the ability to stabilize HMW2 [Willby et al., 2004]. 
The data reported above correlated with the results from the two-hybrid pilot experiments. If 
the HMW2 fragment 3 was used as bait and screened against random fragments of 
M. pneumoniae genomic DNA (pray), the C-terminal region of HMW1 was frequently 
identified as a positive clone. In the pairwise tests, the interaction of HMW1 C-terminal region 
with HMW2 fragment 3 was also confirmed. Furthermore, the C-terminal region of HMW1 
was additionally found to interact with the C-terminal region of P1. This finding supported 
previous reports about interaction of these two proteins (more detail in “MPN141”). 
 
MPN297 (conserved hypothetical) 
The gene product of MPN297 (H10_orf149) appeared to be a promising new protein 
candidate for the functional group of proposed structural proteins, not only because it is 
interacting with HMW2, but also because it was found in the Triton X-100 insoluble 
fraction [Regula et al., 2001] and has a predicted coiled-coil structures (Fig. 7.4, appendix). 
Protein fragments of the gene product of MPN297 were found as positive clones by 
screening HMW2 fragment 3 (bait) against the random fragments of M. pneumoniae 
genomic DNA (pray) in the two-hybrid pilot experiment.  
In the pairwise test, using the entire protein, the interaction with HMW2 was confirmed. 
Interstingly, this protein was observed to interact with another important protein, the C-
terminal region of the adhesin P1. Furthermore, it was shown to form homopolymers. This 
was also observed in Western blot analyses. Three different forms of the proposed 17-kDa 
protein of MPN297 were found in total protein extracts of M. pneumoniae WT, monomers, 
trimers and higher, not exactly defined multimeric forms. 
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MPN141 (Adhesin P1; ORF5, P1 operon) 
The adhesin P1 of M. pneumoniae, a transmembrane protein with a molecular mass of 170 
kDa, as well as the adhesin-related 30 kDa protein and the two cytadherence-associated 
proteins of 40 and 90 kDa cluster densely in the membrane of the attachment organelle 
[Dallo et al., 1990; Feldner et al., 1982; Franzoso et al., 1993; Layh-Schmitt and 
Herrmann, 1992, 1994]. P40, P9 and and the P1 molecules are retained in the Triton-X-
100-insoluble fraction of thM. pneumoniae cells [Regula et al., 2001]. The participation of 
the P1 adhesin in gliding of M. pneumoniae was examined by Seto and coworker. They 
reported that anti-P1 antibodies reduced the gliding speed and removed the gliding cells 
from the glass over time in a concentration-dependent manner but had only a slight effect 
on nongliding cells, the authors concluded that the conformational changes of P1 adhesin 
and its displacement were involved in the gliding mechanism [Seto et al., 2005]. 
Although the influence of binding of the anti-P1 antibodies on other proteins for sterical 
reason was not considered. Layh-Schmitt and coworkers analyzed interactions of the P1 
adhesin with other membrane proteins or with cytoskeleton-like proteins by cross-linking 
studies using the membrane permeable reagent paraformaldehyde. The cross-linked protein 
complex was isolated by immunoaffinity chromatography, and proteins complexed to the 
P1 protein were identified by immunoblot analysis and by mass spectrometry [Layh-
Schmitt et al., 2000]. In addition to the P1 protein and a truncated form of the same protein, 
P30, P40, P90, P65, HMW1, HMW3, DnaK and E1a subunit of pyruvate dehydrogenase 
were found to be components of the isolated protein complex or complexes.  
The interaction between P1 and HMW1 was confirmed by the pairwise tests in this work. 
The regions of P1 and HMW1 required for the physical interaction were determined. It was 
shown that the C-terminal part of  both proteins interacted with each other. Furthermore, 
additional direct interactions
 
of P1 with other proteins was detected by the pairwise test: 
the weakly/ transient interaction of P1 with the gene product of MPN297, which
 
might not 
be detectable by other physical methods such
 
as co-immunoprecipitation. 
No direct interaction between HMW2 and P1 was observed in either the cross-linking 
experiments [Layh-Schmitt et al., 2000] or in two-hybrid experiments in this work. 
However, P1 was shown to interact with the same proteins which also interact with 
HMW2, indicating a indirect links between those two proteins. 
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HMW2 fragment 4 
A speculative model for the structural role of HMW2 in the formation of the 
M. pneumoniae attachment organelle has been published [Balish et al., 2003]. This model 
described the possible role of HMW2-s together with HMW2 in the arrangement of the 
electron-dense core. It was suggested that HMW2 and HMW2-s might be arranged in 
parallel fashion. Monomeric HMW2 may cross over to interact with other monomers, 
resulting in a network. If dimer and trimer formations were important in specifying the 
degree of network interactions among HMW2 monomers, then HMW2-s might limit the 
cross-linking within the HMW2 network [Balish et al., 2003]. 
Physical associations of HMW2-s and part of HMW2 were determined by two-hybrid 
pairwise tests. Instead of the complete HMW2, the HMW2-4 fragment (amino acid position 
1413-1818) was used in the pairwise test which included also HMW2-s (amino acid 
position 1617 – 1818). It was shown that the HMW2 fragment 4 could interact with itself, 
but not with the HMW2 fragment 3 indicating a specific defined binding region within this 
coiled-coil rich protein (HMW2 fragment 4). Concerning the proposed model, HMW2-s 
might specifically binds to the C-terminal region of HMW2 or even bind themselves, 
although no dimeric or multimeric forms of HMW2-s were found in Western blot analyses. 
 
False positive results and disadvantages of the two-hybrid system 
Although the two-hybrid system is presently one of the most powerful methods for 
detecting protein-protein interaction, this system still has several disadvantages. Based on 
the observation that most characterized proteins interact with 5–7 other proteins [Ito et al., 
2000], about 30,000–40,000 interactions were estimated to take place in yeast [Snyder and 
Kumar, 2002]. These numbers are significantly higher than the 4500 interaction identified 
thus far. This is likely due to the fact that most of the studies done thus far have been 
carried out in pools of yeast transformants and therefor failed to detect all possible 
individual interactions [Zhu et al., 2003]. Therefore, the screens are not saturated and 
direct pairwise tests of all possible individual interactions have to be done. A second 
disadvantage of the two-hybrid system is that it identifies a large number of false positives, 
presumably by spurious interactions between proteins that do not normally occur in vivo 
[von Mering et al., 2002]. Approximately 50% of the interactions are estimated to be false 
positives [Zhu et al., 2003]. A third drawback of the conventional two-hybrid analysis is 
that the interaction occurs in the nucleus and uses a transcriptional readout. Consequently, 
the interaction of many membrane proteins and transcription factors cannot be measured. 
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The results of the pairwise tests in this work also showed that 50% of the interactions found in 
the two-hybrid screenings (pilot experiment) were false positives. The interactions of HMW2 
fragment 3 with the C-terminal region HMW1 and with the gene product of MPN297 were 
confirmed, but the interactions of HMW2 with P115 and the gene product of MPN298 could 
not, and therefor they might be false postive results from the screening experiments.  
However, P115 was found as a component of protein complexes isolated by means of the 
TAP-tagged HMW2. This disagrees with the negative result in the pairwise test, but 
supports the results of the two-hybrid screen pilot experiment. In these experiments, the 
initial interaction between P115 and HMW2-3 was found with a peptide fragment 
containing 173 aa of P115, but in this pairwise test the full-length P115 containg 983 aa 
was tested (Fig. 7.6, Appendices). This could lead to a negative result in this test, since 
large protein fragment should be avoided by two-hybrid experiment [Dr. Koegl, personal 
communication]. The two-hybrid system might not be able to accommodate such large 
fragement and the protein probably could not fold properly in yeast due to its large size. 
This could be one of the limitations in the two-hybrid system. 
Limitation in developing a two-hybrid test for M. pneumoniae is the inability to express all 
proteins of M. pneumoniae in heterologous expression systems due to the unusual codon 
usage of the UGA codon. Although in S. cerevisae and other organisms this is a stop codon, 
in M. pneumoniae it codes for tryptophan. In the two-hybrid screening test, random, about 
1200 bp long genomic DNA fragments of M. pneumoniae were prepared by sonifying the 
genomic DNA and then cloning individual fragments into the pray vector. That means, a 
fraction of the cloned M. pneumoniae fragments contains one or more UGA codons causing 
a premature translational stop of a potentially interacting peptide and will not be detected. 
The introduction of a UGA suppressor tRNA in the yeast strains could help, but this might 
create problems for the host, since the UGA (Trp) codon does not function as a terminal 
codon in all instances and promote readthrough and synthesis of elongated proteins. 
 
Autoactivation 
It must always be tested whether the fusion protein can initiate the transcription of the reporter 
gene by itself. If such a case happens, all other tests would be meaningless. It could be that 
such a protein is a transcription activator by itself. It has benn also described that short acidic 
domains are responsible for undesirable, nonspecific activation. Many proteins that 
autonomously activate reporter genes in the two-hybrid system have been found to contain 
such acidic domains. In fact, acidic residues are thought to be associated with activating 
regions of transcription factors [Ma and Ptashne, 1987; Ruden, 1992; Ruden et al., 1991]. 
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Several examples for autoactivation were found in my studies, for instance, the C-terminal region 
of HMW1, which was strongly autoactive as bait construct and weakly autoactive as pray. 
Therefore, the pairwise test could be done only with the pray construct of the HMW1 C-terminal 
region. In addition, HMW2 and the gene product of MPN297, both in bait construct, were also 
weakly autoactive, while the P1 in the pray construct was found to be strongly autoactive. 
Protein profiles indicate that the C-terminal region of HMW1 contains both coiled-coil 
domains and acidic domains (negatively charge region) (Fig. 7.3, appendix), both features 
increase the possibility for autoactivation of this part of HMW1. HMW2 fragment 3 does not 
contain significant acidic regions but there are extended coiled-coil domains present in the 
entire fragment (Fig. 7.2), being a possible reason for its weak autoactivity observed in the 
bait construct of this fragment. Although the gene product of MPN297 contains both coiled-
coil and acidic domains (Fig. 7.4), it showed only a weak autoactivation when it baits 
construct was used. This might be due to its small size (149 aa), compared to the larger C-
terminal region of HMW1 (399 aa) since insertions of large DNA fragments in two-hybird 
vectors could increase the possibility of autoactivation [Dr. Koegl, personal communication]. 
Autoactivation mostly occurred when proteins were used as bait [Dr. Koegl, personal 
communication]. However, the strong autoactivation in the pray construct observed for the 
C-terminal region of P1 might be caused by its acidic stretches within this fragment.  
It is still unclear why a certain protein is autoactive in one construct but not in the another 
one. It should be noted, however, that not all acidic proteins have transcriptional activation 
function. According to observations from the pairwise tests, proteins containing acidic 
domain showed stronger autoactivity than those without such domains.  
A spontaneous, nonspecific activation is often not very strong and therefor the possibility 
to get falsh-positive results can be reduced by strengthening the test conditions for the 
HIS3 reporter gene. 3-Amino-1,2,4-Triazole (3AT), a competitive inhibitor of the HIS3 
gene product should help to reduce the activity of the HIS3 gene and eliminate weak 
positive signals. This application is useful in library screenings to reduce the number of 
false-postive clones. But 3AT is a toxic substance, which could inhibit cell growth at 
concentrations above 30 mM, so that in case of a very strong autoactivation, additional 
selection markers should be applied. The use of two different reporter genes under the 
control of significantly different promoters automatically eliminates many false positive. In 
the case of a very strong autoactivation of the transcription of the reporter gene, suitable 
methods to use that protein in the two-hybrid experiment are not available. It would be 
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conceivable to remove the autoactivating domains from the protein by introducing 
deletions within the gene until no autoactivating function is left. However, one has to 
consider that such deletions could also eliminate the potentially interacting domains. If all 
these manipulations do not work, the choice of another test system with other binding and 
activator domains might solve the problem. 
In the pairwise tests, I applied both, HIS3 and ADE2 reporter genes for identifying protein-
protein interactions. The GAL7 promoter of the lacZ gene appears to be activated in 
response to treatments commonly used for cell permeabilization, such as flash freezing. 
This causes background beta galactosidase activity that makes the use of filter assays 
unfeasible. However this is not a serious problem, since two simple and effective plate 
assays already exist using the GAL2-ADE2 and GALl-HIS3 reporters. The GAL2-ADE2 
reporter in this yeast strain was so efficient that at the end of proper pairwise testings, only 
true positive genes/ proteins are left. [James et al., 1996]. 
 
5.5 Components of the fraction from TAP-tag purification 
The identified proteins (table 4.7) were retrieved by purification of the TAP-tagged 
HMW2. This indicated that those proteins could potentially interact with the HMW2 
protein. The newly identified protein provide additional informations about the 
involvement of HMW2 in the organisation of cellular structures in M. pneumoniae.  
HMW1 and the gene product of MPN297, which were found to interact with HMW2 in two-
hybrid system, could be detected in the enriched protein complexes by Western blotting. This 
data supports their direct interaction with HMW2. Furthermore, P115 was also presented in 
this components, confirming its interaction with HMW2 derived from the initial two-hybrid 
screen pilot experiment. P1 and P90 were also found in very small amount in this components. 
 
MPN426 (P115)  
P115 is a member of the SMC (Structural maintenance of chromosomes) ubiquitous protein 
superfamily, members of which are present in almost all organisms so far analysed except 
for a few bacteria [Koshland and Strunnikov, 1996; Melby et al., 1998]. They function in 
vivo in chromosome condensation, chromosome segregation and DNA recombination repair 
in eukaryotes, and are able to introduce positive writhe into DNA in vitro [Graumann, 2001; 
Hirano 1999; Holmes and Cozzarelli, 2000; Strunnikov and Jessberger, 1999]. 
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SMC proteins and the structurally homologous MukB protein are unusual ATPases that 
form antiparallel dimers, with long coiled-coil segments separating globular ends capable of 
binding DNA [Graumann, 2001; Harvey et al., 2002; Koshland and Strunnikov, 1996; 
Melby et al., 1998]. Recently, SMC proteins have been shown to be essential for 
chromosome condensation, segregation and cell cycle progression in bacteria [Britton et al., 
1998; Graumann, 2000; Graumann, 2001; Jensen and Shapiro, 1999; Moriya et al., 1998]. 
In M. pneumoniae, P115 belongs to the same structural family with HMW2. It has the 
Leucine-Zipper motive and coiled-coil domains. Interestingly, it turned out by searching 
HMW2 for conserved domains (NCBI) [Marchler-Bauer and Bryant, 2004],that HMW2 
also has conserved domains for SMC proteins (Fig. 7.2, appendices). Both fragment 
(HMW2 fragment 3 and P115 fragment identified from two-hybrid screen) contains 
ATPase domains. P115 proteins are also found in other mycoplasmas [Alexander, 1987;  
Notarnicola et al., 1991]. 
 
MPN015 (conserved hypothetical) 
A non-redundant amino acid sequence database (National Center for Biotechnology 
Information, NIH) was searched for similarity of MPN015 to related proteins using the 
BLAST program [Altschul et al., 1990]. The output of the BLAST search showed both a 
similarity of the amino acid sequence and conserved domain (NCBI Conserved Domain 
Search; [Marchler-Bauer and Bryant, 2004]) of MPN015 to RimK, an RNA-binding 
protein [Koonin et al., 1994]. RimK is an enzyme that catalyzes in E. coil the addition of 
glutamic acid residues to the N-terminus of the ribosomal protein S6 [Kang et al., 1989]. 
The members of a protein family including RimK from E.coli are defined as ATP-
dependent carboxylate-amine ligase activity, where acylphosphate intermediates are 
involved in the catalytic mechanism [Galperin and Koonin 1997]. Nothing is known about 
functional interaction of MPN 015 with HMW2 so far, future experiments like 
construction of mutants in MPN015 and their characterization have to be done. 
 
MPN160 (conserved hypothetical; MG147 homolog) 
No putative conserved domains were detected by the BLAST search of the amino acid 
sequence of MPN160. The gene product of MPN160 shows significant homology to 
MG147 of M. genitalium and poor similarity to Mfl543 of Mesoplasma florum. To further 
characterize this protein, additional experiments have to be done. 
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MPN392 (Pyruvate dehydrogenase E1-beta subunit; PdhB) 
Proteome maps of total protein extracts of M. pneumoniae showed that, PdhB gave a very 
strong protein signal [Ueberle et al., 2002]. It is also one of the main components of the 
Triton X-100 insoluble fraction [Regula et al., 2001]. In addition to its function as a 
pyruvate dehydrogenase, it was found as a surface exposed protein and acting as a 
fibronectin binding protein implying that PdhB has two completly different functions 
[Dallo et al., 2002]. In B. subtilis, PdhB was reported to effect the late stages of engulfment 
(or membrane fusion) during the sporulation [Gao et al., 2002]. 
The presence of HMW2 and PdhB, both in the Triton X-100 insoluble fraction and in the 
purified protein complex, provided evidence that PdhB might be one of the interacting 
partners of HMW2. To finally confirm this result, the physical interaction between HMW2 
and PdhB has to be demonstrated by a second independent method (e.g. two-hybrid). 
 
MPN430 (Glycerladehyde-3-phosphate dehydrogenase; Gap; GAPDH) 
Glyceraldehyde-3-phosphate dehydrogenase is a key component of the glycolytic pathway. It 
is a tetrameric NAD-binding enzyme involved in glycolysis and glyconeogenesis. An 
interesting additional function of this protein is its ability of M. genitalium to bind human 
vaginal/cervical (V/C) mucin [Alvarez et al., 2003]. Antiserum raised against recombinant 
GAPDH blocked binding of intact biosynthetically labelled mycoplasmas to mucin to 
approximately 70% [Alvarez et al., 2003]. Whole cell radioimmunoprecipitation indicated 
that GAPDH was surface-accessible and surface localization of GAPDH was further verified 
by membrane fractionation and immunoelectron microscopy [Alvarez et al., 2003]. Their 
results indicated that 10% of total GAPDH is membrane localized [Alvarez et al., 2003]. 
The non-metabolic function of GAPDH (i.e. mucin binding) in M. genitalium is 
biologically appealing and not only provides insights into the organism’s mechanisms of 
adherence and colonization but is also relevant to the genetic limitations and versatility of 
this microorganism. Impressively, the association of a certain percentage of GAPDH to the 
M. genitalium membrane surface confers a completely unrelated and unpredictable 
property. The important role of GAPDH from other organisms in targeted host cell 
parasitism has also been reported. 
Pancholi and Fischetti [Pancholi and Fischetti,1992] described a surface located 
dehydrogenase (SDH) present in Group A streptococci with the ability to bind fibronectin, 
lysozyme, as well as the cytoskeletal proteins myosin and actin. SDH did not bind to the 
streptococcal M protein, tropomyosin, or the coiled-coil domain of myosin. This SDH was 
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later identified as GAPDH, and was found to be expressed on the surface of GBS (serotype III 
group B streptococci)  [Seifert et al., 2003]. A similar phenomenon was reported in Candida 
albicans in which a phosphorylated form of GAPDH was surface located and possessed 
fibronectin binding ability [Gozalbo et al., 1998]. In eukaryotic cells, GAPDH is known to be 
associated with cytoskeletal structures and it binds specifically to both tubulins and colchicine 
[Gupta and Soltys, 1996]. In muscle cells, GAPDH-containing protein complex was suggested 
to be involved in reinforcement of established cytoskeletal structures [McDonald et al., 1998]. 
 
MPN573 (heat shock protein; GroEL)  
Among all the protein spots indentified from the 2-D gel electrophoresis analyses of the 
total protein extract of M. pneumoniae, GroEL represented the fourth largest protein spot 
(6.5 % of the total spot volume) [Ueberle, 2001] indicating that it is one of the most 
abundant proteins in M. pneumoniae.  
GroEL belongs to TCP-1/cpn60 chaperonin family. This family includes members from the 
HSP60 chaperone family and the TCP-1 (T-complex protein) family. Chaperonins are key 
components of the cell machinery and are involved in the productive folding of proteins. 
Chaperonins have been classified into two groups according to their sequence homologies: 
type I, whose better known member is GroEL, and type II comprising the eukaryotic 
cytosolic chaperonin (CCT) and the archaebacterial thermosome, among others [Carrascosa 
et al., 2001]. Two mechanisms have thus far been characterized for the assistance by 
chaperonins of the folding of other proteins. The first and best described is that of the 
prokaryotic chaperonin GroEL, which interacts with a large spectrum of proteins. A second 
mechanism has been described for the CCT, which interacts mainly with the cytoskeletal 
proteins actin and tubulin [Llorca et al., 2001]. Furthermore, GroEL requires a cofactor 
(GroES) that is not present in the type II chaperonins [Carrascosa et al., 2001].  
Although M. pneumoniae has a cytoskeleton-like structure, it lacks sequence homolog to the 
CCT. Due to the reduced genome size of M. pneumoniae, GroEL might also take function 
like CCT and, playing a role as a universal chaperonin, interacting with ‘cytoskeletal proteins’ 
e.g. HMW2 of M. pneumoniae. The presence of GroEL in the purified protein complex of 
TAP-tagged HMW2 indicated the interaction of GroEL with HMW2. This finding supports 
the suggestion about possible additional function of GroEL as discussed above. 
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MPN665 (EF-Tu) 
The elongations factor Tu (EF-Tu) is the second most prominent protein of the complete 
soluble protein extract of M. pneumoniae and of the Triton X-100 insoluble fraction [Regula et 
al., 2001]. EF-Tu binds an aminoacyl-tRNA (GTP-dependently) and inserts this at the correct 
anticodon-position into the nascent polypeptide chain. Hydrolysis of GTP to GDP changes the 
conformation of EF-Tu and releases the connection with the tRNA [Nyborg and Kjeldgaard, 
1996]. EF-Tu is then present  freely diffusable as a monomer protein in the cytosol. 
Beside the well characterized feature of EF-Tu in the protein synthesis [Nyborg and 
Kjeldgaard, 1996; Yogev et al., 1990], structural characteristics of this protein were 
reported by Beck and coworkers. Purified EF-Tu polymerized in vitro to filaments and 
filamental bundles and binds DNase I in presence of KCl and MgCl2 [Beck et al., 1978]. 
By applying a protocol for the isolation of actin, Neimark characterized a protein isolated 
from Mycoplasma pneumoniae [Neimark, 1977]. This protein had the same solubility as 
actin, a molecular mass of 45 kDa in the SDS-PAA gel, ATP- and Mg
2+
-dependent 
filament formation, binding affinity to the heavy Meromyosin (specific cleavage product of 
myosin) and represents approximately 6% of the total protein by Coomassie Blue staining 
[Neimark, 1977].  This protein was first claimed to be a bacterial actin, but it turned out 
later that it was indeed EF-Tu. Similar characteristics were also described for EF-Tu of E.  
coli [Beck, 1978]. EF-Tu does not have any significant sequence similarity with actin. A 
gene with a sequence similarity to actin was not found in the annotation of the complete 
genome sequence of M. pneumoniae [Himmelreich et al., 1996; Dandekar et al., 2000]. 
Recently, a new aspect arose concerning the function of EF-Tu, since EF-Tu, together with 
PdhB, was found on the surface of  Mycoplasma pneumoniae and showed binding affinity 
to fibronectin [Dallo et al., 2002]. 
By the isolation of protein complexes containing TAP-tagged HMW2, EF-Tu was found as a 
component indicating an (directly or indirectly) interaction between EF-Tu and HMW2. 
Considering the ‘triple’ functions of EF-Tu, one could speculate that HMW2 might somehow 
effect the host-pathogen interaction by it possible involvement in organizing the protein 
complex binding to fibronectin. The possibility also exists that EF-Tu forms cytoskeletal 
structures in cooperation with HMW2 or modulates the features of the cytoskeletal elements 
in M. pneumoniae, indepentdent of its function in translation. Whether the interaction 
between EF-Tu and HMW2 also plays a role in protein synthesis is still an open question. 
Mutants having an inactive hmw2 gene could be used to test whether an interaction between 
HMW2 and EF-Tu is the prerequisit for binding of M. pneumoniae to fibronectin. 
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Proteins of the P1 operon: MPN140 (ORF4 gene product), MPN142 (P90) 
Interestingly, proteins from the P1 operon [Inamine et al., 1988] were found in the purified 
protein complex of TAP-tagged HMW2. The 28 kDa encoded gene product of the ORF4 
gene has still not been experimentally well characterized. Hence, the presence of this 
protein as a component of protein complex with the TAP-tagged HMW2 indicated that, in 
addition to P1 (from two-hybrid experiment), the gene product of ORF4 also link the 
cytadherence to cytoskeletal proteins in M. pneumoniae. 
By the BLAST search [Dandekar et al., 2000; http://www.bork.embl-heidelberg.de/ Annot/ 
cgi/annot1.pl?min=014&max=014&toggle=0] MPN140 was shown to have sequence 
similarity to a novel family of predicted phosphoesterases (DHH family) including the 
Prune protein from Drosophila melanogaster and the bacterial RecJ exonuclease [Aravind 
and Koonin, 1998]. It was suggested that the gene product of ORF4, as a phosphoesterase, 
should functinally aid the attachment process by modification of selected proteins.  
Recently it has been shown that the protein P40 and P90, cleavage products derived from the 
ORF6 gene (MPN142) of the P1 operon [Inamine et al., 1988; Sperker et al., 1991] are essential 
for the the correct integration of the adhesin protein P1 in the terminal organelle [Catrein et al., 
2004; Waldo et al., 2005]. By cross-linking experiment, they were linked to other two proteins, 
P1 and P30, in the intact bacterial membrane indicating that these proteins are located as a 
complex in the tip structure of M. pneumoniae [Layh-Schmitt and Herrmann, 1994].  
 
Summary of the co-purified proteins with TAP-tagged HMW2. 
Presently, it can not be decided how the HMW2-containg proteins complexes look like. It 
is fair to assume that several different complexes were isolated and that the co-purified 
proteins do not have to bind directly with HMW2. Some may bind indirectly by a shared 
linking proteins. Other proteins, specially those which are very abundant, could be just 
contaminations. The protein complex containing HMW2 TAP-tagged was very insoluble 
and therefor appeared in the purified fraction only in very small amount that it could be 
detected by Western blotting using sensitive fluorescence like ECF method. To prove these 
preliminary results, isolation of protein complexes has to be repeated, now with those 
proteins tagged which were found in the HMW2 protein complexes. 
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The main problem is the low solubility of HMW2 and probably of all HMW2 containing 
complexes under native conditions. This does prevent the isolation of complexes in 
amounts sufficient to do extended protein biochemistry. Nevertheless, due to the increased 
sensitivity of the analytical methods e.g. mass spectrometry, even with small amounts od 
protein complex(es). The identification of their components can be done. 
In addition, other independent methods should be applied to confirm specially the ‘unsual 
interactions’. That are those with proteins-enzyme which were known to have functions in 
metabolic pathways. There are at least two alternative interpretations of these results: The 
enzymes have also a function as structural components and they interact for this reason 
with HMW2 or, HMW2-independent of its role in formation of cytoskeleton-like structures 
might be also involved in organizing those proteins into complexes which participate in the 
same metabolic pathway. 
 
5.6 Localization of HMW2 in M. pneumoniae 
The localization of HMW2 at the tip structure was proposed based on experiments with a 
fusion protein between HMW2 and GFP [Balish et al., 2003]. However, co-localization of 
the fluorescence signal and tip structure is not a convincing proof that HMW2 is the 
structural component of the rod, since additional structures have been observed in the tip 
organelle [Hegermann et al., 2002] and the resolution of fluorescence microscopy is by far 
to low to assign a fluorescene signal to one of the structures seen in thin sections with an 
electron microscope. 
A more precise sublocalization of HMW2 was succesful with the new anti-HMW2 
antiserum (Fig. 4.57). The immuno-gold labelling of ultrathin cryosections of M. pneumoniae 
with a new anti-HMW2 antiserum showed signals in the proximal region of the rod. This 
indicated that HMW2 is not exposed on the surface and is also not a part of the peripheral 
cytoskeleton [Hegermann, 2003]. The positive reaction near the proximal region of the rod 
suggests a participation of HMW2 in the structure of the proximal end of the rod or a 
participation in the formation of the attached circular structure.  
Balish and coworker suggesteda model of the rod, in which HMW2 molecules, as main 
component of the rod, are arranged in parallel filaments [Balish et al., 2003]. Therefore, the rod 
is flexible and connected laterally with the cytosol oriented part of cell membran by linker. An 
organization of the rod mediated by parallel HMW2 dimers was proposed [Balish et al., 2003]. 
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HMW1 - as a linker connected with the rod  
It was previously shown that HMW2 stabilizes HMW1 [Balish et al., 2001]. The 
stabilization probably occures at the C-terminal region of HMW1 [Willby et al., 2004]. 
This region was also found to interact with HMW2 fragment 3 in the two-hybrid 
experiments. Furthermore, the two-hybrid pairwise tests also confirmed the interactions 
between the C-terminal region of HMW1 and the adhesin P1. The interaction between P1 
and HMW1 was also revealed by cross-linking experiments [Layh-Schmitt et al., 2000]. 
Electron microscopic studies of cells carefully pretreated with Triton X-100 showed that 
P1 is localized at the tip of either cells with cytoplama membrane, or cells, from which the 
cytoplasma membrane was at least partially removed [Hegermann, 2003]. This protein 
seems to be inserted deeper in the membrane, possibly connected neighbouring with the 
peripheral cytoskelett. This is not unexpected, since specific computer programme predicts 
up to five transmembrane segments for P1. This would generate cytoplasmic-oriented P1 
regions located between amino acids 1-14, 504-532 and 1124-1526. The last region was 
included in the P1 fragment used in the pairwise test (amino acid position 1156-1525), 
which interacted with HMW1. 
By immune gold labelling, HMW1 could be located at the rod [Hegermann, 2003]. Based on 
these data, HMW1 was suggested to link between the rod and the peripheral cytoskelett 
[Hegermann, 2003]. The model of the cytoskeleton-like structure of M. pneumoniae described 
by Hegerman and other (Fig. 1.3), are based on the assumption that the rod consists of HMW2 
and HMW1 functions as linker between the rod and the membrane [Hegermann et al., 2002]. 
 
Connection of P1-HMW1-HMW2 
The interaction of HMW1 with the adhesin P1 has been shown previously by cross-linking 
experiments [Layh-Schmitt et al., 2000]. The suggested subcellular location of HMW1 as a 
connected ‘spoke’ linking with P1 is in agreement with the location of the P1 adhesion 
complex and its proposed integration into the membrane. The result of the two-hybrid 
pairwise tests suggest that the C-terminal region of HMW1 interact physically with both 
P1 and HMW2 fragment 3. These observations contradict the suggested model of the 
sublocation of HMW2 and HMW1. 
It is still unclear is how could the C-terminal region of HMW1 interact simultaneously with 
P1 and HMW2, if HMW2 represented the ‘rod’ structure? If HMW2 indeed forms the long 
filament bundle in the middle of the ‘tip’ as observed in the electron microscope, how could 
the same region of HMW1 be connected to two proteins, which are probably not located in a 
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close distance, namely in the membrane and in the middle of the cell? One possible 
explanation is that HMW1 might form a head-to-tail structure, so that N- and C-termnial part 
of HMW1 are presented at both ends of the ‘spoke’ (Fig. 5.4). Based on the results from the 
two-hybrid analysis, the C-terminal region of HMW1 interacted only with the HMW2 
fragment 3 and not with the HMW2 fragment 4, which suggests a certain binding specificity. 
If the ‘spoke’ are assembled from HMW1, which was observed to be distributed along the 
lateral site of the ‘rod’, then it is difficult to concieve a filamentous structure of HMW2.  
Several models have been described trying to combine the results from different 
experimental approaches in a logical way. The main questions concern the protein 
composition of the rod structure in the attachment organelle. The main candidate for the 
structural component of the rod is presently HMW2. The structure could be assembled 
from HMW2 by forming fibers either head-head or head-to-tail, but there is still no 
convincing experimental evidence for this models. 
 
5.6.3 Suggestions for localizing of HMW2 in M. pneumoniae and model of the possible 
organization of P1, HMW1 and HMW2  
The protein A tag has been used in immunoelectron microscopy to localize various 
proteins fused with this tag [Rout et al., 2000]. In those experiments, affinity-purified 
rabbit IgG was used as primary and gold-labeled anti-rabbit IgG as secondary antibodies. 
Since localization of  HMW2 with various antisera against different parts of HMW2 did 
not give a satisfying results, it seemed promissing to localize HMW2 indirectly by 
labelling the protein A domain of the TAP-tagged HMW2 with IgG. This would introduce 
an extended structure which is not coil-coiled like almost the entire HMW2. This new 
structure would improve the specific binding of IgG to this structure, and the possible 
false-positive results from the relative unspecific in vivo binding to of antibodies to coiled-
coil structures would be eliminated. 
To further define the physical interacting region of HMW1 and HMW2, the two-hybrid 
system provides a possibility for such investigation. Taking its advantage that domains of 
the interested protein can be individually tested. In the case of the two-hybrid pilot 
experiment, HMW2 fragemet 1 and 2, corresponding the N-terminal half of HMW2, 
showed autoactivation and could not be used in the screening experiments. This problem 
might be overcome by splitting each of both fragments into two smaller fragments, the 
smaller fragments might not be autoactive anymore and could be tested for their interaction 
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with the likewise splitted small domains of HMW1. This could provide us more details 
about all possible interacting region of those proteins, which could be useful to better 
describe or define the protein-localization and models of the cytoskeleton-like structure in 
M. pneumoniae. 
 
 
  
A B 
 
Fig. 5.4: A) Schematic illustration of the proposed model of the organization of cytoskeletal-like 
structure in M.pneumoniae [Hegermann et al., 2002]. 
  B) Schematic illustration suggesting the possible organization of P1, HMW1 and HMW2 based 
on interactions known from literatures and this study. 
 
    = HMW2;  = HMW2 fragment 3;  = HMW1;  = P1 
 
 
5.7 Conclusions and perspectives 
The mycoplasma cell might serve as a prokaryotic model organism for studying protein-
protein interactions as well as structure-function relationships because its complete genome 
sequence is known, the number of genes and proteins (approx. 700) is relatively low, and 
its architecture (lack of cell wall) is simple. 
With the aim to contribute to the understanding of the formation of cytoskeleton-like 
structures in Mycoplasma  pneumoniae, the following experimental approaches to identify 
proteins interacting with HMW2 were taken: comparative Western blot analysis, 
comparative 2-D gel electrophoresis, two-hybrid pairwise tests and purifying of protein 
complexes containing TAP tagged HMW2. The most straightforward approach is the 
isolation of protein complexes, but this approach os hampered if the complex is not or 
poorly soluble. Important identified proteins interacting with HMW2 from all experimental 
approaches are summary in Fig. 5.5. 
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Fig. 5.5: Schematic illustration showing all identified proteins which are, based on experimental 
evidences, suggested to potentially interact directly or indirectly with HMW2. 
  = Triton X-100 insoluble fraction [Regula et al., 2001]. 
  = result from 2-D gel analysis  
         = results from TAP tag purification  
         = results from TAP tag +Triton X-100 insoluble fraction 
         = results from the preliminary two-hybrid screen [Boonmee, unpublished] + TAP tag 
         = results from two-hybrid pairwise tests + TAP tag +Triton X-100 insoluble fraction  
         =  results from TAP tag purification + Triton X-100 insoluble fraction. 
      * = results from comparative Western blot analyses. # = proteins from P1 operon [Inamine et 
al., 1988; Sperker et al., 1991] 
 
The data presented here provide insights into the interactions 1) between the membrane 
and cytoskeletal proteins, 2) among cytoskeletal proteins and 3) between other cellular 
proteins in the cell and cytoskeletal proteins, of M. pneumoniae. 
For a better understanding of the assembly of the attachment organelle of M. pneumoniae, 
further studies are needed to define: 1) assignment of specific proteins to observed 
structures, 2) the domains of individual proteins essential for the mycoplasma protein-
protein interactions, 3) cellular process concerning mechanisms of the assembly of 
cytoskeletal structures, 4) regulations of their dynamic functions and 5) their possible 
functions in the cell. 
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7 Appendices 
7.1 Figures 
 
Fig. 7.1: DNA sequence of the gene hmw2. Rare codons coding for different amino acids are 
indicated with color: arginine (AGG, AGA, CGA, CGG), leucine (CTA), isoleucine (ATA), proline 
(CCC) and glycin (GGA). Truncated parts of hmw2 which were shown to be well-expressed in 
E.coli are marked with gray 
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Fig. 7.2: Total profile of the protein HMW2 (MPN310). The colored regions indicate protein 
fragments used in the two-hybrid pairwise tests (yellow = HMW2 fragment 3, green = HMW2 
fragment 4). Number above the profile gives amino acid positions. 
 
 
 
Fig. 7.3: Total profile of the protein HMW1 (MPN447). The yellow region indicates protein fragments 
used in the two-hybrid pairwise tests. Number above the profile gives amino acid positions. 
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Fig. 7.4: Total profile of the protein encoded from MPN297. The entired protein sequence was used 
in the two-hybrid pairwise tests. Number above the profile gives amino acid positions. 
 
 
 
Fig. 7.5: Total profile of the adhesin P1(MPN141). The yellow region are protein fragments used 
in the two-hybrid pairwise tests. Number above the profile gives amino acid positions. 
 
Appendices 
 
 188
 
 
Fig. 7.6: Total profile of the adhesin P115 (MPN426). The yellow region are protein fragments 
found from the two-hybrid screen pilot experiment. Number above the profile gives amino acid 
positions. The whole protein was used in the pairwise test. 
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7.2 Tables 
Table 7.1: The codon usage of E.coli and M. pneumoniae [Himmelreich, 1997; Zhang et 
al., 1991] compared with codon presented in hmw2 gene. 
Codon Amino acid Frequency in 
hmw2 gene 
/1000 
Frequency in  
E. coli /1000 
Frequency in  
M. pneumoniae 
/1000 
AAU Asn 18.2 17.6 25.0 
AAC Asn 42.4 21.7 36.9 
AAA Lys 59.4 33.6 46.3 
AAG Lys 62.7 10.2 39.1 
ACU Thr 6.1 8.9 19.3 
ACC Thr 6.1 23.4 21.9 
ACA Thr 11.6 7.0 10.4 
ACG Thr 8.3 14.4 7.9 
AGU Ser 13.8 8.7 21.0 
AGC Ser 11.0 16.0 10.6 
AGA Arg 1.7 2.1 4.0 
AGG Arg 2.8 1.2 2.8 
AUU Ile 29.7 30.4 46.1 
AUC Ile 6.6 25.0 14.4 
AUA Ile 9.4 4.3 5.4 
AUG Met 6.1 27.8 15.6 
CAU His 6.6 12.9 6.2 
CAC His 15.4 9.7 11.9 
CAA Gln 94.1 15.5 37.9 
CAG Gln 37.4 28.8 15.6 
CCU Pro 1.1 7.0 8.3 
CCC Pro 2.2 5.5 9.1 
CCA Pro 4.4 8.5 10.9 
CCG Pro 1.7 23.3 6.6 
CGU Arg 22.6 21.0 9.7 
CGC Arg 22.6 22.0 10.7 
CGA Arg 3.3 3.5 2.5 
CGG Arg 56.1 5.4 5.0 
CUU Leu 7.7 11.0 10.1 
CUC Leu 16.5 11.0 12.2 
CUA Leu 16.5 3.9 10.6 
CUG Leu 134.8 52.8 9.5 
GAU Asp 31.9 32.2 30.3 
GAC Asp 16.0 19.1 19.2 
GAA Glu 82.0 39.6 41.9 
GAG Glu 34.1 17.8 14.7 
GCU Ala 31.4 15.3 25.2 
GCC Ala 13.2 25.5 16.5 
GCA Ala 19.8 20.3 13.8 
GCG Ala 13.2 33.7 11.1 
GGU Gly 2.8 24.9 27.9 
GGC Gly 2.8 29.4 11.8 
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Table 7.1; (continued) 
Codon Amino acid Frequency in 
hmw2 gene 
/1000 
Frequency in  
E. coli /1000 
Frequency in  
M. pneumoniae 
/1000 
    GGA          Gly 0.6 7.9 6.4 
GGG Gly 8.3 11.0 8.9 
UAU Tyr 12.1 16.3 14.3 
UAC Tyr 8.8 12.3 17.9 
UAA STOP 0.6 2.0 2.1 
UAG STOP ? 0.2 0.8 
GUU Val 11.0 18.4 21.2 
GUC Val 5.0 15.2 11.0 
GUA Val 8.8 10.9 13.8 
GUG Val 6.1 26.2 11.8 
UCU Ser 6.1 8.5 8.2 
UCC Ser 5.5 8.6 9.6 
UCA Ser 6.6 7.1 8.7 
UCG Ser 2.8 8.9 6.4 
UGU Cys 1.1 5.2 5.4 
UGC Cys 0.6 6.4 2.1 
UGA STOP
1
/Try
2
 2.2
1
/ ? 2 0.9 6.0 
UGG Try 1
1
/ 2.8
2
 15.3 5.8 
UUU Phe 31.4 22.4 43.1 
UUC Phe 5.0 16.6 12.7 
UUA Leu 52.9 13.9 39.3 
UUG Leu 27.0 13.7 21.5 
1 =  number of the original codon; 2 = number of the codons after mutagenesis. Red = codon frequency more 
than in E.coli and M. p. Red bold = codon frequency with significant different to E. coli and M.p. 
 
Table 7.2: The 8 least used codons in E. coli [Zhang et al., 1991] and M. pneumoniae 
[Himmelreich, 1997]. 
E. coli M. pneumoniae amino acid 
AGA AGA arginine 
AGG AGG arginine 
AUA AUA isoleucine 
CUA  leucine 
CGA CGA arginine 
CGG CGG arginine 
CCC  proline 
UCG  serine 
  UGA tryptophan 
  UGC cysteine 
 UGG tryptophan 
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